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Abstract
Introduction
Laparoscopic colorectal surgery has recently gained widespread acceptance and has been 
endorsed by the National Institute of Clinical Excellence. However, it is still unclear whether 
the laparoscopic approach is cost effective when compared to open surgery, and whether there 
are benefits with this approach. This thesis aims to address both of these issues, evaluating the 
cost effectiveness of laparoscopic colorectal surgery, and investigating whether there are 
short-term benefits in terms of an improved quality of life for patients, and long-term benefits 
by reducing the formation of adhesions.
Patients and Methods
Two studies were performed at The Royal Surrey County Hospital. The first was a 
prospective cohort study evaluating the cost effectiveness of laparoscopic and open colorectal 
surgery. The resources used and the direct healthcare costs of the surgical procedures were 
calculated. The health related quality of life (HRQoL) was assessed using the SF-36 and EQ- 
5D instruments during the patients recovery from the operation over a 6 week period. The 
cost and QoL elements were used to perform a cost effectiveness analysis. The second study 
focused on adhesion formation following laparoscopic and open colorectal surgery, by 
evaluating their formation at a “second-look” operative procedure.
Results
200 consecutive patients were recruited to the cost effectiveness study, with HRQoL data 
available on 169 patients, and cost data on 200 patients. HRQoL was improved in those 
patients who had laparoscopic surgery (p<0.05). Operative costs were greater and the hospital 
costs less in the laparoscopic group (p<0.001). The overall costs were equivalent (£3847 v 
£4382, p=0.286). The economic analyses demonstrated that the laparoscopic approach is cost 
effective (QALY gain 0.014). 46 patients were recruited to the adhesion study; there were 
significantly fewer adhesions in patients who had previously had laparoscopic as opposed to 
open colorectal surgery (p<0.001).
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Conclusions
Laparoscopic colorectal surgery is likely to result in an improved quality of life for patients 
during their recovery, is cost neutral when compared to equivalent open surgery, and is 
probably cost effective. Laparoscopic colorectal surgery causes the formation of fewer 
adhesions than open surgery. The results of our study require verification within a randomised 
controlled trial.
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Chapter One: Introduction
The primary aim of this thesis is to investigate whether laparoscopic colorectal 
surgery is cost effective when compared to open colorectal surgery; secondary aims are to 
evaluate the quality of life of patients following laparoscopic and open colorectal surgery, and 
the incidence of adhesion formation following these types of surgery. In this introductory 
chapter, an overview of the key issues and research questions addressed are presented. The 
full literature review will follow in chapter 2.
Laparoscopic colonic resections were first described in 1991 (Jacobs et al., 1991). 
However, whilst other laparoscopic procedures such as laparoscopic cholecystectomy rapidly 
established themselves as the surgical treatment of choice, laparoscopic colorectal surgery has 
taken far longer to become established. The reasons for this include initial concerns regarding 
the safety of the surgery due to early reports of port-site metastasis, the cost of the 
laparoscopic equipment, and adequate training of surgeons (as these are particularly complex 
and challenging operations). For these reasons, laparoscopic colorectal surgery (LCS) is only 
employed in a minority of cases (Harinath et al., 2005, Sheldon et al., 2004, Schwab et al., 
2008).
The modem National Health Service (NHS) emphasises the importance of patient 
centred care and the vision of “a health service designed around the patient”. Techniques such 
as laparoscopic surgery that minimise the adverse effects of surgery on the patient by 
reducing post-operative pain and the stress response to surgery, faster return to full recovery, 
and improved cosmesis are increasingly being promoted. A group from St Mark’s Hospital 
state that “it is likely that the laparoscopic approach for colorectal procedures will 
increasingly gain acceptance. This will largely be driven by patient choice, as they demand 
improved cosmesis, a shorter hospital stay and early resumption of normal activity” 
(Buchanan et al., 2004).
The clinical efficacy of laparoscopic colorectal surgery for the management of
colorectal cancer has been confirmed in a number of high profile multicentre randomised
controlled trials (RCTs) (2004, Veldkamp et al., 2005, Guillou et al., 2005), meta-analyses
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(Abraham et al., 2004, Schwenk et al., 2005, Schwenk and Kehlet, 2004) and systematic 
reviews (Reza et al., 2006, Chapman et al., 2001), as well as numerous other trials and studies 
(Braga et al., 2002, Stage et al., 1997, Lacy et al., 2002). These findings have also been 
demonstrated in benign colorectal conditions such as abdominal rectopexy (Solomon et al., 
2002) and diverticular disease (Senagore et al., 2002, Purkayastha et al., 2006). These studies 
have confirmed at least equivalent clinical outcomes with the laparoscopic approach 
compared to open surgery, with the short-term benefits of reduced blood loss, post-operative 
pain, and a shorter hospital stay.
Consensus statements from the European Association of Endoscopic Surgery (EAES) 
and the American Society of Colon and Rectal Surgeons (ASCRS) have concluded that 
“laparoscopic resection for colon cancer is a safe and feasible procedure” (Veldkamp et al., 
2004), and results in “equivalent cancer survival to open colectomy” (2003). The National 
Institute for Clinical Excellence (NICE) guidance on laparoscopic surgery for colorectal 
cancer originally recommended that laparoscopic surgery should only be undertaken as part of 
a randomised controlled clinical trial (NICE, 2000); however this guidance has been recently 
reviewed, and laparoscopic resection is recommended as an alternative to open resection for 
individuals with colorectal cancer in whom both laparoscopic and open surgery are 
considered suitable (NICE, 2006).
Now that the clinical efficacy of laparoscopic colorectal surgery has been confirmed, 
studies are required to investigate whether there are benefits such as an improved quality of 
life, a reduction in complications (Buchanan et al., 2004), an earlier return to normal activity 
(Paraskeva et al., 2005), and whether the laparoscopic approach has “positive effects on 
quality of life issues, and is it cost effective?” (Paraskeva et al., 2005).
The introduction of laparoscopic techniques have cost implications, and funding 
bodies require evidence of the efficacy and cost-effectiveness of a new procedure or 
technique (Rawlins, 1999). Health resources are scarce, and the study of costs of different 
treatment options is of the “utmost importance” (Drummond and Jefferson, 1996, Morris S, 
2007).
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The development of a laparoscopic colorectal service in the United Kingdom has 
been limited by a number of factors. A 2004 questionnaire survey of the Association of 
Coloproctology of Great Britain and Ireland (ACPGBI) revealed that only 45 surgeons were 
performing laparoscopic colorectal work in Great Britain (Harinath et al., 2005). Factors 
identified to explain this slow uptake included the training of surgeons, a lack of material 
resources, time constraints, and administrative factors; a third of surgeons responding to this 
survey felt that they had insufficient resources to carry out laparoscopic colorectal work. A 
more recent survey undertaken from our unit also identified training and cost as the major 
factor limiting the development of laparoscopic colorectal surgery (Schwab et al., 2008).
In a review on the economics of surgery, Brazier states that the economic assessment 
of new surgical techniques will be increasingly important (Brazier and Johnson, 2001). She 
goes on to say that “this assessment should be based on well-conducted clinical trials in which 
interventions are provided in a routine service setting, and in which benefits are assessed 
among other things on the basis of the patient’s perceived quality of life”. An EAES 
consensus statement concludes however that “there are no prospective cost-effectiveness 
evaluations for laparoscopic colon resection” (Veldkamp et al., 2004).
NICE commissioned a cost effectiveness analysis of laparoscopic colorectal surgery 
which was used extensively for their technology appraisal (NICE, 2006). The health 
assessment group concluded that there is “a paucity of good quality data on costs following 
laparoscopic colorectal surgery” (Murray et al., 2006). This analysis goes on to conclude that 
laparoscopic surgery for colorectal cancer would be cost effective if there was an 
improvement in the health-related quality of life (HRQoL) of patients equivalent to between
0.009 and 0.010 Quality Adjusted Life Years (QALYs) (Murray et al., 2006).
There is, therefore, a need for studies assessing the cost effectiveness of laparoscopic 
colorectal surgery compared to open surgery. There is also a need to investigate whether there 
is a reduction in late complications such as adhesion formation, and “whether the laparoscopic 
approach is ‘superior’ to open colorectal surgery” (Buchanan et al., 2004).
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The aims of the studies reported in this thesis are two-fold. Firstly, to establish 
whether laparoscopic colorectal surgery is cost effective when compared to open surgery. 
Secondly, to investigate the extent of adhesion formation following laparoscopic and open 
colorectal surgery. Adhesions result in late complications following surgery, and in addition 
to having a significant clinical impact, also result in a large financial burden on health 
resources.
The thesis consists of nine chapters. After this introductory chapter, Chapter 2 
presents a comprehensive literature review of the key areas being investigated; this is based 
on two systematic reviews undertaken as part of the work undertaken for the thesis. Following 
this is the methods chapter, describing the methodology of the 2 clinical studies that have 
been performed. Chapters 4 to 7 describe the cost effectiveness study, with chapters 
describing the sample characteristics, quality of life results, cost results, and the cost 
effectiveness analyses. The results of the adhesions study are presented in chapter eight, with 
chapter 9 dedicated to discussion and conclusions.
In summary, this thesis aims to investigate the null hypotheses that:
1. There are no differences in the quality of life of patients following laparoscopic 
and open colorectal surgery.
2. Laparoscopic colorectal surgery is not cost effective when compared to open 
colorectal surgery.
3. There is no difference in the incidence of adhesion formation following 
laparoscopic and open colorectal surgery.
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Epidemiology of Colorectal Diseases
Colorectal diseases are common, and account for a significant proportion of the 
general surgical workload. It is difficult to obtain accurate data on the total number of elective 
colorectal resections performed annually in the United Kingdom. There is, however, 
comprehensive statistical data on colorectal cancer, and extensive information on hospital 
episodes is available from Hospital Episode Statistics (HES, www.hesonline.nhs.uk).
Colorectal cancer (CRC) is the third commonest cancer in the United Kingdom, 
accounting for 13% of all cancers in England and Wales. 36,000 new cases were diagnosed in 
2002. The incidence has increased over the past 30 years, although there has been a decline in 
mortality over the same period of time (www.statistics.gov.uk) (Rowan S). Approximately 
80% of patients who have been diagnosed with CRC undergo surgery, the majority of which 
are performed as elective procedures. There are therefore between 20,000 and 30,000 elective 
colon and rectal resections for cancer per annum in the UK.
Colorectal cancer accounts for approximately 60-65% (Mehigan et al., 2006, Scala et 
al., 2007) of the elective resections of a colorectal unit in a typical District General Hospital 
(DGH). The remainder is made up from the range of benign conditions that can affect the 
colon and rectum. These include diverticular disease, colonic and rectal polyps, inflammatory 
bowel disease (IBD), sigmoid volvulus, and operations for rectal prolapse.
Hospital Episode Statistics (HES) gives data on finished consultant episodes, based 
on a range of categories including main operations and Health Resource Group (HRG) codes. 
Examining data from 2005-06 pertaining to main operations for the colon and rectum (HB1 
Excision of colon, HC1 Excision of rectum) reveals 20,349 and 13,525 episodes, with 66 and 
77 percent respectively admitted initially from a waiting list. That would give a total of 
23,980 elective resections. The real figure is likely to be higher, since whilst some patients 
may present initially as an emergency, not all require emergency surgery, with a significant 
proportion going on to have elective or semi-elective surgery. HRG data (again only including 
patients admitted from a waiting list) demonstrates 30,679 patients having major, very major, 
or complex procedures of the large intestine (codes F31-34), and a further 2594 episodes for
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complex or major procedures for inflammatory bowel disease (F51, F52); a total of 33,273 
episodes.
HES data also gives detail on hospital stay, with the median for large intestinal 
procedures being 10-12 days. This equates to in excess of 500,000 bed days for the year 2005- 
06. The National Bowel Cancer Audit Project (NBOCAP) report from 2006 found a similar 
length in hospital stay, with a median of 11 days for all resections (Tilney H, 2006).
It can be seen, therefore, that the workload of elective colorectal resectional surgery is 
very significant. Using the various sources of data outlined above suggests that there are at 
least between 30 and 40,000 elective procedures per annum in the United Kingdom, and these 
procedures account for approximately half a million bed days a year.
Colorectal Surgery
The aim of surgery in colorectal cancer, as well as in benign conditions of the large 
intestine, is to achieve an adequate resection of the colon and/or rectum to remove the 
diseased segment of bowel. The anatomy of the large bowel, with its position around the edge 
of the peritoneal cavity involving more than one “quadrant” (Motson, 2005), means that 
resectional surgery tends to be extensive, and there is consequently a major insult to the 
patient.
The established method for performing this kind of procedure requires a large 
incision in the abdominal cavity. The incision needs to be large enough to provide access, for 
example in an anterior resection, from the pelvis to the splenic flexure (Motson, 2005). The 
incision is typically in the midline, although some surgeons prefer a transverse incision, 
particularly for a right-sided resection (Brown and Goodfellow, 2005, Brown et al., 2004). 
These conventional operations, which are also generically referred to as open procedures, are 
well established. Since the second world war, and the development of antibiotics, increasingly 
more complex surgical procedures have successfully been performed with acceptable rates of 
morbidity and mortality. In addition, the oncological techniques required to perform an
22
acceptable cancer resection (such as high tie for the vascular pedicle, and the “no touch” 
technique) have been developed and perfected in open surgery.
There are, however, disadvantages with open surgery. A large incision often results in 
significant post-operative pain, and a large scar may be cosmetically unacceptable. An open 
abdominal operation also results in significant physiological effects. The abdominal wall 
muscles are the main muscles used in passive respiration, and together with pain, this can 
result in respiratory depression, chest infections, and respiratory compromise (Schwenk et al., 
1999). Open surgery leads to handling of the bowel, which can contribute to a paralytic ileus, 
resulting in prolonged hospital stays and significant fluid shifts. In addition, patients can find 
it difficult to mobilise post-operatively, due to pain and discomfort, and the resulting invasive 
tubes (such as a urinary catheter, intravenous drip, epidural catheter, central line) further 
limits their mobility.
There is also a significant incidence of late complications following open surgery, 
such as adhesional small bowel obstruction, and incisional hernia formation. A later section in 
this chapter considers the literature on adhesion formation following open colorectal surgery, 
and the clinical and economic burden that can result from complications due to adhesions.
Laparoscopic Surgery
Laparoscopic surgery consists of operations in the abdominal cavity performed 
through small incisions, and is facilitated by the use of imaging systems that allow sufficient 
resolution for complex surgical procedures (Darzi et al., 1997). It is also described as 
minimally invasive, minimal access, or keyhole surgery.
A distinction should be made between laparoscopic and laparoscopically-assisted 
surgery. In laparoscopic surgery, the entire procedure is performed “intra-corporeally”, 
whereas in laparoscopic-assisted surgery a part of the operation is performed extra- 
corporeally. This typically occurs in colorectal surgery when the initial mobilisation is 
performed laparoscopically, but the anastomosis is performed extracorporeally. The reason 
for this is that an incision has to be made to remove the specimen, and as it is easier and
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quicker to perform an anastomosis extra-corporeally, the incision is used to facilitate this. 
The practice in Guildford is to perform the anastomosis extracorporeally. Whilst this 
technically is a laparoscopic-assisted procedure, for simplicity I will still describe this 
throughout the thesis as laparoscopic surgery.
Laparoscopic surgery gained widespread popularity amongst general surgeons 
following the first laparoscopic cholecystectomy, described by Phillipe Mouret (a 
gynaecologist) in 1987 (Mouret, 1996). Laparoscopy had previously been performed, 
particularly by gynaecologists, with the first documented laparoscopy dating from 1901 
(Vecchio et al., 2000), but it was only in the late 1980s, with the advent of new technologies, 
that the use of laparoscopic surgery became more common. The technological innovations 
that were essential included the new chip camera, high-powered light sources, insufflators to 
maintain the pneumoperitoneum, and the development of laparoscopic instruments such as 
clip applicators.
Laparoscopic cholecystectomy rapidly established itself during the 1990s as the 
treatment of choice for cholelithiasis (Cuschieri et al., 1991, Fullarton and Bell, 1994). 
However, there was a cost with the introduction of this new technique, with a small increase 
in the incidence of major complications (Beart, 1995), in particular bile duct injuries. As this 
became apparent, there was a realisation that having the skills for open surgery did not 
necessarily equate to an ability to perform laparoscopic surgery. New surgical techniques 
needed to be learnt, and together with an awareness of the challenges resulting from operating 
without haptic feedback, visualising the anatomy from a different perspective, and loss of 
depth perception using two-dimensional monitors, meant that the concept of a learning curve 
for laparoscopic surgery began to be appreciated.
Since the 1990s, laparoscopic surgery has cemented its role within general surgery, 
with many routine procedures such as hernia repair, anti-reflux surgery, nephrectomy, and 
appendicectomy, being commonly performed laparoscopically. Subsequently, more complex 
surgery such as gastrectomy, anti-obesity surgery, and many emergency procedures are 
amenable to laparoscopic techniques (Beart, 1995, Darzi et al., 1997).
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Proponents of laparoscopy claim that there are significant benefits with the 
laparoscopic approach when compared to open surgery: it limits the stress of surgical trauma 
(Kuntz et al., 1998, Hazebroek, 2002), with less inflammatory-cell and immune-mediated 
effects (Whelan et al., 2003, Schwenk et al., 2000); there is a reduced rate of post-operative 
ileus (Delaney, 2004); there may also be a reduction in some post-operative morbidities such 
as wound infection and cardiorespiratory complications (Schwenk et al., 1999); and there is a 
shorter length of hospital stay, with a faster return to normal activities.
There are however disadvantages with laparoscopic surgery: there is a learning curve, 
with the potential for an increase in complications compared to open surgery; it tends to take 
longer than equivalent open operations; and there is a financial burden relating to the 
operative costs. This last point will be assessed later in this chapter, but the costs relate to the 
capital outlay for laparoscopic equipment (such as for the camera and operating stack), and 
ongoing costs relating to the procedure itself (the laparoscopic ports, disposable instruments, 
and the length of the operation).
Laparoscopic Colorectal Surgery
Laparoscopic colorectal surgery was first described in 1991 (Jacobs et al., 1991). 
However, after a number of encouraging early reports and studies, a significant concern was 
highlighted. This arose following a report by Berends (Berends et al., 1994), suggesting an 
unacceptably high incidence of port-site metastasis following resection for colorectal cancer. 
In addition there was a degree of resistance from “senior and often influential surgeons” 
(Motson, 2005), and an appreciation that laparoscopic surgery for colorectal diseases is 
technically very demanding. These factors meant that there was justified caution in the 
development of laparoscopic colorectal surgery.
Largely in response to the issue of wound recurrences, a number of large multicentre 
randomized clinical trials were started. In the United Kingdom, the Conventional versus 
Laparoscopic-Assisted Surgery in Colorectal Cancer (CLASICC) trial (Guillou et al., 2005), 
began recruiting patients in 1996. Due to the issue of oncological safety, surgeons in the UK 
were advised to only perform laparoscopic colorectal surgery if  their patients were entered
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into a RCT. Similar studies were set-up in Europe (the Colon Cancer, Laparoscopic or Open 
Resection (COLOR) trial (Hazebroek, 2002)) and the United States (the Clinical Outcomes of 
Surgical Therapy Study Group (COST) trial (The COST study group, 2004).
These three trials have all now reported at least short-term outcomes, providing good 
evidence for the oncological safety and clinical efficacy of laparoscopic colorectal surgery. A 
meta-analysis and systematic reviews have confirmed that in surgery for colorectal cancer 
there are at least equivalent outcomes with respect to extent of resection and lymph node 
harvest (confirming a more than adequate oncological clearance), as well as disease-free and 
overall survival (Abraham et al., 2004, Murray et al., 2006).
Benefits with the laparoscopic approach for colorectal surgery include less 
postoperative pain and analgesia, a shorter hospital stay, less blood loss, and a faster return to 
normal activities (Reza et al., 2006, Abraham et al., 2004). Data on cost and health related 
quality of life (HRQoL) are conflicting, and are dealt with in the next two sections of this 
chapter.
Some trials have suggested a reduction in complications with the laparoscopic 
approach (Schwenk et al., 1999, Abraham et al., 2004), although most reviews have found no 
significant difference between the two approaches (Murray et al., 2006, Reza et al., 2006). A 
RCT from Barcelona reported an improvement in 5-year survival for patients with Dukes’ C 
disease (Lacy et al., 2002), although these findings have not been supported by the three large 
RCTs described above.
Disadvantages with the laparoscopic technique include a longer operating time, a 
significant learning curve, and a conversion rate of up to 29% (Guillou et al., 2005). All of 
these aspects relate to the experience of the surgeon involved. The CLASICC trial 
demonstrated that conversion rates fall with increasing experience (Guillou et al., 2005), and 
the COLOR trial demonstrated a similar effect with regards to conversion rates and the length 
of the operation (Kuhry et al., 2005). It has been estimated that a surgeon needs to have 
performed at least 55 procedures to have completed their learning curve (Tekkis et al., 2005).
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Studies have also suggested that the clinical outcomes (such as morbidity, length of 
hospital stay) following a converted laparoscopic case are similar (Gonzalez et al., 2006) or 
possibly even worse (Guillou et al., 2005) than those following open surgery. Conversions 
also have a significant effect on cost, as these patients tend to have a prolonged hospital stay 
when compared to patients successfully treated laparoscopically.
The importance of the above is that the large RCTs (and therefore the meta-anlyses 
and systematic reviews that are typically based on them) included a high proportion of 
surgeons who were still on their learning curve, by stipulating that experience of only 20 
laparoscopic cases was necessary to enter patients into the trials. This may explain the high 
conversion rates seen in these studies (29% CLASICC, 21% COST, 17% COLOR). Each of 
these studies reported on an intention to treat basis, and so the high conversion rates are likely 
to have affected some of the clinical, cost, and quality of life outcomes. However, despite this, 
the multicentre trials demonstrated no adverse clinical or oncological features with the 
laparoscopic approach. A paper from Korea has demonstrated that the learning curve has an 
adverse effect on the costs (Park, 2007).
There is therefore now a need for studies from experienced surgeons and units, to 
investigate the question of whether there are benefits with the laparoscopic approach.
Costs of Laparoscopic and Open Colorectal Surgery1
The introduction of laparoscopic techniques has cost implications, particularly 
relating to the costs of disposable equipment, and the prolonged operating time compared to 
open surgery. The perception that laparoscopic procedures are more costly than open 
procedures has been a major reason for the slow acceptance of LCS.
A systematic review was undertaken to examine the current literature on the costs of 
laparoscopic colorectal surgery. The data available mainly examines the direct (healthcare) 
costs. However, there are no papers in the literature assessing the start-up costs, as this is very
1 This section is based on a systematic review that was prepared for this thesis and published in 2007 
(Dowson et al, 2007). There is an addendum at the end of this section which incorporates papers 
published since the review was submitted in 2006.
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dependent on the equipment and experience already available within an institution. This 
aspect of cost is difficult to accurately evaluate, subject to wide variations between different 
hospitals, and is beyond the scope of this thesis.
Method
Search strategy
Studies comparing the costs and outcomes of laparoscopic and open colorectal 
surgery were sought from a systematic review of the literature. The electronic databases 
Medline, Embase, and the Cochrane library database were searched for relevant articles 
between the years 1991 and 2005. Search terms used were: costs (or economic), laparoscopic 
(or endoscopic or minimally invasive), and colorectal (or colectomy). In addition a search was 
made of the same databases using the keywords laparoscopic and colorectal, and the abstracts 
identified searched for economic outcomes. The references of all relevant articles were hand- 
searched for any previously missed papers.
Inclusion and exclusion criteria
All studies that compared costs between open and laparoscopic colorectal surgery are 
included in this review. Reviews and case series with no control group were excluded, whilst 
case-matched and cohort studies were included.
Articles were independently appraised by two authors (HD and YS) in terms of their 
methodology and design using a predetermined protocol, and graded as to the level of 
evidence (Table 1) (National Health, 1999). Differences were resolved by discussions 
between the authors.
1
2
3-1
3-2
3-3
4
Evidence obtained from a systematic review o f all relevant randomised controlled 
trials
Evidence obtained from at least one properly designed randomised controlled trial 
Evidence obtained from well-designed pseudorandomised controlled trials 
Evidence obtained from comparative studies with concurrent controls and allocation 
not randomised (cohort studies), or interrupted time series with control group 
Evidence obtained from comparative studies with historical control, two or more 
single-arm studies, or interrupted time series without a parallel control group 
Evidence obtained from case series, either posttest or pretest/posttest
Table 1: Designation of levels of evidence (National Health, 1999) 
Outcomes analysed
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The primary endpoints analysed for this review were: operating room costs; total 
hospital costs, which includes the operating room costs; and indirect costs. Secondary 
outcomes were conversion rates and length of hospital stay. Note was made as to whether cost 
was specified as a primary or secondary endpoint.
The economic impact of a surgical procedure can be divided into direct medical costs, 
and indirect costs (Table 2) (Cuschieri et al., 1997). Direct costs relate to healthcare costs and 
include those relating to the hospital stay, operative procedure, community healthcare costs, 
as well as any complications caused by the treatment. Operating room costs relate to the 
instruments and equipment used for a procedure, the duration (including anaesthetic time), 
staff costs, and overheads of the theatre. Indirect costs are the societal (due to a loss of 
productivity) and individual costs relating to a patient’s absence from work or normal 
activities; this also includes costs of carers. Wherever possible, costs have been classified in 
this manner, although some of the studies vary in their definitions.
Direct
(Healthcare)
costs:
Short-term costs -  those relating to the operative procedure and hospital 
stay. Includes: Operating room costs; hospital overheads; diagnostic 
tests; labour costs of staff.
Follow-on direct costs -  Relate to medical costs incurred after the initial 
admission and relate to follow-up visits, complications, readmissions & 
reoperations etc.
Indirect costs: Societal -  Loss of productivity; employers, payers of compensation, etc.
Individual -  lost wages, private carers.
Table 2: Economic outcomes to be measured in endoscopic procedures (Cuschieri et al., 1997)
Direct costs are defined as the total costs to the healthcare system for a patient 
episode (in this instance, having a colorectal operation); community healthcare costs should 
be included, but most studies did not attempt to assess these. In this review, therefore, hospital 
costs are compared, as this is an endpoint which was measured in almost all of the studies.
Statistical analysis
The papers were heterogeneous in terms of the date of publication (the studies 
included in this review span thirteen years, during which time inflation is a factor); the 
currency in which costs were calculated; the range of costs that were included; the statistical
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methods employed; and disease processes examined (Table 3). It is therefore difficult to 
compare the studies directly and a meta-analysis was not possible. The percentage difference 
between costs for open and laparoscopic surgery were calculated for each study, and these 
figures compared. This approach presumes consistency in measurement of costs within trials, 
and minimises the effects of methodological differences between them.
The papers reviewed employed a variety of statistical methods (table 4); analysis by 
the authors was mainly on an intention-to-treat basis, with converted cases included with the 
laparoscopic group, although five papers considered costs for converted cases separately.
Data are presented as medians (interquatile range [IQR]), unless otherwise stated. The 
Wilcoxon signed-rank test and Sign test were used to compare the significance between 
groups, using the null hypothesis that the median difference would be 0. Data was analyzed 
using the Minitab version 14 software (Minitab Inc., 3081 Enterprise Drive, State College, PA 
16801-3008, USA).
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First
Author
Year Country Operation Indication LC o c Conver­
sions (%)
Level of 
Evidence15
Comment
Falk* 1993 USA RHC and SC Cancer 34 34 44 3-3 Retrospective cohort study
Senagore 1993 USA All resections All diseases 38 102 32 3-2 Cohort study; surgeon selection of 
cases
Musser 1994 USA All resections All diseases 24 24 25 3-3 Retrospective cohort study with 
historical controls; not consecutive
Hoffman 1994 USA All resections All diseases 80 53 22 3-3 Prospective and consecutive
cohort study with historical 
control
Van Ye 1994 USA All resections Cancer 14 20 7 3-3 Cohort study with historical
controls; surgeon selection of
cases
Saba 1995 USA All resections All diseases 25 25 20 3-3 Retrospective cohort study with
historical control; no details on
patient selection
Pfeiffer 1995 USA All resections All diseases 53 53 12 3-2 Not analysed on an intention to
treat basis; no description of
patient selection
Liberman 1996 USA SC Diverticular 14 14 0 3-3 Cohort study; consecutive cases
with historical controls
Philipson 1997 Australia RHC Cancer 28 33 excluded 3-3 Retrospective cohort study; not
analysed on an intention to treat
basis
Kohler 1998 Germany SC Diverticular 27 27 7.5 3-3 Retrospective cohort study
Khalili 1998 USA All resections All diseases 80 90 8 3-3 Retrospective cohort study; not
matched
Joo 1998 USA All resections Colonic 23 22 17 3-2 Cohort study; ?retrospective
(mainly RHC) polyps
Bouvet 1998 USA All resections Cancer 91 91 42 3-2 Prospective cohort study; high
conversion rate; not analysed on
an intention to treat basis
Young- 2001 USA Ileocaecal Crohn’s 33 33 5.9 3-3 Retrospective cohort study
Fadok resection
Senagore 2002 USA SC Diverticular 61 71 6.6 3-2 Retrospective cohort study; patient
selection by surgeon; case-
matched
Duepree 2002 USA Ileocaecal Crohn’s 21 24 5 3-2 Prospective cohort study
resection
Shore 2003 USA Ileocaecal Crohn’s 20 20 5 3-2 Retrospective cohort study;
resection prospective database
Delaney 2003 USA All resections All diseases 150 150 Figure not 3-2 Retrospective cohort study; case-
given matched
Janson 2004 Sweden All resections Cancer 98 112 14 2 RCT; cost analysis "piggybacked"
onto main trial; some surgeons on
learning curve
Maartense 2004 Nether­ Proctocolect­ UC or FAP 30 30 0 2 RCT
lands omy & IPAA
Leung 2004 Hong Anterior Cancer 203 200 23 2 RCT; data collected over 9 years
Kong Resection
Sokolovic 2004 Swiss All resections All diseases 121 48 6.1 3-3 Retrospective cohort study;
(SC
commonest)
Salkfield 2004 Australia Abdominal Rectal 20 19 0 2 RCT; "piggybacked" onto larger
Rectopexy prolapse trial
Zheng 2005 China RHC Cancer 30 34 6.7 3-2 Cohort study; case-matched;
?retrospective
Delaney 2005 USA BMI >30, All All diseases 94 94 30 3-3 Retrospective cohort study from
resections prospective database; case-
matched
Pokala 2005 USA Total FAP, Crohn’s, 34 34 11.8 3-2 Retrospective case-matched cohort
collectomy & UC, study; prospective database
ileo-rectal constipation
anastomosis
Senagore 2005 USA All resections All diseases 100 100 excluded 3-2 Retrospective case-matched cohort
study; prospective database
Braga 2005 Italy All resections All diseases 258 259 5 2 RCT; long hospital stay
King 2005 UK All resections Cancer 42 19 6.6 2 RCT; detailed cost analysis
including indirect costs.
Total 1846 1835 7.8% (IQR 6-21%)
Table 3: Overview of relevant papers (Cost review). LC, laparoscopic colectomy; OC, open
colectomy; RHC, right hemicolectomy; SC, sigmoid colectomy; IPAA, ileal pouch anal anastomosis; 
UC, ulcerative colitis; FAP, familial adenomatous polyposis; RCT, randomized controlled trial. *66 
laparoscopic cases were included in the study, but cost data only available for 34.
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Results
Selection of studies
The literature search revealed 29 studies in which costs were compared between open 
and laparoscopic colorectal surgery (Falk et al., 1993, Senagore et al., 1993, Musser et al., 
1994, Hoffman et al., 1994, Van Ye et al., 1994, Saba et al., 1995, Pfeifer et al., 1995, 
Liberman et al., 1996, Philipson et al., 1997, Kohler et al., 1998, Khalili et al., 1998, Joo et 
al., 1998, Bouvet et al., 1998, Young-Fadok et al., 2001, Senagore et al., 2002, Duepree et al., 
2002, Shore et al., 2003, Delaney et al., 2003a, Janson et al., 2004, Maartense et al., 2004, 
Leung et al., 2004, Sokolovic et al., 2004, Salkeld et al., 2004, Zheng et al., 2005, Delaney et 
al., 2005, Pokala et al., 2005, Senagore et al., 2005, Braga et al., 2005b, King et al., 2005); 
these are detailed in Table 3. The economic data in most studies was limited, with some 
giving no breakdown of the costs measured. There were six randomised-controlled trials 
(RCT), with the remainder cohort studies; the majority of these were retrospective, with 
varying degrees of case matching. 12 papers identified costs as a primary, and 13 as a 
secondary, outcome measure (Table 3).
There were nine papers identified from the literature search that were excluded: one 
paper (Bokey et al., 1996) reported on the same cohort of patients as another publication 
(Philipson et al., 1997), but contained less economic data; two were case series with no open 
surgery control group (Tucker et al., 1995, Gibson et al., 2000); a further series compared 
laparoscopic and hand-assisted resections, with no open control group (Targarona et al., 
2002); two were predominantly review articles (Ballantyne, 1995, Casillas and Delaney,
2005); Braga et al presented an interim analysis (Braga et al., 2002), and have recently 
published the completed series which is included in this review; one retrospective review 
examined the costs of converted laparoscopic resections (Casillas et al., 2004); and one small 
series looked at robot-assisted resections (Delaney et al., 2003b).
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Overview of included studies
The total number of patients included in the studies who had laparoscopic colorectal 
surgery was 1846, with the open group 1835. The majority of the papers originate from the 
United States (19), with two from Australia, six from Europe (including one from the United 
Kingdom), and one each from China and Hong Kong. The papers cover the entire spectrum of 
colorectal surgery, including nine examining all colorectal conditions, eight focusing on 
cancer, three on Crohn’s disease, and three on diverticular disease (Table 3). There was a 
similar spread when examining the operative procedures performed, with 15 including all 
colorectal resections, and 14 focusing on a specific procedure. Half of the papers have been 
published in the last three years.
Operative costs
Seventeen studies (including four RCTs) examined operating room costs (Table 4). 
Three of these did not analyse on an intention to treat basis, considering laparoscopic and 
converted procedures separately (Falk et al., 1993, Hoffman et al., 1994, Pfeifer et al., 1995). 
In all 17 studies, the costs were greater in the laparoscopic group than the open group, and in 
all but five, this difference was statistically significant according to the authors’ criteria. The 
median difference in operating room cost between laparoscopic and open surgery was 50% 
(mean 55, IQR 27-78). This difference is significant (p<0.001, using both the Sign and 
Wilcoxon signed-rank tests, against the null hypothesis that the median is zero).
There is a wide range in the costs reported by authors for the operative procedure. 
Some estimate them to be as low as £1160 or £907 for the laparoscopic and open group 
respectively (Salkeld et al., 2004), to as high as $10589 (Liberman et al., 1996) and $12350 
(Pfeifer et al., 1995) (both for laparoscopy). This highlights the difficulty in comparing the 
individual trials, as there are significant differences in the way costs were measured; for this 
reason the presumed internal consistency of the trials has been utilised to calculate the 
percentage difference between the two techniques, and these differences compared.
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Paper- number % difference in Significant % difference in total Significant Statistical Comment on cost data
& first author operative cost difference? hospital cost difference? test used by 
authors
1 Falk + 90
(+75% for conversions)
Yes 0
(+26% for 
conversions)
No KW No details on costs 
measured
2 Senagore n/a -19 
(+31% for 
conversions)
No ANOVA No details on costs 
measured
3 Musser + 18 No -14 No Student’s t Reasonable cost details
4 Hoffman + 82
(+79% for conversions)
Yes + 25 No Student’s t No cost details
5 Van Ye n/a + 20 Not
described
None No cost details
6 Saba + 135% Yes n/a Student’s t No cost details
7 Pfeifer + 27 No + 10 No Not Good breakdown o f costs
(+11% for conversions) (-27% for 
conversions)
described measured.
8 Liberman + 29 Yes + 23 Yes Student’s t Minimal cost details
9 Philipson + 62 Yes + 15 Yes MW Good breakdown o f hospital 
costs
10 Kohler n/a -25 Yes W, Fisher’s Minimal cost data
11 Khalili + 75 Yes + 4 No Student’s t No cost details
12 Joo n/a + 24 No Student’s t No description o f costs in 
main paper, just in abstract
13 Bouvet n/a + 18 Yes MW Minimal cost details
14 Young- + 27 No -34 Yes Student’s t Confusion with definition of
Fadok indirect costs
15 Senagore + 19 Yes -25 Yes Student’s t Moderate cost detail
16 Duepree n/a -17 Yes Student’s t No cost details
17 Shore n/a -78 Yes Student’s t Minimal cost detail
18 Delaney + 75 Yes - 14 Yes Student’s t, 
W
Good cost detail (staff costs 
excluded)
19 Janson + 50 Yes + 29 Yes Student’s t Detailed cost analysis; 
financial data from one 
centre applied to remain­
der for the cost analysis
20 Maartense + 97 Yes + 25 No KW Moderate cost details
21 Leung +30 Yes MW, t Minimal cost details
22 Sokolovic + 11 No -2 No MW, KW, t Cost data confusing due to 
different insurance types & 
operations
23 Salkfield + 28 No -13 Yes Not
described
Detailed cost analysis
24 Zheung + 56 Yes n/a MW, t Minimal cost data
25 Delaney n/a -5 No W Minimal cost data
26 Pokola n/a 0 No W Minimal cost data
27 Senagore n/a -51 Yes MW, W Minimal cost data
28 Braga* n/a [+125 euros] No MW, KW, 
W ,t
Detailed costings, but actual 
overall costs not 
documented, only 
differences between groups
29 King + 47 Yes + 3 No MW Detailed cost analysis 
including indirect costs.
Total (median, +50(27-78) pO.001** 0
IQR) (-17.5 to +20.8)
Table 4: Percentage difference in Operative and Total hospital costs between laparoscopic and 
open surgical groups. Laparoscopic costs expressed relative to open costs as baseline. Statistical test 
used by authors: KW, Kruskal Wallis; MW, Mann Whitney U test; W, Wilcoxon. *No details were 
given for actual costs, but overall laparoscopic surgery was 125 euros more than open surgery. **Sign 
test and Wilcoxon test against null hypothesis that median=0. f lf  authors state whether billed or 
measured costs are used, this is documented.that there is no difference in hospital costs between the 
two groups (p=0.97, Wilcoxon signed-rank test).
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Total hospital costs
Twenty-seven papers gave details on total hospital costs (Table 4). Thirteen of these 
series found a significant difference in costs between the laparoscopic group and open group: 
laparoscopy was cheaper in eight of these trials, and more costly in five. The median 
difference was 0% (IQR -17.5 to 20.85%). There is no evidence to reject the null hypothesis 
that there is no difference in hospital costs between the two groups (p=0.97, Wilcoxon signed- 
rank test).
Again, there is a wide spectrum in the mean costs reported with respect to total 
hospital costs, ranging from $2547 (Duepree et al., 2002) and DM7185 (Kohler et al., 1997), 
up to $29626 (Pfeifer et al., 1995) and $36745 (Liberman et al., 1996).
Indirect costs
Only two studies (both RCTs) measured indirect costs. These costs were less in the 
laparoscopic group in both of these studies: 2181 vs 2579 euros (18% more in open group) 
(Janson et al., 2004); £447 vs £721 (61% more in the open group) (King et al., 2005).
Hospital stay
The length of hospital stay was shorter for the LCS group than for the open group in 
all 29 studies (Table 5), and was significantly different in 21 of these. Five studies excluded 
converted cases from their analysis of the laparoscopic groups. Excluding these five, the 
median difference between the laparoscopic and open groups was 2.8 days (mean 2.7, IQR 
1.3-4.0), a statistically significant difference (p<0.001, sign test and Wilcoxon signed-rank 
test).
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Laparoscopic
Cases
Open
cases
Converted
cases*
1 Falk 4.5 8 9
2 Senagore 6 9.9 9.3
3 Musser 8.5 9.9
4 Hoffman 5 7 8
5 Van Ye 7.6 8.9
6 Saba 3.6 8.1
7 Pfeifer 7.28 8.41 5.71
8 Liberman 6.3 9.2
9 Philipson 8 8
10 Kohler 7.9 14.3
11 Khalili 7.7 8.2 11.1
12 Joo 6.5 9.4
13 Bouvet 6 7
14 Young-Fadok 4 7
15 Senagore 3.1 6.8
16 Duepree 3 5
17 Shore 4.25 8.25
18 Delaney 3 6
19 Janson 9 9.1
20 Maartense 10 11
21 Leung 8.2 8.7
22 Sokolovic 3.9 6.6
23 Salkfield 13.94 18.25
24 Zheung 3.8 5.8
25 Delaney 11 16
26 Pokola 3 6
27 Senagore 2.1 6.3
28 Braga 5.5 8.3
29 King 9.9 12.4
Median 6 days 8.25 days
(IQR) (3.9-8) (7-9.4)
Table 5: Length of hospital stay (in days). *These papers considered converted cases separately to 
the laparoscopic group.
Conversion rates
The median conversion rate for all studies was 7.8% (mean 14%, IQR 6-21%) (Table 
3). Five papers analysed conversions separately from the laparoscopic group (Falk et al., 
1993, Senagore et al., 1993, Hoffman et al., 1994, Pfeifer et al., 1995, Khalili et al., 1998), 
and three excluded conversions from their analysis (Senagore et al., 2005, Philipson et al., 
1997, Delaney et al., 2003a).
Randomised trials
There are only six published RCTs that have performed an economic analysis for
laparoscopic colorectal surgery (King et al., 2005, Janson et al., 2004, Leung et al., 2004,
Braga et al., 2005b, Maartense et al., 2004, Salkeld et al., 2004). Three were relatively small
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series with only 42, 30, and 20 patients in the laparoscopic arms respectively (King et al., 
2005, Maartense et al., 2004, Salkeld et al., 2004). One of the larger RCTs was a study 
‘piggy-backed’ onto the “COLOR” trial (Janson et al., 2004), in which experience of only 20 
laparoscopic procedures was required. While this was a multicentre trial, the cost analysis was 
only performed on patients from one centre (providing 33 per cent of patients in total), with 
the results extrapolated to the rest of the study population.
The study of Leung et al gave no breakdown on their cost data, and only reported 
operative costs; this was a series spread over 9 years (1993-2002), with a relatively high 
conversion rate (23%) and a relatively long hospital stay for the laparoscopic group of just 
over 8 days. Again, no attempt was made to allow for the surgeon’s experience of the 
technique. The papers of Maartense and Salkfield considered single procedures 
(proctocolectomy and abdominal rectopexy respectively), rather than the range of 
laparoscopic colorectal procedures.
It is difficult to carry out a rigorous meta-analysis on the RCTs because of this 
heterogeneity between the papers. However, three papers looked exclusively at patients with 
colorectal cancer (King et al., 2005, Janson et al., 2004, Leung et al., 2004), and these have 
been directly compared with respect to hospital costs. Study currencies were converted into 
pounds sterling at exchange rates of mid 2005 (Bank of England statistics, median date of the 
three studies), and the cost difference calculated between the laparoscopic and open surgery 
groups. This gave cost differences of £1545 (£293 to £2797) (Janson et al., 2004), £1171 (- 
£1122 to £3464) (Leung et al., 2004), and -£353 (-£2167 to £2291) (King et al., 2005) 
(expressed as means with 95% confidence intervals). It can be seen that the confidence 
intervals are wide thus making further statistical analysis unreliable.
Discussion
The aim of this systematic review was to evaluate the costs of laparoscopic colorectal 
surgery compared with open surgery. Healthcare resource constraints mean that it is crucial to 
identify treatments that are cost-effective. The evolution of laparoscopic surgery has been
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delayed, particularly in the United Kingdom, because of the perceived increased costs 
associated with this type of surgery.
The results suggest that the operative costs of LCS are higher than that of open 
surgery, with a median difference of 50%. However, it is important to acknowledge that there 
are potentially high levels of bias within the studies reported, with some significant 
methodological limitations (as described previously and below), thus making it difficult to 
dram firm conclusions. In the United Kingdom, a cost difference of 50% equates to between 
£800 and £1000 (King et al., 2005)). The main factors determining operative costs are the use 
of disposable instruments, the duration of operation, and the conversion rates. The last two 
factors improve with increasing experience.
Total hospital costs (which include operative costs) are more equivalent. Overall, 
there was no difference in the direct costs between LCS and open surgery (median difference 
0%). The main determinant of hospital costs, after taking the operative costs into account, is 
the length of hospital stay, and in all studies this was longer in the open surgery groups. As 
surgeons become more experienced with laparoscopic colorectal procedures, the length of 
hospital stay decreases, as has been demonstrated in the COLOR trial (Kuhry et al., 2005)..
Cost comparisons in this review encountered several problems. Laparoscopic 
colorectal surgery is still a relatively new technique, and is being performed by a minority of 
surgeons (Harinath et al., 2005, Sheldon et al., 2004, Schwab et al., 2008). Inevitably, 
therefore, some of the studies have compared inexperienced laparoscopic surgeons with 
experienced open surgeons. Data from the CLASICC and COLOR trials demonstrates that 
case volume and experience has a significant impact on outcomes such as conversion rates, 
length of procedure and lymph node harvest (Kuhry et al., 2005, Guillou et al., 2005). Both of 
these trials may have failed to allow adequately for the “learning curve”; they stipulated that 
surgeons needed to have experience of 20 laparoscopic cases, whilst recent evidence suggests 
that it is significantly longer than this (Veldkamp et al., 2004). A study from Korea has 
examined costs and the learning curve in laparoscopic colorectal surgery (Park, 2007). They
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found a significantly higher hospital cost during the early learning period, identified as the 
first 37 cases from a scatter-graph of the operative times.
Secondly, many problems arise in making international comparisons of costs. The 
relative prices of resources may differ between countries such that, for example, if  operating 
room costs are higher in one country, and laparoscopic surgery uses more operating time, then 
the cost of LCS relative to open surgery in that country will be inflated relative to other 
countries. In some countries economic (opportunity) costs are not available; for example, in 
the United Kingdom, government regulation affects the prices of resources, whilst in the 
USA, charges are often used instead of costs. In addition, differences between countries in 
payment systems for doctors and hospitals can influence factors such as length of hospital 
stay and outpatient follow-up.
The percentage difference in costs between the laparoscopic and open groups have 
been used to minimise these problems. Currency conversions have not been performed on the 
whole group of studies for a number of reasons: healthcare cost inflation data was not 
available for establishing base year costs in individual countries; moreover, exchange rate 
conversions are problematical because they are affected by short term distortions resulting 
from political factors or changes in financial markets; and country-wide purchasing power 
parities are not available for the healthcare sector.
Thirdly, the analysis is dependent on the data available, and there is significant 
variability between studies in the range of cost categories covered. Whilst some authors give 
reasonable detail on this, many only give scanty information, and in many studies, detail on 
how costs were measured is missing. In addition, a number of the studies have inherent 
methodological weaknesses, including the study designs and retrospective nature of many of 
them, and the use of historical controls.
In conclusion, the current published evidence suggests that whilst the operative costs 
of LCS are greater than those of open surgery, the overall hospital/ healthcare costs are very 
similar.
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New research
Since the systematic review on costs was written and published (Dowson et al., 
2007), there have been further studies published in the literature evaluating the costs of 
laparoscopic colorectal surgery which are briefly reviewed here.
A group from Korea have investigated the costs of the learning curve, as previously 
mentioned, finding that the hospital costs for laparoscopic surgery were substantially higher 
during the early learning period (Park, 2007). They also performed a study evaluating the 
costs of laparoscopic versus open surgery, and found that operating room costs and overall 
hospital costs ($5017 v $4093) were significantly higher in the laparoscopic group (Choi et 
al., 2007). A case-matched study from Ireland found higher operative costs, but overall 
savings with the laparoscopic group (Ridgway et al., 2007). The results of this last study were 
dependent on a large difference in hospital stay (median 5 v 12 days), which may be partly 
due to the use of retrospective open controls.
A short-term (3-month) cost analysis was undertaken on a subset o f  patients 
entered into the CLASICC trial (682 o f  794 patients) (Franks et al., 2006). This found 
that the operative costs were greater for the laparoscopic group by £1703 compared to £1386 
in the open cohort (a 23 percent difference). The total direct (healthcare costs) were similar, 
£5867 v £5638, as were the indirect costs (£1033 v £994). The overall cost analysis 
demonstrated a slightly higher cost in the laparoscopic group, £6899 v £6631, a non­
significant difference of 4 percent.
A case-matched study from Newcastle, compared 30 laparoscopic with 30 open 
resections (Noblett and Horgan, 2007). Average operative costs (combining the costs of 
surgical equipment and operating room time) were significantly more for the laparoscopic 
group, £2979 v £2221 (34 percent more expensive), but there was no difference in overall 
direct costs (£4561 v £4348, p=0.976).
A large cohort study from America, reviewing the billed costs of 32,733 patients 
(33.7% laparoscopic), found the total hospital costs were $398 more in the laparoscopic group 
($8076 v $7678, p=0.0002), a 5 percent difference (Delaney et al., 2008). A group from New
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Zealand also found hospital costs were greater in the laparoscopic group, by $1267 New 
Zealand dollars (approximately £464, at the current conversion rate to GBP)(Hayes and 
Hansen, 2007). This paper also attempts to perform a cost effectiveness analysis, but there is a 
significant methodological flaw in their analysis. The QALY calculation employed is based 
on recovery data from previously published randomised trials, and assumes differences in the 
time to recovery would equate to a whole QALY gain for that day (ie score 1 v 0 on EQ-5D 
scoring). However, this is extremely unlikely to be the actual QALY difference for the 
patients, and as a result the cost effectiveness analysis should probably be disregarded.
The Aberdeen Health Technology Assessment Group, whose comprehensive review 
on laparoscopic colorectal surgery formed the basis of the NICE advice published in 2006 
(Murray et al., 2006), have published summaries of the cost-effectiveness analysis performed 
for their review (de Verteuil et al., 2007, Hernandez et al., 2008). Their analysis is based on 5 
RCTs previously described in our systematic review, and their conclusion is that laparoscopic 
surgery is £300 more expensive, and is “likely to be associated with short-term quality of life 
benefits”, although the utility data were poor. A benefit of at least 0.01 of a QALY would be 
needed for laparoscopic surgery to be considered cost effective; based on the current 
evidence, “a judgement is required as to whether the short-term benefits are worth this extra 
cost”.
These further studies, particularly the two studies from the UK, give very similar 
results to those of the systematic review described above: an increased operative cost for 
laparoscopy, but very similar hospital costs. However, no studies have yet been published that 
have performed an appropriately designed cost effectiveness analysis. To perform a cost 
effectiveness analysis, an outcome in addition to costs needs to be considered. If there are 
differences in clinical outcomes (such as a reduction in morbidity or mortality), those 
outcomes can be used to perform a cost effectiveness analysis. If for example, treatment A is 
cheaper than treatment B, but treatment B prolongs life by an average of one year, it is 
possible to calculate how much it costs to gain an extra year of life.
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With respect to laparoscopic and open colorectal surgery, with clinical outcomes 
such as morbidity and mortality being equivalent, the next most important outcome to be 
considered is quality of life (QoL) (Bottomley, 2002), which can then be used as the basis of a 
cost effectiveness analysis.
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Quality of life following laparoscopic and open colorectal surgery2
This section is based on a published systematic review (Dowson et al., 2008a). 
Quality of life (QoL) refers to an individual's wellbeing, and includes an assessment of their 
ability to function in the ordinary tasks of living. It is a term frequently used in relation to 
healthcare, where the impact of a disease may adversely affect QoL; this aspect of QoL is 
referred to as health-related quality of life (HRQoL). HRQoL is usually measured by asking 
patients to complete specific questionnaires, a patient-reported outcome.
Health-related quality of life has been increasingly regarded as an important 
measurement in clinical trials (Bottomley, 2002). Now laparoscopic colorectal surgery has 
established its clinical efficacy, commentators have stated that studies are required to 
demonstrate if there are benefits with laparoscopic surgery (Buchanan et al., 2004), and 
whether it does have a positive effect on quality of life issues (Paraskeva et al., 2005).
A number of studies have examined quality of life following laparoscopic and open 
colorectal surgery, but no consensus has been reached as to whether there is a real difference 
between the two approaches. Previous reviews (generally performed as part of an overall 
evaluation of laparoscopic colorectal surgery for cancer, with HRQoL only one of many 
endpoints considered) have also differed on their interpretation of the evidence. Some suggest 
that there are modest benefits in favour of the laparoscopic approach in the early 
postoperative period (Schwenk et al., 2005, Patankar and Lee, 2004, Balen et al., 2005, 
Korolija et al., 2004), with one suggesting that there is a significantly better quality of life in 
the longer term (Buchmann and Dincler, 2006). However, others suggest that there is no 
significant difference between the two approaches (Murray et al., 2006, Martel and Boushey,
2006).
No previous reviews have specifically evaluated quality of life, and none have 
performed a systematic review. Therefore, the aim of this systematic review is to compare the
2Dowson H, Cowey A, Ballard K, Gage H, Rockall T. Systematic review: Quality of life following 
laparoscopic colorectal surgery. Colorectal Disease 2008;10(8):757-768.
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QoL of patients recovering from laparoscopic and open colorectal surgery for all colorectal 
procedures, and to assess whether there are any benefits in QoL with the laparoscopic 
approach.
Method
Search strategy
A systematic review was performed according to guidelines published in the 
QUORUM statement (Moher et al., 1999, Wille-Jorgensen and Renehan, 2005). The scientific 
literature was searched using Medline, Embase, Ovid, CINAHL, and the Cochrane library 
databases between 1991 and March 2007 for studies evaluating quality of life following 
laparoscopic and open colorectal surgery. The following Medical Search Headings (MeSH) 
and Boolean terms were employed: “laparoscopy” OR “endoscopy”, AND “quality of life”, 
AND “colorectal surgery” OR “colectomy” OR “colonic” OR “rectal”. The explode function 
was used to broaden the search by including all subheadings, no language restrictions were 
imposed, but the search was limited to human subjects. In addition, the references of relevant 
studies were hand searched for further studies that may have been missed. The most recent 
search was performed in March 2007.
Data extraction
Two reviewers independently evaluated the abstracts of all relevant papers. All 
studies that fulfilled the inclusion criteria were retrieved. Data were extracted and recorded on 
a specially designed proforma and included first author, year of publication, country o f origin, 
study design, intention to treat, number of subjects, underlying disease process, type of 
surgery performed, HRQoL measures used, whether HRQoL was a primary or secondary 
endpoint, and the timing and outcomes of the HRQoL measures.
Studies were graded as to their quality using the Newcastle-Ottawa scale, which was 
adapted to match the needs of this particular study (Tilney et al., 2007, Wells GA, 2000,
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Mahid et al., 2006). This scale allocates stars to studies based on patient selection, 
comparability of the study groups, and assessment of outcome. Specific outcome criteria 
assessed for this review included HRQoL as a primary endpoint, use of a validated HRQoL 
measure, and pre as well as postoperative HRQoL scoring. Studies achieving six or more stars 
(out of a maximum of 10) were considered to have the highest quality.
Inclusion criteria
All prospective studies comparing elective laparoscopic and open colorectal surgery 
that used quality of life as an outcome measure were included. An institution reporting more 
than one study that had similar patient characteristics were limited to the higher quality or 
more recent publication. The search was not limited by language, although articles where a 
translation was not available were excluded. Studies using non-validated (to try and ensure 
that a comprehensive picture of the current published evidence was obtained) as well as 
validated HRQoL measures were included.
Exclusion criteria
Studies that were excluded included: those that did not compare laparoscopic and 
open surgery (control group); studies including paediatric subjects; non-elective surgery; non- 
English publications for which a translation was not available.
Outcomes
The primary outcome measure was HRQoL following colorectal surgery. Secondary 
outcome measures were performance status on discharge from hospital, and cosmesis.
Statistical analysis
Due to the disparate nature of the studies, use of a variety of HRQoL instruments and 
differences in the timings of assessment, it was not possible to perform a meta-analysis.
Studies were compared in table form at particular postoperative stages (two weeks, 
four to six weeks, and at two to three months). Due to the different measures that were 
employed, it also proved impossible to combine the studies on a Forest plot.
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Within the individual studies significance was taken as p<0.05. The analysis was 
performed using Microsoft Excel and SPSS software for Windows.
Quality of life measures
There are many HRQoL instruments in clinical use, and a comprehensive review of 
those used in laparoscopic surgery has been undertaken by the European Association of 
Endoscopic Surgery (Korolija et al., 2004). The measures that have been used in studies 
evaluating laparoscopic colorectal surgery are described in the methods chapter (chapter 3).
Results
18 studies evaluating 
HRQoL, of which 2 also 
assessed cosmesis
4 studies assessing independ­
ent status on discharge
199 excluded
15 excluded
1 cohort study7 Randomised trials 15 case matched series
48 papers retrieved
1 study evaluating 
cosmesis only
primary studies
10 excluded as not 
primary studies 
(review articles etc)
38 primary studies identified
247 studies identified from 
literature search -  abstracts 
reviewed
Figure 1: QoL review: Results of literature search (QoL review)
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The literature search identified 247 papers of which 46 were retrieved (Figure 1). 
Eleven were not primary research studies, and a total of twelve studies were excluded (Thaler 
et al., 2005a, Veldkamp et al., 2005, Braga et al., 2002, Schwenk et al., 1998, Dubemard et 
al., 2006, Breukink et al., 2006, Wind et al., 2006, Antolovic et al., 2006, Auguste et al., 2006, 
Demirbas S, 2005, Thornton et al., 2005, Pace et al., 2002, Shamsia, 2005). Two are still 
recruiting patients (Antolovic et al., 2006, Wind et al., 2006), and one has not reported 
HRQoL results at this time (Veldkamp et al., 2005). In two instances, two studies were 
reported from the same institution (Braga et al., 2002, Schwenk et al., 1998); the most recent 
or better quality publication was used in this review. Eight had no open control group 
(Auguste et al., 2006, Dubemard et al., 2006, Breukink et al., 2006, Demirbas S, 2005, 
Thornton et al., 2005, Pace et al., 2002, Thaler et al., 2005a) (including one study that 
evaluated laparoscopic rectocele repair with transanal repair (Thornton et al., 2005)), and 
translations were not available for one study published in Russian (Shamsia, 2005) and one in 
Japanese (Kobayashi et al., 2006).
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ithor Year Design NOS (max QoL 1° Number of patients Conversion Intention Type o f Type o f QoL Timing of 
10 stars) or 2° Lap Open rates (%) to treat colorectal surgery measure measures
_________________________________________ endpoint_________________________________________________ disease________________________________________
igher
aality
ng 2006 RCT 2° 41 19 7 Yes Cancer All
Colorectal
resections
EORTC-
C30
EORTC-
CR38
2 & 6 
weeks
aartense 2006 RCT 1° 30 30 10 Yes Crohns Ileocolic
resection
SF36
GIQLI
1, 2, 4
weeks 
3 months
lillou 2005 RCT ******** 2° 526 268 29 Yes Cancer All EORTC- 2 weeks
LASICC C30 3 months
idy) EORTC-
CR38
(3 & 5 
years)
aartense 2004 RCT 1° 30 30 0 Yes UC & FAP IPAA SF36
GIQLI
1, 2, 4
weeks 
3 months
eeks 2002 RCT ********* 1° 221 228 26 Yes Cancer All SDS 2 days
OST QLI 2 weeks
idy) Global 2 months
hwenk 1998 RCT 1° 30 30 0 NS Cancer All EORTC-
C30
1 & 4 
weeks 
3 months
>wer
aality
mg 2007 Cohort ** 1° 125 103 NS NS Cancer TME EORTC-
C30
EORTC-
CR38
3-6
months 
12-18 
months 
2-5 years
iriv 2006 Case
matched
*** 2° 86 86
(7% o f lap 
cohort)
No Prolapse Rectopexy NV 59
monthsf
•aga 2005 RCT 1° 190 201 4 Yes Cancer All SF36 12, 24, 48 
months
:hiedeck 2005 Case
matched
* 1° 22 22 - NS Cancer TME EORTC-
CR38
48
monthsff
irson 2005 Case
matched
**** 1° 33 33 - No UC & FAP IPAA NV 13
monthsf
taler 2005 Case
matched
**** 1° 21 16 - No Crohns Ileocolic
resection
SF36
GIQLI
42
monthsf
ikolovic 2004 Case
matched
*** 1° 121 48 6.1 Yes All All SF36 32
monthsf
laler 2003 Case
matched
*** 1° 49 50 ■ No Benign disease All SF36 40-54
monthsff
iachi 2003 Case
matched
** 2° 26 87 No Cancer All NV > 1 year
following
surgery
)blick 2002 Case
matched
*** 1° 45 45 No Diverticular
disease
Sigmoid
colectomy
SF36 2 years 
(lap), 7 
years 
(open) f
anker 2001 Case
matched
1° 15 17 NS No UC & FAP IPAA SF36
GIQLI
14-16
monthsf
anker 1998 Case
matched
**** 1° 11 11 NS No Crohns Ileocolic
resection
IBDQ 7 months 
(lap) 40 
months 
(open)f
)tal 1622 1324
Table 6: QoL review: Overview of included studies. Quality of studies was assessed using the NOS, 
Newcastle-Ottawa score. IPAA Ileal Pouch Anal Anastamosis. f  mean, f f median. NS, not stated. NV, 
non-validated.
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Author Year Design NOS Number o f  
patients
Intention to 
treat
Type o f  
surgery
Measure Timing o f  
measure
Findings Comment
Lap Open (conversion
rate)
Independent
status on
discharge
Vignali 2005 Case
matched
*** 61 61 Yes (6.%) All Independent 
status (NV)
On
discharge
Significantly 
better for lap
(p=0.02)
Stocchi 2000 Case
matched
**** 42 42 Yes (14%) All Independent 
status (NV)
On
discharge
Significantly 
better for lap 
(p=0.025)
Pfeifer 1995 Case
matched
*** 53 53 No All Independent 
status (NV)
On
discharge
No
difference
Senagore 1993 Case
matched
*** 38 102 No (32%) All Kamofsky
performance
status
On
discharge
Superior for 
lap
Cosmesis
Hashimoto 2001 Case ** 17 13 No IPAA NV Significant
matched
Dunker 2001 Case
matched
**** 15 17 No IPAA NV, Body 
image
questionnaire
14-16
monthst
Significant
(p=0.03)
No difference in 
body image scale
Dunker 1998 Case
matched
**** 11 11 No Ileocolic
resection
NV, Body 
image
questionnaire
7 months 
(lap) 40 
months 
(open)t
Significant
(p<0.01)
Pfeiffer As above No Included 2 questions
difference on cosmesis
Table 7: QoL review: Studies assessing patient’s performance status and cosmesis. NOS, 
Newcastle-Ottawa score. NV, non-validated measure, f  mean.
Twenty-three primary studies (Larson et al., 2005, King et al., 2006, Guillou et al., 
2005, Maartense et al., 2004, Maartense et al., 2006, Weeks et al., 2002, Schwenk W, 1998, 
Kariv et al., 2006, Braga et al., 2005b, Vignali et al., 2005, Sokolovic et al., 2004, Thaler et 
al., 2003, Roblick et al., 2002, Dunker et al., 2001, Stocchi et al., 2000, Pfeifer et al., 1995, 
Senagore et al., 1993, Dunker et al., 1998, Yang et al., 2007, Schiedeck et al., 2005, Adachi et 
al., 2003, Thaler et al., 2005b, Hashimoto et al., 2001) were identified that satisfied the 
inclusion criteria. Six of these studies were evaluated to be high quality (scoring more than 6 
stars on the NOS) with respect to their quality of life data (Table 6), and 17 of lower quality. 
Four of these studies assessed functional (independent) status on discharge, and three 
evaluated cosmesis (Table 7).
The 18 studies evaluating HRQoL included outcomes on a total of 3004 patients, of
whom 1651 (55%) had had laparoscopic surgery. The most frequent diseases were colorectal
cancer (eight studies) and inflammatory bowel disease (3 studies each for Crohn’s disease and
ulcerative colitis (UC)). With regards to the surgery performed, eight studies included all
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colorectal resections, with the remainder focusing on specific procedures (including three 
evaluating pouch procedures).
Quality of life measures
In total, 15 studies (65%) used validated HRQoL measures, with the most common 
being the SF36 (8 studies), EORTC (4), and GIQLI (3) questionnaires. The other validated 
HRQoL measures employed (each in one study) were the Symptom Distress Scale (SDS) 
(McCorkle and Quint-Benoliel, 1983), Quality of life index (QLI) (Tsevat et al., 1990), and 
Inflammatory Bowel Disease Questionnaire (de Boer et al., 1995). Four studies assessed 
independent status on discharge (Vignali et al., 2005, Stocchi et al., 2000, Senagore et al., 
1993, Pfeifer et al., 1995), with one using a validated score (the Kamofsky score) (Senagore 
et al., 1993); the remaining studies employed unvalidated scoring systems.
Higher quality studies
The six higher quality studies (Table 6) were all randomised controlled trials, used 
validated HRQoL measures, and undertook preoperative assessments as a baseline reading. 
Across these six studies, 12 different HRQoL assessments were performed, all during the first 
three postoperative months. The timings of these measures and their results are displayed in 
Table 8.
Of the 12 different HRQoL assessments performed, only two demonstrated 
significant differences. One of these was a single-item global utility score (in effect a visual 
analogue score out of 100) performed as part of the COST study(Weeks et al., 2002), which 
demonstrated a small but significant (when comparing the median score, although not the 
mean scores) difference in favour of the laparoscopic group at two weeks postoperatively 
(laparoscopic 80 (76.9) vs open 75 (74.4), median (mean), p=0.009 (p=0.09)). However this 
should be interpreted with the results of the other, more sensitive measures (SDS and QLI) 
performed within the COST study, which showed no significant difference at the same time. 
As the authors comment, there is “no statistically significant improvements in symptoms or 
QoL in the immediate postoperative period or over 2 months follow-up” (Weeks et al., 2002).
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The study of Schwenk et al from 1998 (published in German) also demonstrated a 
significant difference between the laparoscopic and open groups (Schwenk W, 1998). The 
authors found an improvement in QoL in the laparoscopic group, as measured by EORTC- 
QLQ-C30 at one week and four weeks postoperatively (for the global score, p=0.05). The 
post-operative data was only presented on a graph, and it is difficult to extract the precise 
data. This was a relatively small study (60 patients in total), and is therefore underpowered to 
detect differences of less than 30-35 percent.
Examining the other studies (Table 8) demonstrates some minor advantages for the 
laparoscopic group in the first two postoperative weeks. However these advantages should be 
interpreted with caution. For example, in Maartense’s paper of 2006, there were differences in 
the preoperative scores (which mirror the postoperative scores) in favour of the laparoscopic 
group for both SF36 (38 (lap) v 34, p=0.10) and GIQLI (90 (lap) v 85, p=0.13), but they did 
not compensate for this by looking at the mean change in scores.
In summary, evaluating the higher quality studies has demonstrated only one study 
(with one HRQoL instrument) that has shown a significant advantage for the laparoscopic 
approach. No other studies have shown a significant or consistent difference between the 
laparoscopic and open groups.
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Lower quality studies
Twelve studies were assessed to be lower quality with regards to their quality of life 
data. None of these studies performed preoperative measures as a baseline, and the QoL 
assessments were performed at a variety of times postoperatively (Table 9).
Nine studies did not find a difference between the laparoscopic and open techniques. 
One paper, using the EORTC measure, found that physical functioning in the first 3-6 
months, and sexual function during the 12-18 month postoperative period were improved in 
the laparoscopic group(Yang et al., 2007). No details were given on this data. Braga (at 12 
months) and Sokolovic (at 2.75 years) found a significant difference in two out of the eight 
domains using SF-36, although neither reported the overall SF36 score (Sokolovic et al., 
2004, Braga et al., 2002). In both these studies physical functioning was one of the domains 
where a difference was demonstrated (Table 9).
Author Pre­ Timing of measures Findings Comments
operative postoperatively (mean) 3-12 months 1-2 years 2-5 years
assessment?
Yang No 3-6 months, 12-18 months, 2- 
5 years
Improved PF Improved 
sexual function
Paper states that there were 
significant improvements in 
certain scores, but no data 
was given, no p values
Kariv No 5 years No Difference
Braga No 12,24,48 months Improved PF No Difference No Difference 2 out o f 8 SF36 domains
(p=0.006) and GH showed a difference at 12
(p=0.05) with lap months, but at no other time.
group Overall SF36 score not given.
Schiedeck No Postop ? No Difference
Larson No 13 months No Difference No Difference
Thaler No 42 months No Difference
Sokolovic No 2.75 years Improved PF and VT with 
lap group (p<0.05)
2 out o f 8 SF36 domains 
demonstrate a significant 
difference
Thaler No 40-54 months No Difference
Adachi No 7 and 14 days No difference
Roblick No 2 (lap) & 7 (open) years No Difference
Dunker No 14 (lap) &16 (open) months No Difference
Dunker No 7 (lap) & 40 (open) months No Difference No Difference (open)
(lap)
Table 9: QoL review: Results of lower quality studies. PF, physical functioning; VT, vitality; GH, 
general health.
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Independent status and Cosmesis
Four studies, including 2 assessing patients over 80 years old, evaluated performance 
status or independent status on discharge (Senagore et al., 1993, Stocchi et al., 2000, Vignali 
et al., 2005, Pfeifer et al., 1995), with three demonstrating a significant difference in favour of 
the laparoscopic group. Only one reported using a validated measure (Senagore et al., 1993).
Three small studies, each with significant methodological flaws, have investigated 
cosmesis; all of these favoured the laparoscopic group, but cosmesis is an area which requires 
further research, particularly in this group of patients.
Discussion
The aim of this review was to evaluate the available evidence on the quality of life of 
patients following laparoscopic and open colorectal surgery, and to ascertain whether there 
are benefits with the laparoscopic approach. Health-related quality of life has been 
increasingly regarded as an important measurement in clinical trials.
The result of this review suggests that there are no significant advantages in terms of 
HRQoL with the laparoscopic approach compared to open surgery, based on the current 
evidence. Studies that have assessed QoL up to 3 months postoperatively have generally been 
good quality randomised controlled trials, and these have shown no significant difference 
overall. Other studies, evaluating outcomes up to 5 years after surgery, have similarly shown 
no consistent advantages for either approach.
Some studies have demonstrated minor benefits in the first month after surgery with 
the laparoscopic approach, and these findings have been reinforced by studies evaluating 
performance status on discharge (which has been used as a surrogate marker for QoL). 
However, these benefits are not reproduced consistently.
A further problem with the current literature, is that some studies reported differences 
in the subscales or domains of various QoL measures, but did not report all the subscale
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results or overall scores, making it difficult to rigorously assess their data; other studies gave 
no data at all, just stating whether there were significant differences or not.
Taking these factors into consideration, it can be seen that there is a paucity of good 
quality data, and we were unable to perform a meta-analysis. The results have therefore been 
presented in table form, but it can still be clearly seen that the current evidence demonstrates 
at most minimal differences between laparoscopic and open surgery with regards to 
postoperative QoL.
What are the explanations for this?
Firstly, that there is no real difference between the two approaches. However, many 
studies have previously demonstrated (and has been confirmed by meta-analyses (Murray et 
al., 2006, Schwenk et al., 2005, Abraham et al., 2004)) that patients having laparoscopic 
surgery have less postoperative pain, an earlier discharge from hospital, and a faster recovery 
in terms of returning to normal activities. One would expect that these factors would 
contribute to an improved postoperative QoL. In addition, studies have demonstrated 
improvements in QoL following other procedures performed laparoscopically, such as groin 
hernia repair (Liem et al., 1997, Wellwood et al., 1998), and cholecystectomy (McMahon et 
al., 1994).
Secondly, it is possible that there may be differences in QoL, and the previous studies 
included in this review have not been able to demonstrate this? There are possible 
explanations that might account for this.
The QoL instruments used may not be sensitive enough to pick up significant 
differences. This has been suggested previously, with Gill et al suggesting that most 
measurements of QoL in the medical literature seem to aim at the wrong target (Gill and 
Feinstein, 1994). However, a variety of instruments have been used to investigate recovery 
after laparoscopic colorectal surgery, and the results from this review are very consistent.
Alternatively, the timing of the measurements may be an issue. If there were to be 
differences between laparoscopic and open colorectal surgery, it would be most likely that 
these are observed in the first few weeks postoperatively. Few studies have assessed this time,
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and those that have, have tended to perform only one measure (typically at two weeks). There 
is a need for well constructed QoL studies to investigate the early postoperative period in 
greater detail.
A further point to be made is that QoL was not a primary outcome measure in many 
of the studies, and some therefore are unlikely to have been powered adequately to 
demonstrate differences in QoL. The higher quality studies in this review are dominated by 
the large multicentre randomised trials, CLASICC and COST. Both of these studies reported 
data on an intention to treat basis, but had very high conversion rates (29 and 26 percent 
respectively), and these trials also demonstrated that there is a significant learning curve with 
laparoscopic colorectal surgery, with many surgeons entering patients into these trials whilst 
still on their learning curve. Results from experienced laparoscopic centres report lower 
conversion rates of 5-10 percent (Senagore et al., 2002, Braga et al., 2005a, King et al., 2006). 
The COST study demonstrated that patients who required intraoperative conversion, had a 
poorer QoL outcomes than those who had a successful laparoscopic resection. It seems 
reasonable to assume that as experience with laparoscopic colorectal surgery increases and 
conversion rates reduce, QoL outcomes are likely to improve.
Evidence has also already shown a faster return to normal activities and an earlier 
discharge from hospital with laparoscopy, and these have previously been used as surrogate 
markers for improved quality of life. The current review has suggested that there are benefits 
in functional status at the time of discharge and cosmesis, and these factors would indicate an 
improvement in QoL.
This systematic review has shown that the current evidence does not demonstrate an 
advantage for laparoscopic surgery compared to open surgery, with respect to QoL during a 
patient’s recovery from surgery. There are trends in favour of the laparoscopic approach 
during the first month postoperatively, supported by an improvement in performance status at 
the time of discharge from hospital. Further studies of good methodological quality are 
required, particularly to evaluate the early postoperative period.
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National Institute for Clinical Excellence
The National Institute for Clinical Excellence (NICE) commissioned a clinical and 
cost effectiveness analysis on laparoscopic and open colorectal surgery for CRC (NICE, 
2000, NICE, 2006). This has already been discussed in the thesis, but their main advice, 
particularly with regards to costs and quality of life, are briefly reviewed again here. Given 
the fundamental role that NICE guidance plays in the practice of evidence-based medicine in 
the United Kingdom, it is important to bear their findings in mind.
The analysis was performed by the Aberdeen Health Technology group, who 
performed a comprehensive systematic review and meta-analysis based on RCTs published 
between 2000 and 2005 that compared laparoscopic and open surgery for colorectal cancer 
(Murray et al., 2006). Laparoscopic surgery was associated with a longer operating time, and 
the mean conversion rate was 20%. There was a shorter post-operative stay of 2.6 days, and 
no difference in overall and disease-free survival.
With regards to costs, the health assessment group concluded that there is “a paucity 
of good quality data on costs following laparoscopic colorectal surgery” (Murray et al., 2006, 
de Verteuil et al., 2007, Hernandez et al., 2008), with only 5 studies meeting the inclusion 
criteria, and “considerable variation in the reported differences in mean costs”. Their analysis 
concluded that laparoscopic surgery was more expensive by £265. With respect to quality of 
life, again the assessment group conclude “that little data was available”, but “there was little 
direct evidence of quality of life benefits associated with the laparoscopic procedure”.
The assessment group used a Markov model to estimate the long-term costs and 
benefits, and performed a cost-effectiveness analysis. This analysis goes on to conclude that 
laparoscopic surgery for colorectal cancer would be cost effective if there was an 
improvement in the health-related quality of life (HRQoL) of patients equivalent to between 
0.009 and 0.01 Quality Adjusted Life Years (QALYs) (Murray et al., 2006).
It should be remembered that the cost effectiveness analysis was based on only 5 
RCTs (dominated by the CLASICC and COLOR studies), and as with all meta-analyses, it is
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limited by the quality of the primary studies. In these, the mean conversion rate was 20%, 
which as has been described previously, is quite high, suggesting that in some of the studies, 
surgeons were still on their learning curves.
Adhesions
This section reviews the incidence and clinical consequences of adhesion formation. 
There is currently little published research relating to adhesion formation following 
laparoscopic colorectal surgery. Therefore the aim of this section is to give a broad overview 
of adhesions and their clinical effects, with the literature that is available and relevant to 
laparoscopic colorectal surgery reviewed in more detail.
Background
Adhesion formation is a potential complication of any abdominal surgery. 
Complications due to adhesions result in significant morbidity and mortality (Menzies, 1993, 
Parker et al., 2001), and result in a large financial burden (Menzies et al., 2001). Colorectal 
surgery accounts for a large proportion of the patients who go onto develop adhesion related 
problems (Parker et al., 2004).
Adhesions can either be congenital or acquired secondary to intra-abdominal 
inflammation. They have been defined as “internal scars that form through a series of 
complex processes, involving injured tissues and the peritoneum” (Ellis et al., 1999). 
Adhesion formation is an inevitable consequence of peritoneal wound healing, and can be 
caused by a diverse range of irritants, such as exposure to infection or intestinal contents, 
ischaemia, irritation from foreign materials such as sutures or mesh, and abrasion (Gutt et al.,
2004).
Following the peritoneal injury, healing begins with the formation of a fibrin gel 
matrix. When two injured peritoneal surfaces covered with this matrix come into contact, 
sticky fibrin bands and bridges form between them. Whilst the fibrinolytic system should then 
dissolve these fibrinous adhesions, fibrinolytic activity is reduced following surgery
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(Holmdahl et al., 1998). Persistence of this fibrinous matrix results in collagen deposition by 
fibroblasts to form a permanent adhesion. Angiogenesis subsequently occurs due to the 
relative ischaemia of the underlying tissues.
Adhesions cause a variety of clinical problems, including bowel obstruction, pelvic 
and abdominal pain, and infertility (Vrijland et al., 2003). In patients having a reoperation, 
adhesions prolong the time to gain access to the abdominal cavity and the overall operative 
time (Coleman et al., 2000), and may increase the incidence of complications due to 
inadvertent enterotomies.
Epidemiology
Adhesions are a common problem. Studies vary in their reports of the incidence of 
adhesion formation following general surgical procedures, but it is estimated to be between 
63% and 97% (Menzies and Ellis, 1990, Weibel and Majno, 1973, Parker et al., 2005). Up to 
33% of patients are readmitted to hospital an average of 2.2 times for adhesion related 
problems during the 10 years following open abdominal surgery (Ellis et al., 1999, Parker et 
al., 2001). Within the 2 years after surgery, a large retrospective cohort study found that 20-25 
percent of patients were admitted with obstruction and 3.4% required surgery with lysis of 
adhesions (Beck et al., 1999).
Following an intestinal resection, 30% of the episodes of adhesive small-bowel 
obstruction occur within 30 days, and 50% within three months (Kariv et al., 2006). This 
implies that adhesion formation occurs in the early postoperative period. An animal study 
looking at the formation of adhesions following mesh repair of incisional hernia supports this, 
stating that the “visceral barrier [of a mesh] should be present for at least one week, because 
this is the time frame in which adhesion formation takes place” (Burger et al., 2006).
The Surgical and Clinical Adhesions Research (SCAR) group have extensively 
investigated the morbidity associated with adhesions, and published three studies on their 
epidemiological, clinical, and economic aspects (Ellis et al., 1999, Parker et al., 2004, Parker 
et al., 2005). The SCAR-2 study demonstrated that there has been no significant change in the
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incidence of adhesions between 1996 and 1999, despite advances in anti-adhesion prevention 
strategies (Parker et al., 2004).
Adhesions have also been implicated as the aetiological factor in up to 40% of cases 
of infertility (Milingos et al., 2000, Vrijland et al., 2003), and 82% of patients with chronic 
abdominal pain (Swank et al., 2003).
With respect to abdominal surgery, colorectal procedures are associated with the 
highest incidence of adhesion-related readmissions. Although the greatest burden of 
readmission is in patients who have had excision of the rectum, panproctocolectomy (15.4%), 
total colectomy (8.8%), and patients having ileostomy surgery (10.6%) have been shown to 
result in the highest risk of readmission due to adhesions (Parker et al., 2005). Beck et al 
found a higher proportion of patients required adhesiolysis following operations on the 
rectum and rectosigmoid than other intestinal procedures (Beck et al., 1999).
It has been estimated that 71% of adhesions involve the laparotomy scar (Luijendijk 
et al., 1996), and conventional open colorectal surgery tends to require a sizeable incision. 
Results from an animal study performed in Japan suggests that the manual handling of the 
small intestine at open surgery is a cause of postoperative adhesion formation (Hiki et al., 
2006).
Economic aspects
There is a large financial and economic burden on healthcare providers as a result of
adhesive bowel obstruction. In the United Kingdom, the total cost per admission for adhesive 
small bowel obstruction was £4,677.41 for patients treated surgically and £1,606.15 for those 
treated conservatively (Menzies et al., 2001). Based on these figures, Wilson et al developed a 
model which estimated the direct UK costs of adhesion related readmissions over a 10-year 
period to be over £569 million (Wilson et al., 2002). Using this model, the mean cost of 
adhesion-related readmissions per patient one year after lower abdominal surgery is estimated 
as £153, and after 10 years as £602. They go on to state that use of a low cost (defined as £50 
per patient) adhesion reduction product with a 25% reduction in readmissions would provide
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cost savings for the NHS of up to £71 million over the next 10 years. However an adhesion 
reduction product costing £200 would incur net losses to the NHS.
In the US, the cost of hospitalisations relating to intra-abdominal adhesions was 
estimated to be $1,179.9 million (Ray et al., 1993). A 1997 Swedish study found that 
adhesive bowel obstruction causes 2330 hospital admissions annually, which is associated 
with an estimated direct cost of about US$13 million (Ivarsson et al., 1997).
A recent retrospective cohort study from Oxford has attempted to estimate the cost of 
adhesions following open proctocolectomy and ileal pouch formation (Sileri et al., 2008). 
They have reviewed the incidence of adhesive small bowel obstruction in a cohort of 276 
patients who have undergone open pouch surgery, and compared this with a small group of 
patients who have had laparoscopic surgery. The laparoscopic group only contained 9 patients 
in whom a second-stage procedure was performed, at which time the adhesions could be 
evaluated. They estimate the cost of adhesions in the open group, and model the potential 
economic impact of a laparoscopic approach reducing adhesion formation by 50%. The model 
leans heavily on an infertility economic modeling, which is estimated to save $1996 per 
laparoscopic pouch, with a further $1286 saving in costs due to adhesive small bowel 
obstruction. The savings outweigh the increased costs of a laparoscopic procedure ($1450) by 
$1832 per pouch constructed. It needs to be bourne in mind that this is a retrospective series, 
modeling potential savings, based on only a small number of laparoscopic patients (and so is 
very underpowered), and it is difficult to assess the accuracy of the infertility financial model.
Prevention of adhesions
The SCAR study group suggest that “failure to take precautions to prevent adhesion 
formation may have medico-legal consequences” (Parker et al., 2005). A number of different 
techniques have been employed in efforts to reduce the formation of adhesions, and these are 
briefly reviewed here. It is difficult, however, to measure the effect of these techniques, due to 
the large numbers of patients required in prospective studies in order to demonstrate a 
reduction in adhesive small bowel obstruction (Wilson et al., 2002), and the difficulty in
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assessing the accuracy of surrogate markers for adhesional small bowel obstruction (this point 
is examined in more detail later in this section).
Surgical Technique
It has been suggested that the formation of adhesions may be reduced by “observing 
well-established surgical principles”, such as gentle dissection, careful haemostasis, 
prophylaxis against infection, irrigation, putting little tension on tissues, and avoidance of 
ischaemia, thermal injury, and the introduction of foreign materials (Bullen and Hershman,
2004). However, there are no studies demonstrating fewer adhesions with “good” surgical 
technique, and these concepts are beneficial in theory only (Brazier and Johnson, 2001).
Adhesion reduction techniques
Gels and solutions
Crystalloid solutions such as Ringer’s lactate have been used as a means of physically 
separating healing surfaces, but studies have not shown this to be efficacious (Wiseman et al., 
1998). Hyaluronic acid (HA) gel produced fewer adhesions in an animal study, although the 
gel’s high viscosity made its application difficult (De Iaco et al., 1998). Many other solutions 
(including Carboxymethylcellulose (CMC), Dextran 70, Heparin, and Povidone) have been 
tried, but with little success (Kavic and Kavic, 2002, Brazier and Johnson, 2001) . There is 
currently no convincing evidence of their efficacy.
Icodextran 4% solution (Adept®, Baxter International Inc.) reduced the incidence of 
adhesion formation in gynaecological patients in a double-blind RCT of 400 patients (Brown 
et al., 2007). The endpoints of this study were an evaluation of adhesion formation at a 
“second-look” laparoscopy and American Fertility Scores, but not episodes of adhesional 
small bowel obstruction. However, adept is contra-indicated in surgery involving bowel 
resection (due to the risk of septic complications), and is therefore not applicable to colorectal 
surgery.
Barriers
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Seprafilm (Becker et al., 1996, Kusunoki et al., 2005) and Sepracoat (Diamond, 
1998) (HA and CMC ) have been shown to reduce adhesion formation after various types of 
abdominopelvic surgery. A RCT looking at the incidence of adhesive small bowel obstruction 
demonstrated that whilst Seprafilm did not reduce the overall rate of bowel obstruction, it did 
reduce the operative rate for adhesive small bowel obstruction (relative risk reduction of 47%, 
from 3.4 to 1.8%) over a mean follow-up of 3.5 years (Kariv et al., 2006). A meta-analysis 
has concluded that whilst Seprafilm seems to decrease abdominal adhesions after general 
surgery, there was no reduction in postoperative intestinal obstruction (Zeng et al., 2007); of 
greater concern, however, is that Seprafilm was associated with an increase in the incidence 
of abdominal abscesses and anastomotic leaks. Other barrier agents include oxidised 
regenerated cellulose (Interceed®), which has been proven to be safe and reasonably 
efficacious (Larsson, 1998), and expanded polytetrafluoroethylene (Haney et al., 1995). 
Systemic therapies
A number of systemic agents have been tried, including fibrinolytic agents and 
corticosteroids, but none have been successful in preventing adhesions in clinical studies 
(Kavic and Kavic, 2002).
Summary
Overall, despite the large number of techniques and materials that have been tried, the 
use of anti-adhesion agents in general surgery has been limited. This is because of doubts 
regarding their efficacy (the SCAR-2 study demonstrated that there had been no significant 
reduction in adhesion-related admissions despite the increased use of adhesion reduction 
techniques), and concerns over an increase in complications, particularly abdominal sepsis, 
associated with their use.
Adhesion formation in laparoscopic and open surgery
It has been hypothesized that laparoscopic surgery, by minimising peritoneal trauma,
may result in reduced adhesion formation following abdominal and pelvic operations. Recent 
experimental (Hanly et al., 2003) and clinical (Sietses et al., 1999) evidence has demonstrated
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that postoperative inflammation (as assessed by measurement of acute phase markers) is less 
pronounced after laparoscopic procedures than open surgery. This supports the evidence that 
manual manipulation of the small intestine is associated with increased adhesion formation in 
animal models (Hiki et al., 2006).
Two reviews have been undertaken comparing laparoscopy and laparotomy with 
regard to adhesion formation (Gutt et al., 2004, Kavic and Kavic, 2002). In both of these 
reviews, a total of 15 studies dating from between 1987 and 2001 were identified (11 in 
animal models, 4 in humans described in more detail below). 12 of these (including all 4 
human studies (Lundorff et al., 1991, Milingos et al., 2000, Audebert and Gomel, 2000, 
Polymeneas et al., 2001)) demonstrated fewer adhesions following laparoscopy than 
laparotomy, with respect to at least one of the different areas assessed (the operative site, 
access wound, and distant sites). However, some of the animal studies report finding no 
difference in adhesion formation between laparoscopic and open procedures (Filmar et al., 
1987, Marana et al., 1994, Chen et al., 1998). The reviews conclude that laparoscopy may 
reduce postoperative adhesion formation relative to laparotomy (Kavic and Kavic, 2002).
Gynaecological studies
Audebert et al evaluated 814 gynaecological patients undergoing laparoscopy 
(Audebert and Gomel, 2000). They assessed the incidence of umbilical adhesions, and 
divided the patients into 4 groups: Group I, no previous surgery; Group II previous 
laparoscopic surgery; Group III previous laparotomy with a supra-pubic incision; and Group 
IV, previous laparotomy with a midline incision. In those patients who had had previous 
surgery, nearly all had undergone gynaecological procedures. The incidence of umbilical 
adhesion formation in the respective groups was 0.68%, 1.6%, 19.8%, and 51.7% (Audebert 
and Gomel, 2000). Two further human studies in gynaecological patients both demonstrated 
reduced adhesion formation at the operative site in the laparoscopic arm (Lundorff et al., 
1991, Milingos et al., 2000). However, a large epidemiological study of gynaecological 
patients (15,197 patients following laparoscopic surgery, 8849 after an open procedure),
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found that open and laparoscopic gynaecological surgery were associated with comparable 
risks of adhesion-related readmissions (Lower et al., 2004).
General surgical studies
With respect to general surgical procedures, there have been studies looking at 
adhesion formation (by assessing the extent of adhesion formation at a second procedure) 
following laparoscopic and open cholecystectomy, both in human subjects (Polymeneas et al., 
2001) and animals (Cainzos et al., 2006, Gal et al., 2000). These studies were small (the 
human study had 26 patients in total, with 18 having had a laparoscopic and 8 an open 
cholecystectomy), but all demonstrated significantly fewer adhesions in the laparoscopic 
groups. A further study has assessed the formation of new adhesions (in a rabbit model) 
following laparoscopic and conventional adhesiolysis, and this demonstrated significantly 
fewer adhesions in the laparoscopic arm (Tittel et al., 2001).
Majewski retrospectively reviewed the incidence of readmissions and reoperations in 
153 patients following laparoscopic and open surgical therapies for an acute abdomen, and 
found fewer episodes of adhesion related small bowel obstruction in the laparoscopic 
treatment arm (Majewski, 2005). It is difficult to draw firm conclusions from this study, as 
the study patients had had an acute abdomen (the cause of which could increase the likelihood 
of adhesions); only 49% of the original patient cohort were available for follow-up; and there 
were small numbers of adhesion related complications in both groups. A letter was published 
in the Lancet presenting findings of a RCT evaluating adhesions following laparoscopic and 
open appendicectomy (de Wilde, 1991). The authors re-laparoscoped the patients 3 months 
after their appendicectomy, and found significantly fewer adhesions in the laparoscopic 
group. However, this study has never been reported completely, and so these results should 
also be interpreted with caution.
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Colorectal studies
With respect to colorectal procedures and adhesions, there is even less evidence 
available. A small animal study evaluated the formation of adhesions in 5 pigs following a 
laparoscopic anterior resection, and reported only “minimal insignificant adhesions” in one 
animal, with no adhesions to the port sites (Reissman et al., 1996).
Sileri and colleagues compared the incidence of adhesive small bowel obstruction 
following open and laparoscopic pouch formation (Sileri et al., 2008). The laparoscopic 
patients had fewer episodes of small bowel obstruction, and required less adhesiolysis at the 
time of reoperation, than their open counterparts. However, a number of methodological 
issues compromise this study, as have already been described with respect to the economic 
modelling, including that it was a retrospective review of case notes, and only had 9 patients 
in the laparoscopic group who were followed up completely.
The most pertinent study with regards to colorectal surgery, is an analysis looking at a 
sub-group of patients from the CLASICC trial (Taylor, 2007). This analysis has not been 
published, but was presented at the Association of Surgeons of Great Britain and Ireland 
annual meeting in 2007, and the following details are taken from the abstract published at that 
meeting. The primary endpoint of this study was adhesive intestinal obstruction (AIO) 
readmission rates within 3 years of surgery. Notes on 468 patients were reviewed 
retrospectively, and the authors estimated the study had 80% power to detect a difference in 
readmission rates of 3.8 percent. This required a reduction from 5.1% in the open group to 
1.3% in the laparoscopic arm, an overall reduction of 72%. Early results suggest that there 
were fewer readmissions following laparoscopic colonic surgery, but more readmissions 
following rectal surgery in the laparoscopic group. Significance values are not given, but the 
conclusion states that laparoscopic surgery was associated with lower rates of AIO. Again, 
these claims need to be interpreted with caution until all the results are formally reported.
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Summary
The literature reviewed, suggests that there may be fewer adhesions formed following 
laparoscopic surgery as compared to open surgery, but there is a paucity of robust evidence, 
particularly in human studies. In particular, there have been no prospective studies looking at 
adhesion formation in laparoscopic and open colorectal surgery.
Measures of adhesion formation
One problem encountered when trying to assess the impact of adhesions, is in 
identifying an appropriate end-point. Concentrating on adhesional small bowel obstruction, 
endpoints that can be considered in studies include the number of acute admissions, length of 
hospital stay, or the number of operative interventions. Since the absolute risk of an episode 
of adhesive obstruction is relatively low, it has been shown that very large numbers of 
patients are required to demonstrate significant differences between two groups of patients 
with respect to these end-points (Wilson et al., 2002).
Wilson et al estimate that, when considering an adhesion-reduction agent, between 
5686 and 7766 patients would be needed to demonstrate a difference with a statistical 
significance of 80 or 90% power; as they conclude, the feasibility of undertaking such a trial 
is doubtful, due to the large number of patients required (Wilson et al., 2002). For example, a 
trial from America prospectively followed 1701 patients who were randomised to receive 
seprafilm or not following intestinal resection (Kariv et al., 2006). Despite the large number 
of patients recruited, according to the work done by the SCAR study group, this trial was still 
underpowered. Results from this RCT demonstrated that the primary endpoint of overall 
bowel obstruction was the same in both groups, although there were fewer episodes of 
adhesive small bowel obstruction requiring reoperation in the treatment arm.
As a result of these challenges in performing prospective studies using episodes of 
SBO as an endpoint, alternative measures have been sought. The most commonly employed is 
a visual assessment of the peritoneal cavity for adhesion formation during a second-look 
procedure (Cohen et al., 2005, Kusunoki et al., 2005). It should, however, be emphasised that
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there is no direct evidence linking the incidence of clinically relevant adhesion related 
problems to the extent and severity of adhesion formation. This has been hypothesized and 
presumed in many studies (see below for studies using adhesion scoring systems), but again 
the numbers required to demonstrate this conclusively are very large making a prospective 
study almost impossible to perform.
Assessing adhesion formation is also problematic, partly due to the practical 
difficulties in performing a second operative procedure (for ethical reasons, it is not possible 
to perform a randomised study involving further surgery, so assessment at a second-look 
procedure has to be opportunistic) (Majewski, 2006), but also because of significant 
variability in the evaluation of adhesions. To try to limit this variability, a number of scoring 
systems have been developed, although none have been universally accepted.
Adhesion Scoring Systems
The majority of scoring systems have been developed for gynaecological patients, 
with particular reference to women with fertility problems. Examples of these include those 
developed by Hulka (Hulka, 1982) and the American fertility Society (AFS) (American- 
Fertility-Society, 1988). These were refined in 1994 by the Adhesion Scoring group, who 
proposed a system based on the extent (0-3), and severity (0-3), for 23 individual locations, 
mainly in the pelvis (Adhesion scoring group, 1994). This is probably the most widely used 
scoring system, and has been used as the basis for the assessment of adhesions in urological 
(Pautler et al., 2002) and surgical patients (Kusunoki et al., 2005). Other scoring schemes, 
based on similar criteria and variations thereof, have been put forward by Nair (Nair et al., 
1974), Blauer (Blauer and Collins, 1988), and Oncel (Oncel et al., 2004).
In colorectal surgery, a number of studies have used adaptations of the adhesion 
scoring group score. Kusonoki used the same extent and severity scores in the evaluation of 
seprafilm, examining the midline and ileostomy incisions at the time of closure of ileostomy 
following anterior resection in 62 patients (Kusunoki et al., 2005). A multicentre study from 
the United States (again looking at patients at the time of ileostomy closure, this time
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following restorative proctocolectomy) utilised a similar scoring system, with the same 
severity score of 0-3, but in this case the extent was assessed from the length of the midline 
incision associated with adhesions (Cohen et al., 2005). There are no previous studies, 
however, that have attempted to evaluate adhesions following laparoscopic and open 
colorectal surgery.
It can be seen that there are a range of different scoring systems, many of which are 
based on the same criteria of assessing the severity and extent of adhesion formation. 
However, the key features of a scoring system are that it needs to be simple, accurate, and 
reproduceable, with a high inter- and intra-observer validity.
Discussion
Adhesions are a significant problem. Formation of adhesions following lower 
abdominal (and particularly colorectal) surgery is almost inevitable, with the incidence of 
intraperitoneal adhesions in patients following general abdominal surgery ranging from 
between 63% to 97% (Parker et al., 2005). Patients undergoing lower abdominal surgery have 
a 5% risk of admission directly related to adhesions during a 5-year period (Parker et al.,
2005). The SCAR study group suggest that there could be medico-legal consequences in 
failing to take precautions to prevent adhesion formation. Adhesional small bowel obstruction 
also results in a large financial burden to health providers (Menzies et al., 2001, Wilson et al., 
2002).
Whilst there are a range of adhesion-prevention strategies available, their clinical 
efficacy is at best variable, some reports have identified an increase in septic complications, 
and there is a significant cost associated with them (Wilson et al., 2002).
There is some evidence, particularly from animal studies, that laparoscopic 
procedures may be associated with reduced adhesion formation. However, there is a paucity 
of evidence evaluating adhesions following laparoscopic and open colorectal surgery. The 
studies available in human subjects tend to be retrospective, and have evaluated a range of 
abdominal procedures. In order to demonstrate a reduction in clinically relevant adhesion-
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related problems, prospective studies would require extremely large numbers of patients 
(Wilson et al., 2002), making such studies very difficult to perform.
Surrogate endpoints, by the use of adhesion scoring systems, have therefore been 
used in an attempt to estimate the formation of adhesions. These have been particularly used 
in gynaecological surgery, and more specifically infertility investigation and treatment. They 
have also been used in the assessment of adhesions and evaluation of adhesion-reduction 
products, both in experimental and human subjects. These scoring systems tend to focus on 
the extent and severity of adhesions at specific sites.
Some authors have claimed that one of the benefits with laparoscopic surgery is a 
reduction in adhesions (Sauerland and Neugebauer, 2005), and others that there is a need for 
laparoscopic colorectal surgery to “demonstrate its superiority with regards to late 
complications” (Buchanan et al., 2004). There is therefore a need for prospective studies to 
compare the incidence of adhesion formation in laparoscopic and open procedures, and 
particularly in colorectal surgery.
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Chapter 2: Summary
• Colorectal diseases are very common. A high proportion, especially in patients with 
colorectal cancer, will require surgery.
• Conventional open colorectal surgery is the current standard treatment, but requires a 
large incision. This can lead to significant postoperative pain, various physiological 
effects, and a longer hospital stay. There is also the risk of late complications such as 
adhesions and incisional hernia.
• Laparoscopic colorectal surgery has been proven to be clinically efficacious in large 
RCTs. However, it is challenging surgery with a long learning curve, prolonged 
operating times, and high conversion rates, particularly for less experienced surgeons.
• Overall costs of laparoscopic and open colorectal surgery appear to be equivalent. 
However the operative costs are significantly more for the laparoscopic approach.
• Whilst laparoscopic surgery is associated with a shorter hospital stay and faster return 
to normal activities, studies evaluating quality of life have demonstrated no 
significant differences between laparoscopic and open surgery.
• There have been no prospective studies evaluating the cost effectiveness of 
laparoscopic and open colorectal surgery.
• NICE found the costs of laparoscopic surgery for colorectal cancer to be marginally 
more than open surgery; they state that there is little good quality data on costs and 
quality of life.
• Adhesions are common, and result in a significant clinical and financial burden. 
Laparoscopic surgery may be associated with a reduction in the formation of 
adhesions, and adhesion-related complications.
• There are no studies prospectively evaluating adhesion formation in laparoscopic and 
open colorectal surgery.
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Introduction
There are two main sections to this chapter, relating to the two studies that have been 
performed. Following the aims and objectives, I will discuss the methodology of each study 
in turn.
The overall aim of this thesis was to perform a comprehensive cost effectiveness 
analysis comparing laparoscopic and open colorectal surgery. There are two areas pertaining 
to this topic that have not been extensively investigated previously and that were considered 
to be of relevance. Firstly quality of life, and combining quality of life within a cost utility 
analysis; secondly, examining a longer-term outcome, such as adhesions.
Aims and Objectives
o To evaluate the costs of laparoscopic and open colorectal surgery,
o To investigate whether there are differences in a patient’s quality of life at different
stages of their recovery following laparoscopic colorectal surgery as compared to 
open surgery.
o To undertake a comprehensive cost effectiveness analysis comparing laparoscopic 
and open colorectal surgery, 
o To assess the severity and extent of adhesion formation in patients who have had
previous colorectal surgery, comparing patients who have had laparoscopic and open 
surgery.
Null hypotheses
o There is no difference in the costs of laparoscopic colorectal surgery as compared to 
open surgery.
o There is no measurable difference in health-related quality of life between patients 
recovering from laparoscopic and open colorectal surgery.
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o There is no difference in the cost effectiveness of laparoscopic and open colorectal 
surgery.
o There is no difference in the incidence and severity of adhesion formation following 
laparoscopic and open colorectal surgery.
Study 1: Cost effectiveness - Research design
This is a prospective cohort study comparing patients undergoing open and 
laparoscopic colorectal surgery. The aim of the study was to perform a detailed cost analysis 
of laparoscopic and open colorectal surgery, together with a comprehensive quality of life 
assessment on these patients during their recovery. By combining these results, a cost 
effectiveness analysis will be performed.
This is not a randomised trial. One of the problems with RCTs in surgery is that 
individual surgeons tend to primarily use a single surgical approach to treat a specific 
problem (van der Linden, 1980, Rudicel and Esdaile, 1985), resulting in a “differential 
expertise between procedures”, and this differential expertise bias can compromise the 
validity of a conventional RCT (Devereaux et al., 2005).
Furthermore, a review article published in The New England Journal of Medicine has 
demonstrated that there is no significant difference in the estimate of treatment effects 
between observational studies and RCTs, confirming, as the authors state, the validity of 
observational studies (Benson and Hartz, 2000). A previous comparison of RCTs and non­
randomised studies identified 18 papers that directly compared the results of RCTs and 
prospective non-randomised studies. No obvious patterns emerged, with neither the RCTs nor 
the non-randomised studies giving larger or smaller estimates of the treatment effect. The 
type of intervention did not appear to be influential (Britton et al., 1998).
All surgical interventions have a learning curve, and for many procedures, surgeons 
are unlikely to reach the plateau of the learning curve until they undertake many more 
procedures than are required to participate in a RCT. For example, an observational study
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evaluating colon resections has demonstrated that surgeons with 5 or more years experience 
had a lower risk adjusted death rate than less experienced surgeons (Prystowsky et al., 2002). 
This is a criticism of the MRC CLASICC trial (Guillou et al., 2005), in which surgeons were 
more experienced in the open than the laparoscopic technique.
For this study surgeons are used who are experienced in a particular technique, and 
therefore patients are not allocated randomly. However, the study takes advantage of the 
individual expertise of the surgeons.
Sample
Between February 2006 and July 2007, consecutive patients having elective 
colorectal surgery at The Royal Surrey County Hospital were recruited into the study. 
Inclusion criteria
All patients with a colorectal condition (including those with colorectal cancer, 
inflammatory bowel disease, and diverticular disease) and requiring elective surgery were 
eligible for the study. Surgery consisted of a resectional procedure (including right 
hemicolectomy, left hemicolectomy, sigmoid colectomy, anterior resection, abdominoperineal 
resection, sub-total or procto-colectomy), a pouch procedure, or abdominal rectopexy. 
Exclusion criteria
Patients admitted as emergencies, children (under the age of 18 years), patients with 
endometriosis (as in this institution, none of these patients have an open procedure), and those 
who were either unable to consent for the study or complete the quality of life diary were 
excluded.
Selection process
Patients had laparoscopic or open surgery based on the discretion of the consultant in 
charge of their case. There is a random allocation of patients referred by General Practitioners 
to one of the colorectal consultant’s clinics (allocation depending on clinic space, and 
performed by booking clerks who have no knowledge of a consultant’s preference for a 
particular technique). In-hospital referrals tend to be to Professor Rockall, but there is no
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selection of these patients, with all being entered into the laparoscopic patient group 
(including any patient’s who required a conversion, and the few patients who were excluded 
from having a laparoscopic resection). A higher proportion of patient’s with inflammatory 
bowel disease are referred to John Stebbing, as this is one of his areas of specialist interest.
Sample size
As no cost-effectiveness study has previously been undertaken, it was impossible to 
use cost effectiveness (as measured by QALYs) as the endpoint for a power calculation. The 
power calculation was based on cost and quality of life.
Healthcare costs for both open and laparoscopic procedures was estimated to be 
approximately £6000 +/- £1500 (estimated from our pilot study and the literature (King et al., 
2006)). Taking p<0.05 as being statistically significant, and assuming normal distribution on 
the range of costs (1 standard deviation=£1500) with a sample size of 200 patients, the size of 
effect that would be detected with 90% power in a two-sided test is 0.46 SD units, or £690. It 
has already been demonstrated in the literature review chapter that costs are approximately 
equivalent when comparing the laparoscopic and open techniques, and we therefore expected 
to find no significant difference in costs.
HRQoL assessments in previous colorectal (Maartense et al., 2006, Thaler et al., 
2003) and hernia (Liem et al., 1997) surgery studies, using the SF-36 and EQ5D instruments 
measures, have assumed a 20% difference in quality of life between the two groups to be 
significant. Maartense et al performed a power calculation for their study using SF-36. They 
found that a sample size of 30 patients per group was required to find a 20% difference in the 
QoL scales with 90% power (standard deviation 20-25%, P=0.1, a=0.05) (Maartense et al.,
2006).
For the HRQoL part of this study, multiple measures were being undertaken on many 
days. One of the strengths of this study was to be combining these measures in a multiple 
regression analysis, however it is not possible to perform a power calculation involving data 
from multiple days. Day 14 was felt to be the time at which there was most likely to be a
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difference between the two groups, and it was felt that at this time a 20% difference would be 
significant. Data from the pilot study suggested that the open group would have an EQ-5D 
score of approximately 0.5 (SD 0.2). Therefore:
20% difference of 0.5 = 0.1.
Standardised difference = 0.1/0.2 = 0.5.
To detect this difference with 80% power, each study group would need 64 patients 
(total 128); for 90% power, 86 (total 172) patients would be needed. It should be noted that 
the study was designed to identify whether there is a difference in quality of life between the 
two groups over the whole six-week duration of the study, as opposed to one individual day. 
Therefore to detect a significant difference between the groups, it was likely that fewer 
patients would be required.
There is inevitably a pragmatic element to performing clinical trials of this type. 
There are approximately 150 major colorectal procedures performed per year in our 
department, with about 80-100 performed laparoscopically. It was felt to be reasonable to aim 
for recruitment of 200 patients to the study during the period of February 2006 to July 2007, 
and there were likely to be more patients in the laparoscopic group, given the nature o f the 
surgery undertaken in our unit. The study was therefore expected to be sufficiently powered 
to detect a difference in quality of life between the laparoscopic and open groups, but unlikely 
to demonstrate a cost difference.
Recruitment process
Eligible patients were identified from the operating diaries of the three colorectal 
surgeons involved in the trial, the pre-assessment clinic list, and from the CRC 
multidisciplinary team (MDT) meeting. Nearly all of these patients are seen in the pre­
assessment clinic prior to admission, and it was at this time that patients were approached to 
enter the study. The principle researcher (HD) was responsible for recruitment of patients to 
the study. Patients were given an information sheet (Appendix 1), and if willing to participate, 
the patient diary (Appendix 2) to take home to consider the study in more detail. Those
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patients who did not attend pre-assessment clinic were either approached the day before 
surgery, or during an out-patient appointment.
Written informed consent was obtained from all patients. Consent was taken either 
during the pre-assessment clinic or on admission (the day before surgery), and was taken by 
HD in over 95% of cases. When the principle researcher was away, members of the colorectal 
team took consent.
Operative procedures
Laparoscopic procedures were performed by Professor Timothy Rockall, who is a 
laparoscopic colorectal surgeon, and has performed over 500 laparoscopic colorectal 
procedures. Professor Christopher Marks and Mr John Stebbing are experienced colorectal 
surgeons, with forty years experience as practising consultants between them. The technique 
of each surgical procedure was left to the discretion of the operating surgeon. Operations 
performed by trainees were personally supervised by the consultant in charge of the case.
The open procedures are performed by a lateral to medial technique, mobilising the 
colon medially allowing identification and conservation of the ureter. Right sided resections 
are anastomosed using either a handsown or stapling technique. Left sided resections have a 
trans-anal stapled anastomosis.
The laparoscopic procedures are performed by a medial to lateral technique, with 
identification of the vascular pedicle, which is divided with an endoscopic stapling device 
(ATW 45, ethicon endo-surgery). The colon is mobilised by dissection over Toldt’s fascia, 
thereby conserving the ureter. The lateral attachments are divided, before the specimen is 
removed via a small incision. Right sided anastomoses are performed extra-corporeally with a 
linear stapling device (TLC 75, ethicon endo-surgery). Left sided procedures have an 
anastomosis performed with a trans-anal circular stapling device, after the anvil-head was 
inserted extra-corporeally.
Conversion from a laparoscopic to an open procedure was defined as an incision that 
is larger than that needed to remove the specimen. There is a policy in the unit that if
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conversion is required, to convert as early as possible to prevent unnecessary waste of 
instruments and time. All cases were analysed on an intention to treat basis, so for the cost 
and quality of life analysis, conversions were treated as laparoscopic cases.
Very few patients are excluded from having a laparoscopic procedure, the main 
indication being if the patient has a large mass that will necessitate a significant incision for 
removal of the specimen.
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Data collection 
Outcome measures
Endpoints
The primary endpoint was the cost effectiveness of laparoscopic colorectal surgery 
compared to open surgery.
Secondary endpoints were the direct (healthcare) costs, and Health Related Quality of 
Life (HRQoL).
Clinical outcomes
A prospective secure database (SPSS) was kept to record all demographic and clinical 
outcome data. This included details of patient demographics (age, sex, weight, BMI), details 
of the patients diagnosis (and if CRC, site of tumour), and operative details. Patients who 
required a stoma were expected to have a reduced quality of life compared to patients with no 
stoma, and it was therefore decided to analyse these groups separately.
The length of post-operative hospital stay, use of Level one, HDU, and ITU facilities, 
as well as any complications during the hospital stay and after discharge were also recorded. 
This data was collated prospectively, but was reinforced by information from the patient 
diaries. In addition the notes of every patient recruited to the study were reviewed to ensure 
data accuracy. In total over 200 variables (including the quality of life instruments) were 
measured on each patient.
Return to normal activity was measured in the patient diaries, by requesting patients 
to state weekly whether they had returned to their normal activities (or work if applicable) 
“not at all”, “partially”, or “fully”. The number of days after their operation that they 
commenced driving was also recorded.
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M easurement of costs
There is significant heterogeneity in the methodology of previous studies looking at 
the costs of laparoscopic colorectal surgery. Some studies, particularly from the United States, 
have used billed costs rather than actual charges, whilst other studies varied greatly with 
regards to the different costs measured (see Ch. 2, Table 3 (Dowson et al., 2007)).
This study includes a comprehensive cost analysis, measuring all direct healthcare 
costs, including those relating to the operation, hospital stay, and community health costs). 
We have not attempted to calculate indirect (societal) costs, as these are not of direct 
relevance to healthcare provision, and are difficult to measure accurately (Sculpher, 2001). 
All cost items were measured prospectively, although the actual cost of each item was 
calculated at the end of the study to nullify a confounding effect due to inflation.
Operative costs measured included those relating to the theatre overhead costs 
(dependant on the duration of the anaesthetic and surgery); staff costs for the surgeons, 
anaesthetist and theatre personnel; and equipment used in the operation (including reusable 
and disposable items). The form used for theatre data collection is reproduced in Appendix 2.
The costs of theatre overheads and staff were calculated from The Royal Surrey 
County Hospital financial records for the financial year 2006-2007. These calculate the cost 
of a theatre session of 5 hours (which includes preparation, cleaning time, and recovery staff) 
for a typical theatre staffed by one Band 2, four Band 6, and one Band 7 nurse. The consultant 
surgeon and anaesthetist costs were calculated hourly, and are based on the average salaries at 
The Royal Surrey County Hospital.
Hospital costs measured include those relating to the length of post-operative hospital 
stay and use of level one, high dependency, and intensive care units (calculated from hospital 
financial records). Costs of analgesics, blood investigations, transfusions performed, and 
those relating to post-operative complications and readmissions, were all individually 
calculated. However, if a patient was readmitted to another hospital (we only know of one 
patient in whom this occurred) this cost was not included.
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Community healthcare costs were calculated from the Unit Costs of Health and 
Social Care from the University of Kent (Curtis and Netten, 2006b). In the patient diary (see 
below), patients were asked to record on a weekly basis all episodes when they had used 
community healthcare services, as well as all medical complications, and contact with any 
other healthcare professionals. The diary continued for 6 weeks post-operatively. Hospital 
follow-up costs were calculated from the hospital financial records.
Quality of life measures
A number of trials have previously assessed a patient’s recovery following 
laparoscopic and open colorectal surgery by using quality of life measures. However none of 
these studies have demonstrated a significant difference between the two groups. As was 
discussed in Chapter 2, there are a number of reasons that might explain this. These reasons 
include the study being underpowered (King et al., 2006, Maartense et al., 2004), not 
performing the measures at frequent enough intervals in the immediate post-operative period 
(Guillou et al., 2005, Maartense et al., 2004), and ensuring that an appropriate HRQoL 
instrument is employed.
For this study, we wanted an instrument that evaluated a patient’s global health- 
related quality of life in the early post-operative period. In other words, a measure that could 
assess the patient’s ability to perform their usual activities (such as their mobility, washing 
and dressing, driving, etc), would give an accurate assessment of a patient’s recovery from 
surgery, and could be used for a cost utility analsis. The focus of this study was therefore to 
employ a generic HRQoL measure, rather than a disease-specific instrument. There are a 
number of symptom-specific scales that have been used in previous studies comparing 
laparoscopic and open colorectal surgery. These examine general gastrointestinal symptoms 
(such as the Gastrointestinal Quality of Life Index (GIQLI), or the Gastrointestinal Symptom 
Rating Scale (GSRS)), whilst others have been used to assess urogenital complications after 
colorectal surgery. However, these important aspects were beyond the remit of this study, and
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have been covered in previous studies (Dunker et al., 2001, Maartense et al., 2006, Jayne et 
al., 2005).
We aimed to closely evaluate the early post-operative period, and therefore required 
HRQoL measures that could be performed repeatedly, but that were simple and quick to use 
(to ensure compliance in patients who were recovering from major surgery). Furthermore, we 
needed a quality of life measure that could be used to perform a cost effectiveness evaluation. 
As has already been discussed in Chapter 2, there are a wide variety of HRQoL measures 
available, a number of which were considered for this study, and these are described briefly 
below.
The European Organization for Research and Treatment of Cancer (EORTC) QLQ- 
C30, and the colorectal cancer-specific QLQ-CR38 module, are validated cancer 
questionnaires (Aaronson et al., 1993), which have been employed extensively in patients 
recovering from laparoscopic and open colorectal surgery (King et al., 2005, Guillou et al.,
2005). However, it is a cancer-specific instrument, and one of the important aspects of our 
study was to evaluate the entire spectrum of colorectal diseases. It can also only be performed 
at two-weekly intervals, and can not be used for a cost effectiveness analysis.
The Symptoms Distress Scale (SDS) (McCorkle and Quint-Benoliel, 1983) and 
Quality of Life Index (QLI) (Tsevat et al., 1990) were used in the COST study, but again 
these scales can only be employed at most weekly, and do not allow a cost effectiveness 
analysis to be performed.
This study employed two quality of life measures, both of which could be completed 
by the patient independently. These are both described in detail, as are the reasons for their 
use.
EuroQol-5D (EQ-5D)
This is a simple generic profile measure of HRQoL that consists of five domains: 
mobility, self-care, usual activities, pain/discomfort and anxiety/depression (Appendix 2). 
Each domain is divided into three levels of perceived problems, no problem, some problem,
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or an extreme problem. The EQ-5D index is obtained by applying pre-determined utility 
weights to the five domains, which gives a global quantification of the patient’s health status 
on a scale ranging from 0 (death) to 1 (perfect health). Patients are also asked to rate their 
overall HRQoL on a visual analogue scale (EQ-5D VAS), consisting of a vertical line 
(thermometer) ranging from 0 (worst imaginable health status) to 100 (best imaginable).
EQ-5D has a number of advantages that recommended its use: it is simple and quick 
to complete, enabling even patients who are unwell to complete it independently; it can be 
used frequently, having been validated for use on a daily basis (Parkin et al., 2004); it has a 
domain for pain, an important factor in recovery after surgery; and has quality weights 
assigned for quality-adjusted life year (QALY) calculations, and so can be used in economic 
evaluations. It has also been used previously to evaluate HRQoL following abdominal surgery 
(Langenhoff et al., 2006), although not specifically following laparoscopic and open 
colorectal surgery.
Given that EQ-5D can be apllied frequently, this study required patients to complete 
both the EQ-5D index and VAS on alternate days for the first four weeks after surgery, and 
also at five and six weeks post-operatively. Evidence from previous studies has shown that 
HRQoL differences are minimal after six weeks (Chapter 2), and to try to ensure a high 
completion rate, data collection ended at this time. EQ-5D was measured on alternate days, 
thereby trying to prevent patients from learning and repeating the same scores each day, but 
still allowing an accurate picture to develop of their post-operative recovery.
Short form 36 (SF-36)
Whilst EQ-5D is quick and simple to complete, it will only provide a global score, 
and one therefore can not measure specific aspects of QoL separately. A second HRQoL 
instrument was therefore utilised, to give further detail on specific aspects of a patient’s 
recovery (such as pain and physical function), and to provide a comparison of HRQoL scores.
SF-36 is a generic questionnaire (Ware and Sherboume, 1992) with 36 items which 
measure eight multi-item variables: physical functioning (10 items), social functioning (two
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items), role limitations due to physical problems (four items), role limitations due to 
emotional problems (three items), mental health (five items), energy and vitality (four items), 
pain (two items), and general perception of health (five items). For each variable item scores 
are coded, summed, and transformed on to a scale from 0 (worst possible health state) to 100 
(best possible). The eight variables can be combined into physical and mental health 
summaries, as well as an overall score.
Minor modifications to the original American wording of six items on the SF-36 were 
made to make it more acceptable to British subjects, and it has been validated for use within 
the United Kingdom and the National Health Service (Jenkinson et al., 1993, Brazier et al., 
1992, Garratt et al., 1993). The original version of SF-36 was designed to be performed at 
monthly intervals. An acute version has been developed and validated, which can be used 
weekly (Bowling, 1997). In this study assessing patients recovery from surgery, we have 
employed the SF-36 acute UK version.
Advantages with SF-36 include the fact that it is one of the most widely used health 
status questionnaires in the world (Bowling and Ebrahim, 2005), and this therefore allows 
comparison with other patient groups. It has previously been utilised following laparoscopic 
and open colorectal surgery (Roblick et al., 2002), and has been recommended for the 
evaluation of these procedures by the EAES (Veldkamp et al., 2004). SF-36 is also simple, 
relatively quick to use (each questionnaire taking 10 minutes to complete), and is suitable for 
self-administration.
Patients were required to complete SF-36 questionnaires at 0, 1, 2, 4, and 6 weeks 
post-operatively, so that the early stage of their recovery would be evaluated as closely as 
possible. However, we did not want to burden patients with too many questionnaires in case 
that reduced compliance.
Data Collection Tools
Patient Diary
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Since study subjects needed to fill in a significant number of HRQoL questionnaires 
for the trial (17 separate EQ-5D and 5 SF-36 forms), a patient diary was developed to 
combine all the questionnaires together in chronological order (Appendix 4). The diary also 
contained the study information sheet, instruction notes on filling in the diary, background 
demographical data, and a section on use of community healthcare resources after discharge 
from hospital. The diary was a critical part in ensuring patient compliance and an acceptable 
response rate, and was therefore designed with ease of use as a priority.
In addition to the HRQoL measures, a form to be completed weekly was included for 
patients to record their community healthcare episodes. Patients were asked to record all visits 
to their GP, practice nurse, and any district nurse home visits. Contact with the colorectal 
nurse specialist, stoma nurses, and other specialist nurses was also requested. Finally, patients 
were asked to assess weekly to what extent they had recovered their normal activities, by 
grading this as either “not at all”, “partial”, or “fully”. They had to state how long in total they 
had taken off work (or when they had fully resumed their normal activities), and when they 
had started driving.
Pilot study
A pilot study was performed on the first 10 patients recruited to the trial to evaluate 
the collection of QoL data. Each of these patients was either contacted by telephone, or had a 
face-to-face meeting with the primary researcher when attending the hospital for an out­
patient appointment.
These interviews were structured to gauge the diaries for ease of use and 
understanding, and how patients felt that compliance in completing the diaries could be 
ensured. Overall, there was positive feedback from all patients, with the diary being described 
as “easy to use” and the study “interesting” and “helpful to do during the recovery”.
The main change that was introduced was increasing the length of post-operative 
follow-up from 4 weeks to 6 weeks (by adding in assessments at 5 and 6 weeks post­
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operatively). Patient compliance was high with regards to completing the diaries, and it was 
felt that lengthening the period of follow-up would not reduce overall patient compliance.
Minor changes were made to the diary to ensure clarity: the SF-36 questionnaire was 
re-typed in a more user-friendly fashion, with a larger font; the information sheet was placed 
first within the diary, with contact details of the researcher put on the front cover; the diary 
was split into a “before operation” and “after operation” sections; and the day each 
questionnaire was to be completed was typed at the top of that page.
Further alterations were also made to the questionnaire on usage of community health 
services, again to increase clarity. A statement was inserted at the top of the page requesting 
patients give details on specifically the past week of their recovery, and a space set aside for 
patient’s own comments.
No significant changes were made to the structure of the diary, or the timings of the 
HRQoL questionnaires, as the study subjects appeared happy to complete all the forms as 
requested.
A pilot study was also undertaken evaluating the cost data, to ensure comprehensive 
and accurate data collection. Minor alterations were made to the theatre ‘cost’ form, as some 
items had previously been missed from it, such as the length of the incision, and use of an 
abdominal drain.
Data analysis
Statistical analysis
The data were analysed on an intention to treat basis, so converted patients were 
included with the laparoscopic group. Data were collated and analysed using SPSS® version 
12 (SPSS, Chicago, Illinois, USA). The mean (standard deviation) was used for parametric 
data, which included all quality of life scores. The median (IQR) was used for non-parametric 
data, such as the cost data, length of hospital stay, and return to normal activities. Students t 
test or Mann Whitney U test were used to compare groups, as appropriate. The quality o f life
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data of the two groups were compared at each assessment point, but also overall using a 
repeated measures statistical analysis.
Univariate analyses were performed to assess the impact of potential confounding 
variables (such as the presence of a stoma, age, diagnosis, and the type of operative procedure 
performed). Multivariate analyses were then undertaken to adjust for the impact of these 
potential predictor covariates.
Two multivariate analyses were performed, a repeated measures model, and a linear 
regression analysis. The repeated measures model adjusts for each covariate, and takes into 
account measures though-out the study period. The forwards linear regression analyses the 
data at only one time period. This regression identifies each covariate in order of significance, 
and enters them into the analysis, discarding those variables that have no significant impact, 
or those that have a high correlation with other variables. The forwards regression technique 
was employed, as the majority of variables were dichotomous as opposed to continuous, and 
this method avoids spurious combinations of dichotomous variables coming up as significant.
The advantage of a repeated measures analysis is that data is included for patients 
over the entire study period, with the model able to adjust for the impact of any confounding 
variables; the disadvantage is that data is required on individuals for the whole study period, 
and patients with any missing data are excluded from the analysis. The regression analysis 
includes all patients with data on that particular day, but does not reflect the cumulative effect 
over the study period. By performing both analyses, a robust statistical picture of the HRQoL 
data can be obtained.
Missing data
For the univariate analysis of the quality of life data, missing data was excluded, as 
the remaining data for that patient could be included in the analysis. However, for the EQ-5D 
repeated measures analysis, complete data was necessary for that patient to be included within 
the model. Therefore, the analysis was performed on days 2 to 28. This was because the study 
was expanded to include days 35 and 42 only after the pilot study had been completed, and
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therefore to include these days would have excluded a significant number of patients from the 
analysis. Missing data for only one or two days was dealt with by taking the mean of the QoL 
scores either side of the day missed, and those patients were included in the multivariate 
analysis (14 patients had data missing from one or two days). If more than 2 days data was 
missing, that patient was excluded from the repeated measures analysis.
Economic analyses
The economic analysis was performed using three different techniques. A cost- 
consequences analysis, in which a balance sheet is created comparing all significant aspects 
associated with the laparoscopic and open surgical approaches. This technique summarises 
the clinical, cost, and quality of life data, identifying those results that favour, and those that 
demonstrate no difference, between either of the two surgical approaches.
A cost effectiveness analysis uses simple “decision rules” to compare the costs and 
outcomes of alternative treatments. If either alternative is cheaper or the same cost, and has a 
significantly better outcome than the other, it is the preferred option (dominant solution). 
Value judgements and calculation of Incremental Cost Effectiveness Ratios (ICERs, costs per 
unit of therapeutic gain) are required where one alternative is more expensive, but better than 
the other. An ICER is calculated by dividing the difference in costs with the difference in 
effectiveness.
A cost utility analysis measures the effect of different interventions (in this case 
laparoscopic or open surgery) in terms of a single outcome measure (a utility). This utility 
assesses the impact of the surgical procedure from the patient’s perspective, and is a measure 
of how the operation affects HRQoL. The standard utility measure is a QALY, derived from a 
single measure of HRQoL which is provided by EQ-5D. The difference in QALY scores, 
when comparing two interventions, is obtained by comparing the area under the curve (AUC) 
for the EQ-5D scores for those interventions (in this case laparoscopic and open colorectal 
surgery).
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Ethics
Ethical approval and research governance were obtained prior to commencement of 
the study from the South West Surrey Local Research Ethics Committee (Study 
05/Q1909/74), and the hospital research and development committee.
Study 2: Adhesions - Research design
The aim of this study was to perform a prospective observational study assessing the 
formation of adhesions following laparoscopic and open colorectal surgery. Adhesion 
formation was evaluated during a laparoscopy performed at the time of a subsequent 
operative procedure. The laparoscopies were recorded on DVD, and any adhesions identified 
were evaluated by a scoring system that was independently validated.
All patients who had had previous laparoscopic or open colorectal surgery, and were 
having a further elective abdominal operation were eligible for the study. This was a 
prospective, observational cohort study. This study had to be opportunistic in design, as it is 
ethically unjustifiable to undertake a randomised trial performing re-laparoscopies in 
otherwise fit volunteers (Majewski, 2006).
Assessment of Adhesions
Scoring system
As discussed previously in Chapter 2, a number of different scoring systems have 
been developed for assessing adhesions. However the majority of these have been developed 
in gynaecological patients, with particular emphasis on fertility problems.
A scoring system was therefore employed that could be utilised in patients with 
general surgical conditions. The scoring system was adapted from a system developed by the 
Adhesion Scoring Group in the United States (group, 1994), and variations on this have 
previously been utilised in general surgery (Cohen et al., 2005, Kusunoki et al., 2005). The 
advice of an independent expert was also sought (Mr Michael Parker, Consultant Surgeon, 
Derent Valley Hospital, and member of the SCAR study group, personal communication).
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The scoring system is based on a grading of the severity (Grade O-III) and extent (0- 
25%, 25-50%, >50%) of adhesions at relevant sites within the abdominal cavity (Table 10). 
The sites considered were those of the main access wound or incision (either the laparotomy 
incision or port sites); the area relating to the previous pathology (for example, the right iliac 
fossa for a right hemicolectomy, left iliac fossa and pelvis for an anterior resection); and any 
additional sites of adhesions (such as the liver).
An overall adhesion score out of 10 was calculated by combining the severity as 
measured at the most severe site (0-3); the overall extent of adhesions within the abdominal 
cavity (0-3); the presence of small bowel within the adhesions (0-3); and the total number of 
separate sites involved (to a maximum of 3) (Table 10). In addition, the main access site from 
the previous surgery, either the incision or laparoscopic port-sites, was also scored separately 
according to the severity (0-3) and extent (0-3) of adhesions, giving a score out of 6. The form 
used in theatre to score adhesion formation, and record patient demographic data, is given in 
appendix 6.
For example, a patient with filmy avascular adhesions, involving 40% of a midline 
incision, but with no other sites involved and no bowel within the adhesion, would score 3 at 
the main access site (1 point for severity grade I, and 2 points for extent) and would also score 
3 for an overall score (1 point for severity grade I, only 1 point for overall extent within the 
peritoneal cavity, 0 points for involvement of small bowel, and 1 point for only 1 site 
involved).
The assessment of adhesions was performed by the primary researcher (HD), who 
was not blinded to the type of surgery that was performed originally.
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Main Site 
(Access wound)
Site of 
pathology
Distant
sites
Overall*
Grade
0
I
II
III
Severity of Adhesions
No adhesions
Filmy, avascular adhesions, sep­
arate easily with blunt dissection 
Firm limited vascular adhesions, 
need aggressive blunt dissection 
Dense vascular adhesions, 
require sharp dissection
Grade
0
I
II
III
Extent of Adhesions
No adhesions
Mild: up to 25% of total area 
& length of incision 
Moderate: 26-50% o f total area & 
length of incision 
Severe: >50% of total area 
& length of incision
Number of sites of separate adhesions
Small bowel involved (Y/N)
Table 10: Adhesion scoring system. *Overall score = Worst severity score (1-3) + overall extent of 
adhesions in peritoneal cavity (1-3) + number o f sites (1-3) + involvement o f small bowel (0-1).
Validation of scoring system
The scoring system was validated for inter- and intra-observer reliability. Seven 
experienced surgeons (all at least 8 years post qualification) were shown 10 previously 
videoed laparoscopies on 3 separate occasions. The order of the same ten laparoscopies was 
changed for each viewing, which was at least one week apart. During the first viewing, the 
researcher (HD) was present in order to explain the scoring system in more detail and answer 
questions as necessary, to ensure that the scoring system was appropriately applied. For the 
subsequent two viewings, the surgeons assessed the laparoscopies independently. The 
laparoscopies were scored for the overall score of adhesions (out of a maximum of 10).
Sample
Patient selection
Any patient who has had previous elective colorectal surgery (either laparoscopic or 
open), and is having a second elective abdominal operation, was eligible for recruitment into 
the study.
The majority of patients were recruited from a cohort of patients under-going liver 
surgery for colorectal metastases. It is the standard practice of the hepato-pancreatico-biliary
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(HPB) unit to perform a staging laparoscopy before proceeding to a liver resection. At the 
time of this laparoscopy, the degree of adhesion formation following the primary colorectal 
surgery could be evaluated.
The HPB unit receives referrals from a large region, and whilst some referring 
surgeons are performing laparoscopic surgery, the majority of colorectal resections are still 
performed by conventional open surgery. Therefore, to increase the number of “second-look” 
procedures in patients with previous laparoscopic surgery, any patient having a second 
operation following laparoscopic or open colorectal surgery was eligible. This included 
patients having a completion proctectomy for ulcerative colitis, staging laparoscopy, and 
laparoscopy for abdominal pain following the previous surgery.
In certain instances the second operation did not routinely include a laparoscopy, such 
as for closure of ileostomy. However, if a laparoscopy could still be performed with no 
additional risk to the patients, the patient was eligible for the study. For closure of an 
ileostomy, once ileal continuity has been restored, a laparoscopic port is placed through the 
ileostomy incision, and a laparoscopy performed (Cohen et al., 2005). This additional part of 
the operation took less than five minutes, required no new incisions, and was of no risk to 
patients.
Inclusion criteria
As described above, patients were eligible for the study if  a laparoscopy could be 
performed during a second operation, following previous elective open or laparoscopic 
colorectal surgery. There needed to be a gap of at least six weeks between the original 
colorectal procedure and the subsequent laparoscopy.
Exclusion criteria
Exclusions from the study included those in whom the original procedure was an 
emergency, patients under the age of 18 years, and adults with learning difficulties or who are 
unable to understand the consenting process. Patients were also excluded if they had had an 
additional abdominal operation as this might have resulted in adhesion formation.
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Sample size
The study was designed to have 90% power to detect a 2 unit difference in the 
adhesion scores between the two groups using a two-sided test (alpha =0.05), based upon a 
within group standard deviation of 2 units. For 90% power, a study size of 46 patients was 
required.
Recruitment process
Patients were recruited and consented either at the pre-assessment clinic or on 
admission. Written informed consent was taken for recruitment to the study, and for recording 
of the laparoscopy. The patients were given an information sheet (Appendix 7), and sufficient 
time (at least 2 hours) to consider whether they were willing to be enrolled into the trial.
Data collection 
Outcome measures
Endpoints
The primary endpoint was the overall adhesion score.
A secondary endpoint was adhesion formation at the main access wound (either the 
main incision in the open group, or the laparoscopic port-sites together with the incision for 
specimen extraction in the laparoscopic group).
Demographic data
Data was collected on the demographic details of patients (age, sex, underlying 
diagnosis, and stage of disease if CRC); details of the original operation (open or 
laparoscopic, type of resection performed, and whether a stoma was fashioned); and the 
interval between the original colorectal resection and the laparoscopy.
Three subgroup analyses were planned: for patients with an underlying diagnosis of 
colorectal cancer (the most common diagnosis in our study group); for those who had their 
primary surgery in the last two years, thus compensating for any differences in the interval
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between the two procedures for the two groups; and a procedure specific analysis for the 
commonest original operation.
Data analysis
Data analysis was performed using SPSS software (version 12.0) for Windows 
(SPSS, Inc., Chicago, Illinois, USA), and STATA Version 8 (STATA, Inc., College Station, 
TX).
Data are presented as median (IQR), unless otherwise stated. The Mann-Whitney U 
test was used to compare the significance between groups, using the null hypothesis that there 
would be no difference between the groups.
The kappa coefficient was used to evaluate rater agreement, for both inter- and intra­
observer reliability. In order to quantify the level of agreement, the weighted kappa value was 
employed. In this calculation, observations close to the diagonal, with a difference of only one 
unit, are considered less serious than those where the discrepancy is two or three units. A 
kappa value of 0.61-0.8 indicates a good, and 0.81-1.00 a very good, level of agreement 
(Altman, 1991).
Ethics
Ethical approval was received prior to commencement of the study from the South 
West Surrey Local Research Ethics Committee (Study number 06/Q1909/68), and the 
hospital research and development committee.
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Chapter 3: Summary
• This MD thesis consists of 2 main studies evaluating the cost effectiveness of open 
and laparoscopic colorectal surgery, and the incidence of adhesion formation 
following these procedures.
• The aims are:
o to calculate the costs of laparoscopic and open colorectal surgery; 
o to evaluate quality of life following laparoscopic and colorectal surgery; 
o to assess adhesion formation following laparoscopic and colorectal surgery; 
o to undertake a comprehensive cost effectiveness analysis comparing 
laparoscopic and open colorectal surgery.
• The cost effectiveness study is a prospective cohort study in a consecutive series of 
patients, using an expertise-based study design.
• The study consists of a comprehensive cost and HRQoL assessment.
• The SF-36 and EQ-5D instruments, imbedded within a patient diary, are being used 
to closely evaluate the early post-operative period.
• The adhesions study is an opportunistic study, assessing adhesion formation at the 
time of a second-look operation, in patients who have had previous open or 
laparoscopic colorectal surgery.
• An adhesion scoring system has been adapted from a gynaecological scoring system, 
and this will be validated for inter and intra-observer agreement.
• Ethical approval for both studies has been received from the South West Surrey Local 
Research Ethics Committee and the hospital research and development committee.
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Chapter Four: Cost Study Results -  Sample characteristics &
Clinical outcomes
Introduction 
Sample characteristics 
Patient demographics 
Cancer outcomes 
Length of Hospital stay 
Morbidity and Mortality 
Discussion
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Introduction
This chapter, together with the subsequent three, presents the results of the cost 
effectiveness study. The primary endpoint of the study was the cost effectiveness of 
laparoscopic colorectal surgery as compared to open surgery; secondary endpoints were the 
direct costs and HRQoL of the two approaches. The results of each of these endpoints are 
presented in separate chapters.
The current chapter details the sample characteristics, and essential clinical outcomes 
of the two groups. These include the patient demographics and clinical diagnoses; the type of 
surgery and whether the patient had formation of a stoma; morbidity and mortality; length of 
hospital stay; and readmission and reoperation rates.
Sample characteristics
200 consecutive patients (130 having laparoscopic surgery, 70 open) were treated at 
the Royal Surrey County Hospital during the duration of the study, and all are included in the 
analysis of cost and clinical outcomes. 169 patients (106 laparoscopic, 63 open) were 
included in the quality of life part of the study. Figure 4.1 shows the study flow diagram.
31 patients were not recruited to the QoL part of the study. The main reason for this 
was when the primary researcher was not available to discuss the study with a patient, due to 
study leave or annual leave; 14 patients were missed in this way. 11 patients were unable to 
complete the QoL diary, due to dementia (7 patients), inadequate English language skills (3), 
or blindness (1). 6 patients refused to take part in the study.
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28 laparoscopic
21 were too unwell to 
complete QoL diary
14 laparoscopic
All had cost and clinical 
data analysed
14 missed by 
investigator
31 patients had no 
QoL assessment
200 patients included 
in study
169 patients recruited to 
QoL study
6 refused
19 open
11 unable to 
complete dairy
->
9 did not complete 
diary 7 lost in post
Figure 2: Cost study flow diagram. Laparoscopic group includes conversions and exclusions.
Patient demographics
The groups were similar for age, sex, body mass index (BMI), and ASA grade (Table 
11). Colorectal cancer was the commonest diagnosis (55%), with diverticular disease and 
benign colorectal polyps the next m ost common (Table 12). Patients were grouped according 
to their diagnosis into one o f four groups (cancer, benign, C rohn’s disease, ulcerative colitis) 
to facilitate a more meaningful analysis. 34 patients (13 in the open group and 21 in the 
laparoscopic group) had had previous m ajor abdominal surgery (defined as having a
laparotomy or hysterectomy, but not including appendicectomy).
Laparoscopic Open Significance*
Number of patients 130 70
Gender M:F 60:70 33:37
Age 68.0 (18-90) 69 (31-85) p=0.757
BMI 24 (17-40) 25 (18-36) p=0.568
ASA 2(1 -3 ) 2 (1 -3 ) p=0.731
Cr-Possum 3.28 (0.68-25.98) 3.03 (0.68-32.32) p=0.955
T ab le ll: Cost study: Basic demographic data. Data given as median (Range). *MW-U.
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Diagnostic
group Diagnosis Laparoscopic
Laparoscopic
Converted Excluded Open Total
Cancer Cancer 67 1 2 40 110
Polyp 15 4 19
Benign Diverticular disease 14 2 1 6 23
Volvulus 2 2 4
Fistula 2 2 4
Rectal prolapse 4 1 5
Other 2 1 3
Crohn’s Crohn’s disease 9 1 1 6 17
disease
Ulcerative Ulcerative Colitis 7 8 15
Colitis
Total 122 4 4 70 200
Tablel2: Cost study: Diagnoses and diagnostic groups
The operative procedures were combined into 3 groups for the analysis and are 
presented in Table 13. Rectal procedures were defined as any procedure involving full TME 
mobilisation or resection of the lower or middle thirds of the rectum, and involved nearly all 
patients who had a stoma. High anterior resections for upper rectal and rectosigmoid lesions
were defined for the purposes of this study as left sided resections.
Operative
group Operation performed
Laparoscopic 
Laparoscopic Converted Excluded Open Total
Right Right hemicolectomy 37 1 13 51
Ileocaecal resection 8 1 1 4 14
Left Left hemicolectomy 5 1 6
Sigmoid colectomy 21 1 6 28
High anterior resection 20 1 1 17 39
Rectopexy (no resection) 2 1 3
Subtotal colectomy 3 3 6
Hartman’s procedure 3 1 4
Reversal of Hartmann’s 3 1 1 5
Rectum Low anterior resection 10 9 19
Proctectomy 5 8 13
APR 4 1 6 11
Resectional rectopexy 1 1
Total 122 4 4 70 200
Table 13: Operative procedures performed.
There were a similar number of left sided resections in the two groups, with 47% 
(n=61) left sided resections in the laparoscopic group and 43% (n=30) in the open group 
(p=0.69). Although there was a higher proportion of right sided resections in the laparoscopic
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group (48/130, 37%) than in the open patients (17/70, 24%), this difference was not 
statistically significant (p=0.10). There were, however, more rectal resections in the open 
group (23/70, 33%) compared to the laparoscopic group (21/130, 16%) (p=0.01). There were 
also more stomas performed (26/70; 37%) in the open group, compared with the laparoscopic 
group (22/130; 17%) (p=0.0025).
The length of the operation was shorter in the laparoscopic group (145 (110-180) v 
190 (150-240) minutes), which is unusual when compared to the literature. Possible 
explanations for this include a laparoscopic surgeon who is very experienced and confident, 
the higher proportion of more complex rectal procedures in the open group, and there were 
more procedures performed by trainees (under direct supervision) in the open group. There is 
a potential selection bias as a result of these factors, and grade of surgeon and type of surgery 
was entered into the multivariate analysis.
Both the operative procedure and presence of a stoma were entered into the 
multivariate regression analyses so that adjustments could be made for these 
covariates. In addition, an analysis was performed looking at patients with 
and without a stoma separately. Details of the patients in whom a stoma was 
formed are given in table 14.
Stoma Laparoscopic
Laparoscopic
Converted Excluded Open Total
none 103 3 2 44 152
loop ileostomy 9 0 1 15 25
loop colostomy 0 0 0 1 1
Hartmanns 2 1 0 0 3
permanent stoma 8 0 1 10 19
Total 122 4 4 70 200
Table 14: Proportion of patient’s with a stoma.
Cancer Outcomes
Colorectal cancer and polyps (which were either too large to be removed 
endoscopically, or were potentially thought to be malignant) account for the majority of cases
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in both groups of patients. The tumour sites are given in table 15, with the TNM and Dukes 
staging in table 16.
Site of tumour Laparoscopic
Laparoscopic
Converted Excluded Open Total
Caecum 14 1 0 5 19
Ascending colon 6 0 0 2 8
Hepatic flexure 9 0 0 3 12
Transverse colon 8 0 0 3 11
Splenic flexure 1 0 0 0 1
Descending colon 4 0 0 1 5
Sigmoid colon 14 0 1 5 25
Rectosigmoid junction 6 0 0 3 4
Rectum (upper 1/3) 6 0 1 6 13
Rectum (middle 1/3) 8 0 0 7 15
Rectum (lower 1/3) 6 0 0 9 15
Total 82 1 2 44 129
Table 15: Site of tumour (including benign polyps).
Dukes/TNM stage Laparoscopic Open
Tis 2 0
T1 10 4
T2 13 10
T3 30 21
T4 11 4
NO 42 24
N1 16 10
N2 9 6
MO 64 39
Ml 3 1
Benign / no residual cancer 16 5
A 15 10
B 23 12
C 25 16
D 3 1
Lymph node harvest* 20 (15-27) 26(18-32)
CRM threatened (<lmm) 2 0
CRM involved 1 0
Table 16: Cancer outcomes. *Median (IQR).
The lymph node harvest was more than adequate in both groups, with a higher 
harvest in the open group (median 20 v 26, p=0.026, Mann-Whitney U). Three patients in the
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laparoscopic group had a threatened or involved circumferential resection margin (CRM). 
The first was a 52 year-old male, who had previously had pelvic radiotherapy for a testicular 
terratoma, and who had a low rectal tumour which was associated with a prostatic abscess 
anteriorly. He had an APR, and the histology showed a moderately differentiated T3 NO 
cancer with tumour involving the CRM at the level of the prostate. The second patient was an 
83 year old male who had a upper rectal carcinoma, and the histology demonstrated the 
tumour to be invading within 1mm of the CRM posteriorly. The final patient was a 63 year 
old lady who had a mid rectal carcinoma, and whilst the primary was adequately resected, 
there was an involved lymph node which was threatening the CRM.
Length of hospital stay
The length of hospital stay was significantly greater in the open group, when
compared to those patients who underwent laparoscopic surgery (median 3 v 6 days, 
pO.OO l ). The length of hospital stay was the same for both the laparoscopic and open groups 
when patients with a stoma were excluded (3 v 6 days). Patients who had a stoma experienced 
a longer hospital stay (median of 9 days; IQR 6-13) compared to those who did not have a 
stoma (median of 6.5 days; IQR 4-10) (p=0.045).
More patients having open surgery (20%) were admitted to ICU or HDU than patients 
from the laparoscopic group (10%, p=0.003, student’s t test). Whilst this difference may 
reflect a selection bias between the groups might have resulted in a selection bias, the number 
of patients who had had previous surgery and were ASA 3 were similar between the two 
groups, so it is hoped that any selection bias had a minimal influence on these results. O f the 
laparoscopic patients who were admitted to higher level care, two had had a converted 
procedure.
A summary of the patient demographic details, diagnosis, operation, and clinical 
outcome measures is given in table 17. The laparoscopic and open groups are compared using 
the Mann Whitney U test (non-parametric data), with a p value of <0.05 taken to indicate a 
statistically significant difference.
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Laparoscopic Open Significance*/
Total
Number of patients 130 70 200
Gender M:F 60:70 33:37 93:107
Age 68.0 (18-90) 69(31-85) p=0.757
BMI 24 (17-40) 25 (18-36) p=0.568
ASA 2(1-3) 2(1-3) p=0.731
Cr-Possum 3.28 (0.68-25.98) 3.03 (0.68-32.32) p=0.955
Diagnosis: Cancer/Polyp 85 (65%) 44 (63%) 129 (65%)
Benign 27 (20%) 12(17%) 39 (19%)
UC 7 (5%) 8(11%) 15 (7%)
Crohn’s 11 (9%) 6 (9%) 17 (9%)
Operation: Right 48 (37%) 17 (24%) p=0.10
Left 61 (47%) 30 (43%) NS
Rectal 21 (16%) 23 (32%) p=0.01
Stoma 22 (17%) 26 (37%) p=0.003
Length of operation 145 (IQR 110-180) 190(150-240) p<0.001
Grade of Surgeon 
(Consultant: Trainee)
83 (64%): 47 (42%) 24 (34%): 46 (66%) P=0.005
Admission to ITU/HDU 13 (10%) 14 (20%) p=0.003
Length of hospital stay 3 (IQR 3-4) 6 (IQR 5-9) p<0.001
Complications: Major 14 (11%) 19 (27%) p=0.005
Minor 17(13%) 15 (21%) NS
Total no. of patients with 
complication
24 (18%) 23 (32%) P=0.07
Readmissions 6 (5%) 3 (4%) NS
Reoperations 3 (2%) 1 (1%) NS
Deaths 4 (3%) 1 (1%) NS
Table 17: Summary of patient characteristics (Median (range), unless otherwise stated; Mann 
Whitney U).
Morbidity and mortality
Post-operative complications are listed in table 18. A major complication was defined 
as any resulting in a prolonged hospital stay (longer than the median length of stay for either 
the laparoscopic or open patients), admission to HDU or ICU, surgical or radiological 
intervention, or readmission or reoperation. Information regarding complications was 
obtained from the hospital notes (all notes were reviewed following a patient’s discharge, to
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ensure no adverse events had been missed), or from the patient diary (patients would state 
whether they had been seen by any healthcare professional after discharge, or whether they 
had had any medical problems).
In total, 24 patients in the laparoscopic group, and 23 in the open group, had a 
complication, with some patients having more than one. A greater proportion of patients in 
the open group had a major complication (n=19; 27%) compared to those in the laparoscopic 
group (n=14;l 1%) (p=0.005). These are detailed in table 18.
Complication Laparoscopic 
Minor Major
Open 
Minor Major
Anastomotic leak / rectal stump 2 1
blowout
Abdominal abscess 1 1 2
Ileus /  SBO 2 1 2 2
Intra-operative haemorrhage 2
Port-site complications 2 1
High output stoma 1
Wound infection 7 6 3
UTI 4 1 1
Urinary retention 2 1 2
Urethral injury 1
MRSA sepsis 1
Chest infection 1 2 3
Fast AF 1 2 3 2
Left ventricular failure 1
Pulmonary embolus 1
Total 17 14 15 19
Table 18: Patient complications (some patients had more than one complication).
There were three anastomotic leaks (2 in the laparoscopic group, one of whom had a 
laparotomy and defunctioning stoma; the other patient developed signs of severe sepsis, and 
when re-admitted (to another hospital) rapidly deteriorated and died; the open patient had a 
blow-out of her rectal stump treated at laparotomy with a washout, drainage, and oversowing, 
but she died after a prolonged hospital stay). Intra-abdominal collections were treated 
radiographically. The port-site complications included 2 patients with bleeding who were 
treated conservatively, and a port-site hernia surgically repaired.
In total, there were four deaths in the laparoscopic group (3%, 2 patients completed 
laparoscopically, 1 excluded and 1 converted patient), and one (1%) from the open group. The
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laparoscopic patients were an 87 year old woman who had a large sigmoid carcinoma, which 
meant that she was excluded from a laparoscopic procedure due to the tumour size. She was 
ASA III, and had an uneventful operative procedure, but developed chest complications post- 
operatively (chest infection and pleural effusion), and died on post-operative day 7. The other 
three patients who died all had resections for diverticular disease: an 80 year old (ASA II), 
who appeared to recover well from her surgery, and was discharged on day 4, but was 
readmitted the next day to another hospital critically unwell. A CT scan demonstrated free air, 
which was presumed to be due to an anastomotic leak, but she deteriorated rapidly, was not fit 
for surgery, and died the following day; a 70 year old man (ASA III), who developed a chest 
infection and fast atrial fibrillation (AF) post-operatively, and died on day 23; a 93 year old 
woman (ASA IV), who was a long-term patient under the medical team, and had a 
debilitating colo-vaginal fistula. She and her family were aware surgery was high risk. She 
had a converted procedure, but failed to recover from the surgery, and died on day 15. The 
patient who died in the open group was a 61 year old lady with Crohn’s colitis, who had a 
subtotal colectomy with a rectal stump. She had a rectal stump blow-out, developed severe 
intra-abdominal sepsis, and died following a prolonged ITU stay (37 days).
Six patients having laparoscopic surgery were re-admitted (the reasons for the 
readmissions were: pelvic abscess requiring drainage, anastomotic leak, ileus, urinary 
retention, port-site hernia, and chest infection), with 3 from the open group (pulmonary 
embolus, fast AF, and atypical chest pain). There were 3 re-operations in the laparoscopic 
group (anastomotic leak requiring peritoneal irrigation and defunctioning stoma, reactive 
bleeding from an ovarian ligament removed en-bloc with a sigmoid diverticular abscess 
which required over-sewing, and repair of a port-site hernia), and one in the open group 
(rectal stump blow-out requiring wash out and over-sewing).
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Comparison between patients who did and did not complete QoL 
diary
169 patients were recruited to the QoL part of the study, of whom 32 did not 
complete the diary. 21 patients stated that they were too unwell to complete the diary, and 16 
diaries were not completed. 31 patients were not recruited.
A simple comparison was made comparing these three groups (those who were 
recruited and completed the diary, those who were too unwell, and those who were not 
recruited or whose diary was not completed, Table 19). The main finding of this was in the 
group of patients who were too unwell to complete the diary, with the length of stay in the 
laparoscopic group similar to those who did complete the diary (4 v 3 days), but longer in the 
open group (11 v 6).
Number of 
patients 
(conversions)
Age
Operation
time
Number of 
complications
Length of 
stay
Read­
missions
QoL data 
collected
Lap 88(1) 70 110 14 3 4
Open 44 68 177 13 6 2
Too
unwell,
Lap 14(3) 77 110 3 4 0
no QoL 
data
Open 7 76 180 4 11 1
In study, 
but no
Lap 28(1) 70 107 6 4 2
QoL data Open 19 65 140 5 7 2
Table 19: Outcome data comparing patients who completed and those who did not complete the 
QoL diary. Patients are divided into 3 groups: those in whom QoL data was collected; patients who 
had consented to the QoL study but felt too unwell to complete the QoL diary; and patients who were 
in the study but had no QoL data (patients either were not recruited or did not consent to the QoL part 
of the study, or who did not complete the diary, or in whom the diary was lost).
It should be acknowledged that there may be a difference between the QoL data that 
was missing ‘at random’ (patients who were not recruited or whose diary was lost, and in 
whom there is no reason to suggest that if QoL data had been collected it would have been 
significantly different from the overall study group), and QoL data that was missing for non- 
random reasons (for example patients who were too unwell to complete the diary). There 
potentially may have been a difference in the QoL of patients who felt too unwell to complete
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the diary, as compared to those who did. For this reason, an analysis was performed on the 
whole study group, assigning patients who felt too unwell an EQ-5D score of 0 for the entire 
study period. This analysis demonstrated a similar significant difference between the 
laparoscopic and open patients when compared to the main analysis. However, it is unlikely 
that these patients who were too unwell would have scored 0 for the entire study period, 
particularly the laparoscopic patients who had a mean length of stay of 4 days. It is therefore 
unlikely that the ‘non-random’ missing data would have significantly skewed the study 
results, but this possibility must be considered.
Discussion
This chapter has described the sample characteristics and clinical outcomes of the 
patients recruited to the study investigating cost effectiveness. Patient demographics, clinical 
diagnoses, the type of surgery performed (including whether a stoma was formed), morbidity 
and mortality, length of hospital stay, and readmission and reoperation rates have all been 
described.
This is a pragmatic trial, involving patients undergoing routine care within the NHS, 
and as such there are differences between the two patient groups. This reflects the current 
practice at The Royal Surrey County Hospital.
More patients had laparoscopic rather than open surgery. The Royal Surrey has 
gained a reputation in laparoscopic surgery, and the local population increasingly expects to 
have their surgery performed laparoscopically. In addition, Professor Rockall receives both 
regional and national referrals. John Stebbing has a specialist interest in inflammatory bowel 
disease (IBD), and in particular pouch surgery; this explains why there was a higher 
proportion of rectal procedures and stomas in the open group.
This difference between the groups (with regards to the proportion of rectal 
procedures and stomas) was discussed with the study supervisors and statisticians, in 
particular as to whether the study should be a case-matched study, or whether the study
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should be randomised. The disadvantage of a randomised trial was that the number of patients 
who could be recruited would have been significantly less, as only one surgeon could perform 
both the laparoscopic and open techniques. A case-matched study could have introduced other 
biases, and it was felt that the statistical power would have been reduced by excluding some 
patients because they could not be matched. The statistical advice was that, whilst 
acknowledging the limits of the study, it was better to include all patients, and then adjust for 
important covariates within a multivariate analysis. This was performed for the HRQoL data. 
Having laparoscopic or open surgery, and the presence of a stoma, were identified as the 2 
most significant covariates. The cost analysis was therefore performed on the whole study 
group, and the “stoma” and “no stoma” groups separately.
Although not all patients were recruited to, or completed, the QoL part of the study, 
the overall response rate of those recruited was high (80%). Clinical outcomes were similar 
between those patients who completed the QoL diary, and those who did not, suggesting that 
there are likely to be no significant differences between those groups.
Fourteen patients were missed by the investigator from recruitment to the HRQoL 
part of the study. Considered together with those patients who did not complete the diary 
(including those who declined to participate, did not complete the diary, or in whom the diary 
was lost), there were a total of 47 patients (28 laparoscopic, 19 open) with no QoL data. A 
further 21 patients (14 laparoscopic, 7 open) stated that they were too unwell to complete the 
diary. These three groups of patients were compared with respect to length of hospital stay, 
and morbidity, demonstrating generally similar outcomes. Those patients in the open group 
who were “too unwell” had a longer length of stay (11 days), but this group was small 
consisting of only 6 patients, and it is therefore difficult to draw any firm conclusions on their 
outcomes.
The difference in the length of stay (3 v 6 days) is similar to that reported in other 
series. A systematic review found a difference in the length of stay of between 0.5 and 5.6 
days (Reza et al., 2006), and the NICE review concluded that there is a difference of 2.6 days 
between the groups (Murray et al., 2006). A question commonly posed is whether a shorter
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hospital stay for open patients is achievable using an enhanced recovery programme, thereby 
negating many of the advantages of laparoscopic surgery. There was not a protocol driven 
enhanced recovery programme in place in Guildford at the time of the study, although the 
principles of fast-track surgery were adhered to (with particular emphasis on early resumption 
of oral intake and early mobilisation). Whilst Kehlet has reported short post-operative hospital 
stays (median 2 days) using an enhanced recovery programme following open surgery 
(Kehlet and Mogensen, 1999), these results have not been replicated in the literature. A 
multicentre study, with Kehlet as one of the co-authors, demonstrated a median length of 
hospital stay of 5 days, despite adherence to the enhanced recovery protocol (Maessen et al., 
2007). Therefore, a hospital stay of 6 days following open surgery is very respectable, and is 
unlikely to be significantly shorter with an enhanced recovery programme.
The short-term cancer outcomes (lymph node harvest, CRM involvement) were of a 
high standard in both groups, with a high lymph node yield exceeding most reports from the 
literature (Chapman et al., 2001, Reza et al., 2006). This suggests that the standard of surgery 
was high in both groups.
The rate of complications was higher in the open patients, although the anastomotic 
leak rate (clinically detected, not radiologically tested) was very low in both groups. Overall, 
the morbidity rate was low compared to other published data. Previous studies comparing 
laparoscopic and open colorectal surgery have also suggested a reduction in complications 
with patients having laparoscopic surgery, particularly relating to the wound (Braga et al., 
2005b). However, there were more deaths in the laparoscopic group (non-significant 
difference), although the mortality rate was low in both groups, and less than that predicted by 
the Cr-POSSUM score.
In conclusion, 200 patients were recruited prospectively to the study, and patients 
having laparoscopic or open surgery were similar for most demographic, clinical, and 
oncological factors. 169 patients (85% of 200) were successfully entered into the HRQoL part 
of the study. The most significant differences between the groups were in terms of the 
proportion of stomas performed, and the number of low rectal procedures undertaken, both of
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which were higher in the open group. The length of hospital stay was significantly shorter in 
the laparoscopic group, and this group had fewer complications.
I l l
Summary
• 200 consecutive patients were recruited prospectively to a study investigating the cost 
effectiveness of laparoscopic colorectal surgery
• 169 patients were recruited to the quality of life part of the study, with a 78% 
response rate of a completed diary.
• There were some differences between the laparoscopic and open groups, which 
potentially could result in a selection bias:
o Most of the basic demographic and clinical data was similar between the 
laparoscopic and open groups. Colorectal cancer accounting for 55% of the 
clinical diagnoses.
o However, there were more rectal procedures and stomas formed in the open 
group. This was adjusted for in the multivariate analysis, and by performing 
an analysis of the stoma and no stoma groups separately.
o More procedures in the open group were performed by trainees under direct 
supervision.
• There was no difference in outcomes between right and left sided resections.
• Cancer outcomes were similar between the groups, with a high lymph node yield, and 
few positive CRMs.
• The length of hospital stray was significantly longer in the open group (3 v 6 days).
• More patients were admitted to ICU and HDU in the open group.
• Major complications, defined as prolonging hospital stay or requiring intervention, 
were less in the laparoscopic group.
• There was no significant difference in mortality, although the mortality rate was 
slightly higher in the laparoscopic group (3%vl%).
• There is a potential bias relating to missing data from patients who felt too unwell to 
complete the diary.
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Introduction
A number of studies have previously examined health related quality of life (HRQoL) 
following laparoscopic and open colorectal surgery, but none have identified a significant 
difference between the two techniques as assessed by the QoL instruments. However, it has 
been demonstrated that patients having laparoscopic surgery for colorectal procedures have 
less post-operative pain, are discharged home earlier, return to work faster, and subjectively 
appear to recover more rapidly than patients having an open operation. It would be expected 
that these factors would lead to an improved QoL during a patient’s recovery from surgery.
There are a number of reasons why previous studies may not have identified potential 
differences in HRQoL (a type II error). Few studies have closely evaluated the early post­
operative period, when differences are most likely to be observed; HRQoL was not a primary 
outcome measure in many of the studies, and some therefore are unlikely to have been 
powered adequately to demonstrate differences in QoL; the HRQoL instruments used in 
previous studies may not have be sensitive enough to pick up significant differences; and 
some of the studies had high conversion rates due to many surgeons still being on their 
learning curve with regards to laparoscopic techniques.
There is therefore a need for well constructed studies evaluating HRQoL to 
investigate the early postoperative period in greater detail.
This chapter describes the results of the HRQoL assessment performed as part of the 
current cost effectiveness study. HRQoL was one of the main outcome measures for the 
study, and a detailed and comprehensive HRQoL assessment was made of patients during the 
first 6 post-operative weeks.
The chapter begins with presentation of the results for the whole study group, 
including distribution of the data. A univariate analysis is performed using a number of 
different covariates, to identify potential confounding variables. Two analyses are performed 
which take into account these potential predictor covariates: a repeated measures ANOVA 
analysis, and a multiple regression analysis.
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Potential confounding variables considered and entered into the statistical models 
included age, gender, ASA grade, diagnosis, type of surgery, presence of a stoma, and 
operating surgeon grade (trainee or consultant).
Three subgroup analyses are also presented, assessing the impact of a stoma, 
evaluating QoL in patients without a stoma, and comparing the QoL of patients following 
different operative procedures.
The analysis was carried out on an “intention to treat” basis, with the laparoscopic 
group including those patients who were converted to open surgery, as well as those who 
were excluded from having a laparoscopic procedure.
Quality of life outcomes
A total of 169 patients were recruited to the HRQoL part of the study, of whom 132 
returned the diary (78%). 64.5% of patients were in the laparoscopic group (Figure 2 in 
previous chapter, study flow diagram).
Distribution of data
EQ-5D and SF-36 (Physical component score and total score) data were inspected at 
days 6, 14,28, and 42 to assess the pattern of data distribution. Histograms at these timepoints 
(Figures 5.1a and b, for example) and the raw data were reviewed, and showed a limited level 
of skewness (mainly left-hand, or negative skewness), but no evidence of other irregularities 
such as twin-peak distributions. It is preferable to use parametric tests as they are more 
sensitive than equivalent non-parametric tests, and therefore analysis of the data was 
performed using parametric techniques. To confirm that the use of parametric tests was 
appropriate, non-parametric tests were compared directly with the parametric tests for the 
analysis of the EQ-5D data (comparing the laparoscopic and open groups). At no time did the 
non-parametric test (Mann Whitney-U) contradict the statistically significant results of the 
corresponding t test.
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Figure 3: D istribution o f  data (D ay 14)
Bivariate analyses of whole data set
An initial exploration o f the data was perform ed on the EQ-5D results, by running a 
num ber o f  bivariate analyses, to identify potential confounding variables. A repeated 
m easures analysis o f variance (ANOVA) on the EQ-5D scores up until day 28 was used, with 
different variables, and no adjustment. The EQ-5D results were used, due to the regular and 
frequent m easurements, and a repeated m easures analysis takes advantage o f  this.
Potential predictor covariates were used separately for these bivariate analyses, and 
included laparoscopic or open surgery; stoma or no stoma; diagnosis (divided into four 
groups, carcinoma, benign diseases other than inflammatory bowel disease, C rohns’ disease, 
and ulcerative colitis); the type o f operative procedure (right hem icolectom y, left sided 
resection including high anterior resections, and low rectal or more com plex procedures); age; 
gender; ASA grade; and grade o f  surgeon (consultant, or supervised trainee, as this was 
different between the groups). These variables were subsequently used in both the repeated 
measures model, and in the multiple regression analysis.
Four factors were found to be significantly related to the EQ-5D scores: laparoscopic 
or open surgery; stoma or no stoma; ASA grade 3; and cancer diagnosis (Table 20).
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Variable Significance (repeated measures 
ANOVA) P value
Laparoscopic or open 0.001
Stoma or no stoma 0.001
Diagnosis 0.065
Cancer diagnosis 0.018
Operation type 0.153
Rectal operation 0.058
ASA grade 0.203
ASA 3 0.044
Grade of surgeon 0.394
Gender 0.120
Table 20: Bivariate repeated measures analysis of EQ-5D data.
Unadjusted (bivariate) analysis comparing laparoscopic and open 
surgery
The EuroQol scores for the two patient groups are displayed in Table 21. There was 
no difference in the pre-operative scores between the two groups, but there is a significant 
difference in the post-operative scores for all measures (except for Days 14, 35, and 42). This 
significance is reflected in the repeated measures analysis, demonstrating a significant 
difference in favour of the laparoscopic group (Figure 4, P<0.001).
The SF36 scores show a similar picture, with a significant difference in the physical 
component summary (PCS) score (p=0.002) and total score (p=0.005) at all times (Figure 5, 
Table 22). This difference is still present at Day 42. The SF-36 subscales show significant 
differences in favour of the laparoscopic group for physical functioning (P=0.005), role 
physical (PO.OOl), bodily pain (P=0.045), vitality (P=0.015), and social functioning 
(P=0.001) (Figure 6). The only subscales which do not demonstrate differences between the 
laparoscopic and open groups are general health, role emotional, and mental health.
These results have demonstrated that at a bivariate level there is a significant 
difference in HRQoL between patients undergoing laparoscopic and open colorectal surgery, 
in favour of the laparoscopic group. However, in order to account for potential confounding 
variables, it is necessary to perform a multivariate analysis.
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No. of 
patients
Mean
score
Standard
deviation
Significance 
(P value)*
EQ5D pre-op Laparoscopic 88 .80 .199
score Open 44 .80 .231 .836
EQ5D day 2 Laparoscopic 88 .32 .199
score Open 44 .08 .294 .000
EQ5D day 4 Laparoscopic 88 .42 .290
score Open 44 .29 .220 .007
EQ5D day 6 Laparoscopic 86 .54 .271
score Open 43 .42 .240 .015
EQ5D day 8 Laparoscopic 84 .63 .227
score Open 43 .43 .328 .000
EQ5D day 10 Laparoscopic 83 .68 .219
score Open 43 .53 .276 .001
EQ5D day 12 Laparoscopic 85 .70 .226
score Open 43 .59 .265 .015
EQ5D day 14 Laparoscopic 84 .71 .280
score Open 44 .61 .268 .052
EQ5D day 16 Laparoscopic 83 .75 .226
score Open 44 .65 .224 .022
EQ5D day 18 Laparoscopic 83 .77 .207
score Open 44 .67 .251 .021
EQ5D day 20 Laparoscopic 83 .79 .194
score Open 44 .66 .260 .006
EQ5D day 22 Laparoscopic 83 .81 .185
score Open 43 .72 .241 .019
EQ5D day 24 Laparoscopic 83 .82 .167
score Open 44 .73 .231 .009
EQ5D day 26 Laparoscopic 83 .82 .186
score Open 44 .73 .222 .011
EQ5D day 28 Laparoscopic 83 .84 .178
score Open 44 .75 .217 .015
EQ5D day 35 Laparoscopic 71 .86 .225
score Open 36 .80 .215 .201
EQ5D day 42 Laparoscopic 71 .89 .172
score Open 37 .84 .181 .127
T able 21: D ifferences in m ean EQ -5D  scores betw een patients undergoing laparoscopic and open  
procedures (*student’s t test).
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Figure 4: Unadjusted repeated m easures analysis o f EQ-5D scores in patients undergoing  
laparoscopic and open surgery.
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Figure 5: Unadjusted repeated m easures analysis o f  total SF-36 scores in patients undergoing  
laparoscopic and open surgery.
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SF-36 Score Laparoscopic or Open
Number of 
patients Mean
Std
deviation
Significance 
(P value)*
Pre-op PCS Laparoscopic 88 68.6 20.3 .733
Open 44 67.2 23.4
MCS Laparoscopic 88 71.0 17.7 .656
Open 44 72.5 20.2
Total Laparoscopic 88 71.8 18.4 .885
Open 44 71.3 21.6
Day 6 PCS Laparoscopic 87 33.7 15.5 .035
Open 44 27.2 11.5
MCS Laparoscopic 87 50.4 20.1 .151
Open 44 44.5 16.8
Total Laparoscopic 87 40.7 17.4 .041
Open 44 33.6 13.2
Day 14 PCS Laparoscopic 87 46.3 18.6 .029
Open 44 39.0 17.2
MCS Laparoscopic 87 61.0 19.5 .118
Open 44 55.3 20.7
Total Laparoscopic 87 53.4 18.4 .040
Open 44 46.4 18.4
Day 28 PCS Laparoscopic 84 63.7 21.5 .001
Open 44 50.5 17.7
MCS Laparoscopic 84 73.8 18.3 .004
Open 44 63.8 18.6
Total Laparoscopic 84 69.8 19.7 .001
Open 44 57.7 17.3
Day 42 PCS Laparoscopic 72 73.1 19.7 .003
Open 38 61.6 18.2
MCS Laparoscopic 72 78.7 16.6 .100
Open 38 73.1 16.9
Total Laparoscopic 71 77.6 18.1 .011
Open 38 68.4 17.1
Table 22: Differences in mean SF-36 scores between patients undergoing laparoscopic and open 
procedures (*student’s t test, MCS Mental component summary, PCS Physical component summary).
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122
Multivariate analyses 
Repeated measures model
Data were available on 87 laparoscopic and 43 open surgery patients in whom 
complete EQ-5D data up until day 28 following surgery was available (day35 and 42 
timepoints were excluded, as less data were available for these measures, which would have 
reduced the number of patients included in the overall repeated measures analysis, and 
therefore the power of the analysis). A repeated measures ANOVA was performed on these 
130 patients (14 observations per patient) in order to look for differences in HRQoL between 
the laparoscopic and open surgery groups.
The following variables were included in the model as potential covariates: stoma or 
no stoma, operation type (right, left, or rectal procedure), grade of surgeon, gender, age, ASA 
grade and patient’s diagnosis. None of these variables were found to be statistically 
significant, except for patients with ASA III (who did slightly worse), and patients with a 
diagnosis of cancer (who did slightly better) (table 23).
Variable Significance Observed
Power
Laparoscopic or open .006 .800
Age .966 .050
Gender .147 .304
Grade of surgeon .865 .053
ASA 2 .487 .106
ASA 3 .031 .584
Diagnosis 1: Cancer .038 .548
Diagnosis 3: Crohn’s .444 .119
Diagnosis 4: UC .626 .077
Operation: Rectum .452 .116
Stoma .074 .431
Table 23: EQ-5D repeated measures analysis: tests of potential predictor covariates
123
A statistically significant difference in EQ-5D scores was found betw een the two 
treatm ent groups (p=0.006), with the laparoscopic group achieving consistently higher 
estim ated EQ-5D scores o f  between 0.040 and 0.292 over the period, w hilst adjusting for all 
the other variables described in table 23 (Figure 7, Table 24). The observed pow er o f this 
difference betw een the laparoscopic and open patients is high (0.8), dem onstrating that having 
laparoscopic surgery is strongly predictive o f an improved QoL during this post-operative 
period.
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Figure 7: A djusted repeated m easures analysis o f  EQ-5D scores in patients undergoing  
laparoscopic and open surgery (P=0.006).
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Estimated difference 
Lap v Open groups
Standard Error of 
the Mean Significance
Day 2 .292 .061 .000
Day 4 .097 .052 .066
Day 6 .116 .055 .036
Day 8 .184 .054 .001
Day 10 .140 .048 .005
Day 12 .063 .048 .199
Day 14 .058 .057 .310
Day 16 .066 .046 .151
Day 18 .040 .045 .382
Day 20 .083 .044 .063
Day 22 .080 .041 .057
Day 24 .078 .039 .047
Day 26 .067 .040 .099
Day 28 .061 .039 .122
Day 35 .062 .053 .248
Day 42 .065 .042 .124
Table 24: Estimated difference between laparoscopic and open patients from repeated measures 
model (Used to calculate AUC for cost analysis)
Statistically significant differences the treatment groups (based on the same model as 
that performed for the EQ-5D data) was also found using the SF-36 physical component score 
(PCS) score (P=0.004, Figure 8) and SF-36 total score (P=0.007, Figure 9), with the 
laparoscopic group having a higher quality of life than the open surgery group. As with the 
EQ-5D measure of QoL, having a cancer diagnosis (p=0.033, improved QoL) or an ASA 
grade of 3 (p=0.012, reduced QoL) had a statistically significant effect on the model (data not 
shown).
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Figure 9: A djusted repeated m easures analysis o f  SF-36 total scores in patients undergoing  
laparoscopic and open surgery (P=0.007).
Linear regression
In order to determine whether specific factors were predictive o f an im proved QoL at 
specific points in a patient’s post-operative recovery, a forward stepwise linear regression 
analysis was used. EQ-5D and SF-36 (both the total score and the physical com ponent
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summary score) on days 6, 14, 28, and 42 were used as the dependent variables. Possible 
predictive variables entered into the model were the same as those used for the repeated 
measures analysis.
Forwards and backwards stepwise regression analyses were used, with each 
producing the same final model and result. An advantage of the regression analysis is that the 
change in the EQ-5D score from baseline is modelled for each timepoint, thus compensating 
for any slight differences in the pre-operative scores between the laparoscopic and open 
groups.
EQ-5D
Laparoscopic surgery was identified on days 6 and 28 to result in a significantly 
better HRQoL (table 25), with the “size of the effect” of laparoscopic surgery on the EQ-5D 
score at these timepoints +0.135 and +0.09. The effect of laparoscopy is more pronounced 
early in the study period, which is what would be expected. Comparing the “size of effect” in 
table 25 with the mean scores in table 21 suggests that much of the difference between the 
laparoscopic and open scores can be attributed to the laparoscopic approach, as opposed to 
other variables.
B (size of 
effect)
Significance (P)
Day 6 +0.135 0.014
Day 14 +0.140 0.105
Day 28 +0.09 0.039
Day 42 +0.07 0.44
Table 25: EQ-5D scores, forward regression, effect of laparoscopy.
Other factors that were identified to be predictors of differences in quality of life were 
Crohn’s disease (which as a variable will have a high correlation with right hemicolectomy, 
which was discarded from the model) on days 28 and 42, and rectal operation on day 14.
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SF-36 
Physical component score
The physical component score of the SF-36 was found to be significantly improved in
laparoscopic patients on days 28 and 42, with an effect (B value) of +9.819 and +10.457 
(P=0.013 and P=0.012). However, there is no significant impact on SF-36 made by the 
different surgical approaches on days 6 and 14 (P=0.279, P=0.256). Covariates with a 
significant impact are ASA grade 3 (day 6, 14), rectal operation (day 14, 28), and Crohn’s 
disease (day 42).
Total score
Examining the total SF-36 score within the regression model, reveals a similar pattern 
to the physical component score, with laparoscopy having a significant impact on days 28 and 
42 (B values +9.295 and +9.205, P=0.011 and P=0.018 respectively). ASA grade 3 (day 6), 
rectal operation (days 14 and 28), and Crohn’s disease (day 28) also had a significant effect.
Subgroup analyses
Having demonstrated in the bivariate analysis that the mode of surgery (laparoscopic 
or open), and the presence of a stoma had a significant impact on HRQoL, subgroups were 
created to investigate these, and other relevant factors further. Whilst laparoscopy has been 
shown to have a significant impact on HRQoL in all the analyses performed, the presence of a 
stoma was not identified in either the repeated measures analysis or the specific timepoint 
regression analyses as having a significant effect. However, the type of surgery (in particular 
rectal operations, which has a high correlation with the presence of a stoma) and Crohn’s 
disease (patients having a right hemicolectomy, thus having no stoma) were of significance in 
some of the analyses, with a negative and positive impact on HRQoL respectively.
In addition the pilot study identified stoma as being of relevance for QoL. We have 
therefore performed subgroup analyses (using repeated measures ANOVA) assessing the 
impact of a stoma on both the laparoscopic and open patients respectively, and then have 
evaluated patients with and without a stoma separately.
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Impact of a stoma
L aparoscop ic  patien ts
There is a significant difference in the repeated m easures analysis o f  the EQ-5D
scores betw een patients with and w ithout a stoma (P=0.008, Figure 10). Exam ining the time- 
points separately, the scores for patients w ithout a stoma are always greater, with significant 
differences on all days except Days 2, 6, 8, 10, 35 and 42 (data not shown). The SF36 scores 
dem onstrate a sim ilar pattern, with significant differences on days 14 and 28 (both for the 
total score and physical component summary), with the repeated m easures analysis 
suggesting a benefit in favour o f  the no stoma group (PCS P=0.132, total score P=0.084).
Stoma group
(N=66)
(N= 11)
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Figure 10: Laparoscopic patients only: Patients with and without a stoma. EQ-5D scores, 
repeated measures analysis (p=0.008).
O pen patien ts
There is no significant difference in HRQoL between patients with and without a 
stoma in the open group (Figure 11). The EQ-5D and SF36 scores are comparable at all time 
points, with no differences reaching statistical significance (data not shown). However, this 
analysis is lim ited by a relatively small sample size (N=24).
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Figure 11: Open patients: stoma v no stoma. EQ-5D scores, repeated m easures analysis 
(p=0.458).
P atien ts w ith  no stom a
There were 128 patients (91 laparoscopic (71%), including 3 converted and 2
excluded patients) with no stoma in whom HRQoL data are available. The age, BM I, ASA 
grade, and diagnosis were similar between the laparoscopic and open groups, but w ith more 
male patients in the open group. There was a higher proportion o f right sided resections in the 
laparoscopic group, and rectal resections in the open group. To com pensate for these 
potentially confounding variables, a repeated measures ANO V A  model, w hich adjusted for 
these covariates, was used to analyse the data. The same covariates that were used previously 
were entered into the model.
The individual EQ-5D scores for these patients show a significant difference in 
favour o f  the laparoscopic group at all time points except days 35 and 42, with significant 
differences seen in the physical functioning, role physical, vitality, and social functioning SF- 
36 subscales (p<0.05).
A statistically significant difference was found with the repeated m easures model 
between the laparoscopic and open groups (Figure 12, P=0.002). The laparoscopic group
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achieved consistently higher estimated EQ-5D scores o f  between 0.079 and 0.247 over the 
study period, w ith the observed pow er o f  the effect o f  laparoscopic surgery being very high 
(0.894). Similar results are obtained in the repeated m easures model o f the SF-36 PCS score 
(P=0.002), and SF-36 total score (P=0.003) (data/output not shown).
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Figure 12: Adjusted repeated measures analysis of EQ-5D scores in patients with no 
stoma undergoing laparoscopic and open surgery (P=0.002).
P atien ts w ith  a stom a
The subgroup o f  patients who had a stoma (including both temporary and perm anent
stomas) is lim ited by a small study size (27 patients in total, 12 laparoscopic and 15 open). 
However no difference in the HRQoL between the laparoscopic and open patients was 
identified in either the EQ-5D or SF-36 scores. A repeated measures ANOVA was perform ed
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on the EQ-5D scores (Figure 13, P=0.564), the SF-36 PCS scores (P=0.545), and total score 
(P=0.832), w ith no statistically significant differences identified between these two groups.
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Figure 13: Adjusted repeated measures analysis of EQ-5D scores in patients with a 
stoma undergoing laparoscopic and open surgery (P=0.564).
Effect of operative procedure on HRQoL
The operative procedures perform ed were divided into three groups: right colectomy, 
left colectomy (includes high anterior resection, w ith 13% o f  this group having a stoma), and 
rectal procedure (79% stoma rate). An unadjusted repeated measures analysis was perform ed 
on the EQ-5D data to investigate differences in QoL for each operative procedure. There was 
no difference between the right and left colectomies in either the laparoscopic or open groups, 
and therefore an analysis was perform ed including all o f  the right and left sided resections. 
This showed a significant difference in favour o f the laparoscopic group (P<0.001). Rectal 
operations show no difference between the laparoscopic and open groups (15 lap, 12 open, 
P=0.465).
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Additional indicators of recovery
EQ-5D VAS thermometer
The visual analogue scale, which is performed as part of the EuroQoL assessment,
demonstrated a different picture to that of the other HRQoL questionnaires. Unadjusted 
analysis of the whole dataset demonstrates a significant difference in the VAS in favour of the 
laparoscopic group. However, a repeated measures analysis performed with the covariates 
entered into the model did not demonstrate a significant difference between the laparoscopic 
and open groups (P=0.079). Although there is a trend in favour of the laparoscopic group, the 
observed power of this test is only 0.426.
Return to work / normal activities
In addition to the data collected on HRQoL, patients were asked to state in the diary
when they had returned “partly” and “fully” to their normal activities or work, and also when 
they had resumed driving. Each of these measures demonstrate a significant benefit in the 
laparoscopic group (Table 26).
Laparoscopic Open Significance*
Partly resume normal activities 10.5 (8-17.5) 22 (16-28) P<0.001
Fully resume normal activities 28 (20-42) 46 (38-50) P 0 .001
Resume driving 19.5 (14-25) 35 (20-42) P=0.003
Table 26: Laparoscopic v open patients: Time in days to partly and fully re tu rn  to 
normal activities / work and to resume driving. Median (IQR); *Mann W hitney U test.
Time to reach 80 and 90 percent of pre-operative state
Another method of assessing recovery that has been used in previous studies is to
calculate the number of days it takes for patients to reach 80 and 90 percent of their pre­
operative state. Using the EQ-5D scores for all patients (Table 27), there is a difference of 
approximately a week in favour of the laparoscopic group for both of these time-points.
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80% 90%
Laparoscopic Day 8 Day 14
Open Day 16 Day 22
Table 27: Time to reach 80% and 90% of pre-operative state (mean EQ-5D scores).
Discussion
This prospective study (involving 169 patients with an 80% response rate) represents 
the largest single institution study comparing the recovery of patients following a 
laparoscopic or open colorectal resection. Recovery has been assessed using two validated 
HRQoL questionnaires, EQ-5D and SF-36. EQ-5D (EuroQoL) is a simple and easy to use 
measure that can be used to calculate QALYs. SF-36 (acute version) is more detailed, but can 
only be used weekly, so is less powerful within a repeated measures analysis. It does, 
however, provide a validation of the EQ-5D results.
The results should be interpreted with caution, given that there are some 
methodological weaknesses with the study. There is a potential selection bias, as there are 
some differences between the laparoscopic and open groups, in particular the proportion of 
right hemicolectomies and patients with Crohn’s disease, rectal procedures and patients with a 
stoma, between the two groups. These differences have been adjusted for statistically by use 
of modelling within a repeated measures ANOVA analysis and a multivariate forwards 
regression analysis, however it is not possible to adjust for every potential confounding 
variable. In addition to selection bias, there are issues relating to missing data, which have 
been described earlier in the chapter. Another point to make is the risk of multiple statistical 
testing, as has been performed here, although all statistical tests that were performed have 
been reported and the results are very consistent.
Whilst recognising the points described above, this study has suggested that there is 
an improvement in HRQoL with the laparoscopic approach. The most accurate evaluation of 
the patient’s recovery during this period is obtained with the repeated measures modelling,
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which assesses data from the entire study period, and adjusts for covariates. The results of this 
analysis for EQ-5D and SF-36 (both the total score and physical component summary score) 
are significant, suggesting that there is a difference in HRQoL between patients having 
laparoscopic or open colorectal surgery.
The data over the 6 week study period is consistent, with similar differences 
identified in both of the HRQoL instruments, and an expected tailing off of the difference 
between the groups towards the end of the 6 weeks. In addition, significant differences have 
also been demonstrated in five of the eight SF-36 subscales (those subscales that measure the 
physical aspects of recovery, rather then general or mental health).
Subgroup analyses have confirmed that, in the laparoscopic group, patients who 
require a stoma have a reduced QoL. With respect to the operative procedure, there is no 
difference (in either the laparoscopic or open group) between patients having a right or left 
sided resection. Patients who had a full TME or more complex pelvic procedure (subgroup 
rectal operation) also had a reduced QoL, although nearly 80 percent of this group had a 
stoma, which may well be the critical variable determining QoL.
The only measure which has not demonstrated significant differences between the 
groups was the visual analogue scale (VAS). This is the only subjective measure that has been 
employed in this study. A possible explanation for the VAS result is that this is influenced by 
patient expectation, with the open patients expecting a slower recovery compared to those 
patients who had a laparoscopic procedure. However, the fact that both groups had relatively 
high VAS scores, suggests that both groups were satisfied with the outcome of their surgery.
Previous studies have been unable to identify significant differences in HRQoL 
between patients having laparoscopic or open surgery, although it is accepted that 
laparoscopic surgery results in reduced post-operative pain, a shorter hospital stay, and a 
faster return to normal activities (also demonstrated in the current study). There are various 
reasons why these previous studies might not have identified differences in QoL. These have 
been discussed in Chapter two, but include surgeons still being on their learning curve for
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laparoscopic surgery resulting in high conversion rates, quality of life not being a primary 
outcome measure, and the timing of the QoL measures.
Previous studies have also been limited by employing only one or two measures 
within the early post-operative period. In the study reported here, assessments have been 
performed on alternate days, allowing the repeated measures analysis to be performed. This 
enables the data from the entire study period to be built into a statistical model, with the 
allowance for different levels of within subject variation, and adjustment for covariates.
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Summary
• There is probably a significant difference in the HRQoL of patients following 
laparoscopic or open colorectal surgery in favour of the laparoscopic group.
• This difference has been demonstrated with both EQ-5D and SF-36, and confirmed 
with the different statistical techniques that have been used which incorporate as 
much of the data as possible.
• The results need to be interpreted with caution given that there is a potential for bias 
due to some of the methodological weaknesses that have been highlighted.
• Covariates that significantly influence the HRQoL of patients are:
o Laparoscopic or open surgery 
o Presence of a stoma 
o ASA grade III
o Rectal operation (which often necessitates a stoma)
• Patients with a stoma have a lower HRQoL than other patients
• The VAS thermometer shows no difference between the groups; this might suggest 
that patient’s expectations are met to a similar degree with both approaches.
• Laparoscopic patients resume their normal activities, work, and driving earlier than 
open patients.
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Introduction
This chapter presents the data collected for the cost effectiveness study, including the 
resources that were used to calculate the costs, the unit costs of those resources, and the direct 
costs themselves.
Economic studies are typically considered from one of three possible perspectives: 
the health service, individual, and societal. Healthcare costs are also described as being direct 
(those costs that are bourne directly by the healthcare provider, in this case the NHS) and 
indirect (costs to an individual or society due to an individual’s loss of productivity). This 
study has taken the perspective of the ^ health service, and has therefore measured the direct 
costs.
Whilst the indirect costs incurred due to a patient’s recovery from surgery may be 
significant, and any technique that reduces the length of absence from work will lessen any 
loss of productivity, health economists are increasingly disregarding these costs when 
assessing the short-term cost effectiveness of a new technique (Sculpher, 2001). Indirect costs 
are also notoriously difficult to calculate, are often inaccurate, and as this study is only 
concerned with comparing two alternative approaches over the first 6 post-operative weeks, 
would have a minimal impact. Another reason for not attempting to measure the indirect costs 
is that approximately half of the patients in the study were of retirement age, and thus indirect 
costs are of significantly less importance in these cases.
The chapter commences with a summary of the resources measured in the study (this 
is described in full detail in chapter 3), and goes on to describe the unit costs of these 
resources. The cost results of the study are subsequently presented. Data are presented in 
three sections: costs pertaining to the operation; those relating to the hospital stay (including 
readmissions); and the healthcare costs incurred in the community following discharge from 
hospital. Unless otherwise stated, the costs are fully absorbed (ie including all overheads). 
Data are presented on an intention to treat basis comparing all patients originally assigned to 
laparoscopic (including conversions and exclusions) and open surgery. A separate analysis is
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presented for those with and without a stoma, as these patients had differing HRQoL results 
as presented in the previous chapter. Finally, a sensitivity analysis has been performed 
examining the effect of the operative time on the cost results.
Physical resources and their unit costs
In order to undertake the cost evaluation, healthcare costs were divided into three 
sections: those relating to the operative procedure, in order to obtain a direct comparison 
between the costs of a laparoscopic and open procedure; those relating to the patient’s post­
operative stay in hospital; and community healthcare costs, following a patient’s discharge 
from hospital.
Calculation of costs involves recording the various physical resources used, and then 
assigning a unit cost for each of these resources. The cost can then be calculated by 
multiplying the unit cost by the number of units used. The physical resources that were 
measured are summarised here, but were described in more detail in chapter 3.
Operative costs
The operative costs are calculated by combining the costs of the staff involved, the 
operative equipment utilised during the procedure, and the cost of overheads relating to the 
use of an operating theatre (Table 28). The main factors contributing to the cost of the 
operation itself are the equipment and staff costs.
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Cost item Source
Cost (per hour 
unless otherwise 
stated)
Staff Consultant surgeon (inc HFD £59.62
1 merit award)
Consultant anaesthetist HFD £50.95
Theatre & recovery HFD £118.87
staff
Theatre 35% added to theatre HFD £35.66
overheads staff cost*
Operative Sterilising of instrument Synergy Healthcare £8.31-£19.64 (Table
equipment trays and equipment 6.
Sutures, swabs, and Theatre manager £0.30-£6.11
drapes (pack of 10)
Disposable (single use) Theatre manager and Ethicon See table 6.2
equipment Endo-Surgery
Table 28: Operative costs. Costs relate to financial year 2006-7. *Theatre costs are not fully 
absorbed; to calculate this, the hospital finance department adds 35% to the theatre staff costs. HFD: 
hospital finance department.
Equipment costs
Equipment costs for the operative procedures vary between different patients, so the 
resources used were recorded on a specially designed proforma (appendix 2). This included 
not only all the disposable equipment required for a laparoscopic operation, but a record was 
also kept of all sutures, swabs, instrument trays, drapes, and other instruments used in the 
operation. The costs of each of these items are listed in appendix 8. The costs recorded are the 
costs incurred for each operative procedure. This includes the cost of sterilising reusable 
equipment (such as the theatre sets), but does not include the capital costs of buying such 
equipment.
Laparoscopic colorectal surgery in particular is very dependent on the sophisticated 
instruments and “single-use” equipment that has been designed for laparoscopic surgery. 
Whilst a number of companies manufacture these instruments, most hospitals will have 
individual contracts with the companies, which will result in some discount (typically 10- 
20%) on the list prices. The costs of these resources have therefore been calculated from the
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actual costs charged to the hospital where the study was performed. The most significant 
disposable equipment costs are displayed in table 29.
Item Cost
Ports 10/12mm Xcel Hasson Trocar £88.33
10/12 Bladeless non-handled trocar and sleeve £80.00
10/12mm Xcel Stability sleeve £40.16
5mm Bladeless non-handled trocar and sleeve £63.43
5mm Xcel Stability sleeve £24.16
Stapling
devices 29mm Endopath circular stapler (ECS 29) £326.67
33mm Endopath circular stapler (ECS 33) £384.00
45mm Vascular Articulating Cutter (ATW) £334.13
45 mm reload (ATB) £113.18
75mm Linear Cutter Blue (TLC 75) £166.83
75mm refill £113.75
Curved 45mm cutter (“Contour”) £249.00
30mm linear stapler green (TX 30) £127.60
60mm linear stapler blue (TX 60) £134.87
Medium clips £68.48
10mm clip applier large (ER 420) £134.00
Echelon £225.01
Echelon refill £163.00
Energy
device Harmonic ACE £365.00
Sterilising of Harmonic ACE hand-piece £20
Table 29: Disposable (single use) equipment. All single-use equipment used in this study is 
manufactured by Ethicon Endo-surgery (sourced 2007).
Staff costs
The staff costs that need to be considered include the surgeon and an assistant, 
anaesthetist, theatre nursing staff and operating department assistants. The unit costs for staff 
are calculated as an hourly rate, and were obtained from the hospital finance department 
(HFD). These costs were sourced in June 2007, and refer to the cost for the financial year 
2006-2007. The medical staff costs were calculated from the median hourly cost for a 
consultant surgeon and a consultant anaesthetist (median annual salary, divided into an hourly 
rate; the cost for a consultant surgeon included one merit award, Table 28). All cases had a 
consultant supervising or performing the procedure. Both types of surgery involved the use of 
an assistant from the junior medical staff (specialist registrar, research fellow, or senior house 
officer).
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The cost of the theatre staff, including the nurses and ODPs (operating department 
practitioner) were also obtained from the hospital finance department. These costs were based 
on the total cost of providing staff for a theatre session, and divided into an hourly rate (Table 
30). The fully absorbed cost of running an operating theatre is calculated by the hospital as a 
percentage (35%) of the staff costs.
Grade of 
nursing staff
Number Gross cost per 
hour*
Cost fo r  5 hour 
session
Band 7 1 £29.36 £124
Band 6 4 £24.60 £417
Band 5 0 £19.85 £0
Band 4 0 £16.49 £0
Band 3 0 £14.12 £0
Band 2 1 £12.49 £53
Total 6 £118 £594
Fully absorbed 
cost (+35%) £159 £802
Table 30: Staff Costs per Theatre Session 2007/2008. Typical session time is 5 hours including 
preparation and cleaning. Theatre staff costs are based at mid-point of the Agenda for Change payscale. 
*Gross cost per hour includes 18% absence cover
Hospital costs
The main unit costs for the hospital stay relate primarily to the “bed-day” costs, ie the 
cost for 24 hours in hospital. These costs were calculated by recording the number of nights a 
patient spent in hospital (chapter 4), and in particular whether the patient spent time in ITU or 
one of the High Dependency wards. At The Royal Surrey Hospital, the calculated ward costs 
per day are fully absorbed costs. This includes the costs of ward staffing, consumables, drugs, 
therapies where applicable (physiotherapy, occupational therapy, etc), catering, linen, 
housekeeping, and utilities (gas, electricity, heating, and lighting). Capital charges, 
depreciation and overheads (such as finance, human resources and management) are also 
included within the fully absorbed cost. There are four levels of ward care, and the costs of 
each of these are given in Table 31. The cost of the hospital stay includes the cost of any 
readmissions.
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Level of w ard care Cost per Bed-day
Intensive Care Unit (ICU - Level 3) £1,912.00
High Dependency Unit (HDU - Level 2) £1,376.00
Surgical “step-down” ward (Level 1) £379.00
Surgical ward (Frensham ward) £328.50
Table 31: Costs per bed-day (fully absorbed costs). Source: The Royal Surrey County Hospital 
finance department.
Additional costs that might be incurred by the hospital during the post-operative stay 
include the cost of blood tests, blood transfusions, and analgesic drugs used following 
discharge (Table 32). The costs of these were obtained from the relevant hospital 
departments, with the pathology department able to give an exact cost of each blood 
investigation as well as the cost of blood transfusion, and the pharmacy department giving a 
cost breakdown of analgesics. The use of these resources was recorded, but the costs are
largely insignificant when compared to the bed-stay costs.
Additional hospital costs Source Cost
Blood transfusion Transfusion £134
Analgesics
Paracetamol £0.004
Co-codamol / codydramol £0.01 -£0.08
Codeine phosphate £0.02
Tramadol £0.01-£0.24
Ibuprofen Hospital pharmacy £0.01
Voltarol £0.10
Oromorph £0.08 per 10ml
Morphine £0.33 per lOmg
PC A (lOOmg morphine/5 0ml) £9.81
Epidural (Fentanyl & Bupiv- £8.81 per 250ml
acaine 2mcg & 0.1%)
Blood tests Pathology department
Full blood count (FBC) £3.03
Urea and electrolytes (U&E) £1.39
Table 32: Additional hospital costs.
Community costs
The community healthcare costs are defined in this study as the costs incurred by the 
healthcare provider within the first 6 post-operative weeks (Table 33). These costs include 
home visits by district nurses and GPs, as well as consultations at a GP surgery, attendance at
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Accident and Emergency, and out-patient review (OPA). Unit costs for community healthcare 
resources were obtained from the Personal Social Services Research Unit (PSSRU) at the 
University of Kent (Curtis and Netten, 2006b), which publish an annual review on the ‘Unit 
costs of health and social care’. This gives details on the costs of district nurses, specialist 
nurses and GP home visits, as well as the cost of visiting a GP or nurse at a local surgery. 
Patients recorded all interactions with healthcare professionals in the HRQoL diary they were 
completing.
Community healthcare Source Cost
episode
District nurse £23 per visit
GP home visit Unit costs of health & social £69 per 13 min. visit
GP consultation care 2006 (based on mid-point £25 per 10 min. consultation
Practice nurse for salaries)* £10 per consultation
A&E attendance
Specialist nurse £12 per consultation
Out-patient appointment £23 per visit
Table 33: Community healthcare costs. *Source:www.pssru.ac.uk (Curtis and Netten, 2006a)
Results: Direct Costs 
Distribution of data
Histograms of the operative, hospital, and community cost data were reviewed for
distribution patterns, and these showed some degree of skewness, but no evidence of other 
statistical irregularities such as twin-peak distributions. Parametric tests were therefore used.
Operative costs
The length of each operation (including the “anaesthetic” time) and the hourly staff 
costs (as displayed above) are used to calculate the overall operative staff costs. As reported 
in chapter 4, laparoscopic procedures took significantly less time than the open operations 
(145 minutes (IQR 110-180) v 190 minutes (150-240)). The equipment costs are calculated 
from each individual patient’s operative proforma as described above.
Table 34 gives the operation costs for all patients in the study. The mean operative 
cost for a laparoscopic procedure was £2068 (standard deviation, £568), whilst for the open
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patients this cost was £1263 (SD £475), a difference of £805 (Cl £563-1047, p<0.001). For 
patients with no stoma the costs are similar to those of the whole study group, but are higher 
in the laparoscopic group for patients with a stoma (£2264 v £1521 respectively). This 
increased operative cost for patients with a stoma is almost entirely due to the use of a circular
trans-anal staple gun for the anastomosis (ECS 29 or 33).
Laparoscopic
n mean cost (SD) n
Open
mean cost (SD)
Difference
(Cl)
Significance 
p value*
All Staff costs 95 £433 (153) 37 £675 (238) £241 (166-316) <0.001
patients Equipment costs 100 £1534 (454) 39 £451 (334) £1083 (925-1241) <0.001
Total operation 
costs
93 £2068 (568) 34 £1263 (475) £805 (563-1047) <0.001
No Staff costs 83 £408 (145) 17 £567 (185) £159 (95-267) <0.001
stoma Equipment costs 90 £1519(470) 26 £422 (326) £1097 (862-1266) 0.004
Total operation 
costs
80 £2030 (581) 17 £1127 (328) £903 (594-1174) <0.001
Stoma Staff costs 16 £566(128) 9 £868(202) £349 (145-552) 0.002
Equipment costs 18 £1600(371) 13 £509 (353) £1051 (781-1321) <0.001
Total operation 
costs
15 £2264 (483) 9 £1521 (327) £726 (215-1238) 0.003
Table 34: All patients: Operative costs. All figures are in Mean (SD); *Student’s t test
Hospital costs
The main driver of the hospital cost is the length of hospital stay, particularly if any 
nights were spent in ITU or HDU. Table 35 gives the results of the hospital costs. The 
hospital stay refers to the “Bed-day” costs, and is directly related to the length of hospital 
stay. These costs, as explained above, are fully absorbed costs, and include the costs of all 
ward based services and overheads. Readmission costs are the mean costs incurred if a patient 
was readmitted to the hospital for at least one day. The total hospital costs include the costs of 
analgesics, blood investigations, and blood transfusions.
It can be seen that the mean hospital costs are greater in the open group when 
compared to the laparoscopic group by a difference of £1755 (Cl £957-252, p<0.001); these 
results are similar when considering patients who did not have a stoma. However, in the 
stoma group, there is no difference between the laparoscopic and open patients. Examining 
the laparoscopic group alone, the mean hospital costs are significantly greater in those
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patients who required a stoma (p=0.01). There is no difference between the no stoma and 
stoma patients in the open group.
N
Laparoscopic
mean cost (SD) N
Open
mean cost (SD)
Difference
(Cl)
Significance 
p value*
All Hospital stay costs 122 £1664(1736) 70 £3298 (3723) £1634 (854-2414) <0.001
patients Readmissions costs 122 £32 (229) 70 £108(722) £75 (64-215) 0.287
Total hospital costs* 122 £1712 (1779) 70 £3467 (3805) £1755 (957-2552) <0.001
No Hospital stay costs 111 £1502 (1654) 44 £2576 (2291) £1074(378-1676) 0.002
stoma Readmissions costs 111 £26 (161) 44 £142 £115 (58-288) 0.194
(891)
Total hospital costs* 111 £1534 (1664) 44 £2753 (2424) £1219 (495-1830) 0.001
Stoma Hospital stay costs 21 £2567(1965) .26 £2649 (1932) £78 (-487-711) 0.793
Readmissions costs 21 £121(527) 26 £50(258) £70 (-286- 168) 0.307
Total hospital costs* 21 £2705 (2122) 26 £2879 (2122) £174 (-439 - 643) 0.758
Table 35: Hospital costs. Includes the costs of analgesics, blood investigations, but excludes operative
costs.
Community costs
Community healthcare costs were small in both groups (Table 36). The only
difference between the laparoscopic and open groups is the cost of the District nurses which 
was £27 (SD £65) for the laparoscopic patients, £54 (SD £111) for the open patients 
(p=0.034). There was no statistically significant difference between the community costs of 
the two groups (p=0.385), with these costs contributing only a small proportion to the total
costs.
Community Laparoscopic Open Difference (Cl) Significance
costs N mean (SD) N mean (SD) p value
All patients 122 £120 (120) 70 £138 (169) £18 (23-59) 0.385
No stoma 111 £117(114) 44 £137 (164) £22 (-23-69) 0.377
Stoma 21 £130(154) 26 £139(180) £10 (-78-120) 0.451
Table 36: Community costs.
Total costs
The total cost results are obtained by summating the operative, hospital, and 
community costs (Table 37). When examining the whole study population, there is a trend 
towards the total costs being less for the laparoscopic approach (£535 (Cl -£454 to +£1526),
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p=0.286), which is as a result of their reduced post-operative stay and therefore reduced 
hospital costs. Subgroup analyses demonstrate that in patients having no stoma the cost 
saving is £696 (p=0.218); this is also demonstrated by looking at the right and left sided 
resections (Table 37). In those patients who require a stoma (which is all patients who require 
a low pelvic dissection (classed as “rectal resection” in our type of operative procedure)), the
costs are higher in the laparoscopic group.
Laparoscopic 
N mean (SD) N
Open
mean (SD)
Difference
(Cl)
Significance 
p value*
All Operative costs £2068 (568) £1263(475) £805 (563-1047) <0.001
patients Hospital costs £1712(1779) £3467 (3805) £1755 (957-2552) <0.001
Total costs* 90 £3847 (2002) 26 £4382 (2952) -£535 (-1526 - 454) 0.286
No Operative costs £2030(581) £1127 (328) £903 (594-1174) <0.001
stoma Hospital costs £1534(1664) £2753 (2424) £1219(495-1830) <0.001
Total costs* 80 £3611(1876) 18 £4307 (3303) -£709 (-1845 - 427) 0.218
Stoma Operative costs £2264 (483) £1521(327) £726(215-1238) 0.003
Hospital costs £2705 (2122) £2879 (2122) £174 (-439 - 643) 0.758
Total costs* 15 £5138 (2299) 8 £4525(2321) £827 (-1227 - 2881) 0.413
Operative Right 35 £3253(1196) 8 £3602(1070) -£349 (-1279 - 582) 0.454
procedure Left 47 £3995 (2212) 11 £4702(4091) -£707 (-2483 -1069) 0.428
total costs Rectal resection 13 £5114(2432) 7 £4067(1708) £342 (-2053-2737) 0.358
Table 37: Total costs. Negative values show laparoscopic surgery to be less expensive.
All results displayed above have included patients who required a conversion to open 
surgery, and those who were excluded from a laparoscopic procedure, within the laparoscopic 
group (intention to treat). Table 38 demonstrates the difference between these subgroups. As 
would be expected, the converted and excluded patients have a lower operative and higher 
hospital cost when compared to the true laparoscopic patients. This is because these patients 
behave more like the open patients than the laparoscopic group.
Surgical group N Operative cost Hospital cost Total cost
Laparoscopic 89 £2066(570) £1718 (1786) £3851 (2012)
Converted* 1 £1556 £3454 (992) £3856
Excluded 4 £1724 (611) £2798 (2168) £4510(2625)
Open 26 £1263 (475) £3467 (3805) £4382 (2952)
Table 38: Cost results: Comparison of laparoscopic, converted, excluded, and open patients 
(mean, SD).
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Sensitivity analysis
One factor was identified from the data analysis that is significantly different to 
previously published data, and that is the length of operation. The current study found that the 
laparoscopic procedures took a median of 40 minutes less than equivalent open surgery, 
whereas the literature identifies laparoscopic surgery as taking longer (by approximately 40 
minutes). A difference of 40 operative minutes in our study equates to an economic cost of 
£143 (staff and theatre costs).
Therefore, sensitivity analyses were performed assuming that the length of operative 
procedure was the same in both groups, and then 40 minutes longer in the laparoscopic 
patients. This was performed by subtracting £143 from the open group’s operative cost, and 
then by adding £143 to the operative cost of the laparoscopic group (data not shown). Neither 
of these analyses produced a difference in the significance of the operative, hospital, or total 
costs, when compared to the original data. It can therefore be assumed that the difference in 
the length of the operative procedure had no effect on the overall results of the study.
Outliers
Inevitably following surgery, some patients will have a delayed discharge, some will 
develop complications, and some will be critically ill required prolonged stay in ITU or HDU. 
These patients will skew the cost results, and therefore an analysis was performed excluding 
the most significant outlying patients (more than 2 standard deviations from the mean). The 
results of this analysis again showed no difference from the overall results, with respect to the 
operative, hospital, and total costs (data not shown), thereby confirming that these outlying 
patients have not biased the results as a whole.
Threshold analysis
A further type of sensitivity analysis, a threshold analysis, was performed to 
investigate the relationship of length of hospital stay with the total cost difference between the 
laparoscopic and open groups. This study identified a median 3 days difference in the length
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o f the post-operative stay. Length o f hospital stay is the factor liable to the m ost variation 
am ongst patients with the m ost significant im pact on cost.
The data show that there is a difference in total cost o f £535 between the laparoscopic 
and open groups. The threshold analysis demonstrates that i f  the difference in length o f stay 
was less than 1.37 days, the cost results would favour the open group (Figure 14). A 
difference greater than this, and the laparoscopic group costs would be less than the open 
group.
600
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3 days
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Figure 14: Threshold analysis: Total cost difference compared to length of hospital stay.
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Discussion
In this chapter the differences in cost of laparoscopic and open surgery are presented. 
The different physical resources used to perform this cost analysis, the unit costs of those 
resources, and then the results of the study comparing the laparoscopic and open groups have 
been described. A detailed cost evaluation has been performed, with a detailed and thorough 
collection of cost data relating to all aspects of a patient’s surgical pathway and recovery.
The physical resources relating to all aspects of a patient’s surgery and recovery have 
been identified, and the cost for each of these resources has been presented. The major 
physical resources that need to be costed are the operating staff, equipment costs and the 
length of the hospital stay. Future economic research could be focused on just these factors 
without compromising accuracy, but with a great deal more simplicity.
The unit costs of these resources have been obtained from a number of different 
sources. Costs pertaining to the hospital (operative staff costs and bed-stay costs) have been 
obtained directly from The Royal Surrey Hospital’s finance department, and give a real value 
for these resources. One disadvantage identified in the literature review (chapter 2) was that 
many of the international economic studies were based on billed costs, rather than actual 
costs; this is not a problem with the present study. Hospital costs from different NHS trusts in 
the United Kingdom are directly comparable, based as they are on Government guidelines. 
Centralisation of services also means that staff costs, and many of the overheads, allied 
services, and the like are the same across different areas.
Instrument costs and the cost of the specialist equipment used in these types of 
procedures have been obtained from the companies responsible for their manufacture (or 
cleaning and sterilisation), and also the hospital departments responsible for procurement of 
these items. The so-called disposable instruments are expensive, and whilst subject to some 
variability in cost, the two main companies producing these instruments (Ethicon Endo- 
Surgery and Covidien) charge equivalent amounts for similar equipment. Individual hospitals 
will negotiate discounts directly with the companies, and whilst volume will have some effect
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on the cost, the overall difference in cost from one hospital to another is relatively small. The 
list cost of disposable equipment and the real cost paid by the hospital was similar.
As has been discussed in the previous two chapters, the study does have some 
methodological weaknesses resulting in a bias which may have skewed the results, and so the 
results should be interpreted with caution. In particular, selection bias, leading to differences 
between the laparoscopic and open groups (such as the higher number of low rectal cases, 
stomas, and procedures performed by trainees in the open patients) limit the conclusions that 
can be made with any certainty. Some of these factors will have been adjusted for in the 
multivariate analyses, but many factors (both known and unknown) are likely to have 
influenced the results.
Whilst acknowledging the study limitations, the results obtained have demonstrated 
that the operative costs are significantly higher in the laparoscopic group (£2068), by £905, an 
increase of 61 percent compared to the open group (£1263). These results are very similar to 
those previously published in the literature, with the systematic review described in chapter 2 
demonstrating that the median increased operative cost of laparoscopic surgery was 50 
percent (Dowson et al., 2007), and the RCT by King et al finding an increased operative cost 
of £922 (King etal., 2006).
The opposite is true for the hospital costs, with a significant increase in costs seen 
with the open group, due to their longer length of hospital stay, and a greater use of ITU and 
HDU beds. The current study found that the median length of hospital stay was 3 days less for 
the laparoscopic group, similar to previously published data (literature review, chapter 2). 
Community costs are minimal in both groups, demonstrating that patients after discharge are 
not a significant drain on community healthcare resources.
The total cost comparison between the laparoscopic and open group showed a 
difference in favour of the laparoscopic group of £535 (95% confidence interval £1526 less 
expensive to £454 more expensive for laparoscopy), although this was not a significant 
difference. These findings are again reflected by the literature, with no significant differences 
identified in total costs (Dowson et al., 2007, King et al., 2006).
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The results for those patients who did not require a stoma are similar to the results for 
the whole group. However, a slightly different picture is seen when looking at those patients 
who did require a stoma. The length of hospital stay in these patients was similar between the 
laparoscopic and open groups, and the effect of this is that the overall costs are greater for the 
laparoscopic group by £621, although this difference does not reach statistical significance. 
These findings are supported by a study from Hong Kong, where patients having a 
laparoscopic abdominoperineal resection had increased costs when compared to an open 
procedure (Ng et al., 2008). In our study, comparing patients in the laparoscopic group who 
did and did not require a stoma demonstrates a statistically significant difference of £1291.
In conclusion, the results of our study suggest that there is an increase in the operative 
costs for laparoscopic surgery, but that hospital costs are reduced when compared to open 
operations. Overall costs are likely to be similar between the laparoscopic and open patient 
groups.
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Summary
•  Physical resources, and unit costs for those resources, are identified to calculate the 
operative, hospital, and community costs
•  Operative costs depend on the operating staff costs (which in turn are dependent on 
the length of the operation) and the cost of the equipment needed to perform the 
operative procedure
•  Costs of disposable equipment, used particularly in laparoscopic surgery, are high
•  Hospital costs relate to the length of stay in hospital, and whether part of that stay is 
on ITU or HDU
•  Methodological weaknesses with the study (as discussed and highlighted in the 
previous chapters) limit the number of firm conclusions which can be drawn
•  Operative costs are greater in the laparoscopic group by £905, or 61 percent
(p<0.001)
•  Hospital costs are significantly greater in the open group by £1755
•  Community costs are similar, and contribute minimally to the total cost
•  There is no statistically significant difference in the total cost (p=0.286), although 
there is a trend in favour of the laparoscopic group (difference £535 (Cl -£454 -  
1526)
•  Patients with no stoma show cost results that are similar to the overall study group
•  Patients with a stoma have hospital costs which are similar between the laparoscopic 
and open group, and total costs may be higher in the laparoscopic group (P=0.413)
•  Selection bias may have influenced these results
•  Differences in the duration of surgery, and when excluding outliers, had no effect on 
the overall cost results
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•  A threshold analysis identified a length of stay of 1.37 days as being the position of 
cost equivalence for the open and laparoscopic groups
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Introduction
This short chapter brings together the results of the previous two chapters, combining 
the cost and HRQoL data in an economic analysis, something that has not been performed in 
previous studies evaluating laparoscopic colorectal surgery. However, the context of the 
economic analysis must be understood by bearing in mind the limitations of the study that has 
been performed. Selection bias, missing data, the grade of surgeon, and other factors are 
likely to have influenced the results, and therefore restrict the conclusions that can be drawn.
The economic evaluation takes the perspective of the healthcare provider 
(considering direct costs only), and is in three parts. A cost-consequences analysis using a 
balance-sheet approach, and the construction of a matrix of cost-consequences, gives a 
simple, but clear evaluation comparing the laparoscopic and open approaches. A cost 
effectiveness analysis (in which a ratio, the incremental cost effectiveness ratio (ICER), is 
calculated comparing the difference in costs with a difference in effectiveness) is performed 
utilising the time to return to normal activities as the primary measure of effectiveness. 
Finally, a cost utility analysis is performed, using an area under the curve (AUC) calculation 
to evaluate the difference in EQ-5D scores between the laparoscopic and open patients; this 
can then be used to calculate QALYs (Quality adjusted life years), and whether there is a 
QALY gain with either approach.
QALYs were developed as an outcome measure of both quantity and quality of life. 
They are frequently used to compare different treatments or health interventions, and can be 
used in an economic evaluation by calculating cost per QALY ratios (a cost effectiveness 
analysis). The National Institute for Clinical Evidence (NICE), have calculated that for 
laparoscopic surgery to be considered cost effective, the QALY gain associated with 
laparoscopic surgery as compared to open surgery would have to be 0.010. This equates to 
between 3.65 days of full-health.
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Results
Cost-consequences analysis
This is the simplest form of economic evaluation in healthcare, and takes the form of 
an “inventory” for all costs and benefits. A balance sheet can be created comparing aspects 
that favour the laparoscopic approach, with those favouring an open procedure, and noting 
those that do not favour either approach. This summarises the clinical, cost, and quality of life 
data presented previously; study limitations should be bourne in mind (Table 39).
Favours laparoscopic approach Favours open resection Significance
All patients
Shorter hospital stay p<0.001
Faster return to normal activities p<0.001
Improved HRQoL p<0.001
Shorter operation time p<0.001
Major complications p=0.011
Adhesion formation p<0.001
Proportion of laparoscopic 
procedures converted or 
excluded
5%
No statistically significant difference in:
Cost* p=0.286
All complications p=0.112
Mortality p=0.151
Readmissions p=0.411
Cancer outcomes Both techniques exceed 
guidelines on lymph node 
harvest, no involved CRM.
Patients with no stoma
This subgroup of patients have the same balance sheet as for all patients outlined above
Patients with a stoma
No statistically significant difference in:
Cost* p=0.413
HRQoL p=0.564
Length of hospital stay p=0.218
Faster return to normal activities p=0.125
Complications p=0.372
Mortality p=0.291
Readmissions 0  (one in each group)
Cancer outcomes No difference as above
Table 39: Cost consequences analysis: Balance sheet for laparoscopic and open surgery.
*Trend towards lower cost in the laparoscopic group for all patients, but a higher cost in the 
stoma group.
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This table suggests that there are advantages with the laparoscopic approach, at no 
additional direct cost. However, in the subgroup of patients with a stoma, these advantages 
appear to be lost. As there is a trend towards a higher cost in this subgroup, the laparoscopic 
approach does not seem to be cost effective. It must however be remembered that this 
subgroup of patients with a stoma made up only 15% of the laparoscopic group.
Cost effectiveness analysis 
Decision rules
A cost effectiveness analysis uses simple “decision rules” to compare the costs and 
outcomes of alternative treatments. The different possible solutions are shown in table 40. If 
either alternative is cheaper or the same cost, and has a significantly better outcome than the 
other, it is the preferred option (dominant solution). Value judgements and calculation of 
Incremental Cost Effectiveness Ratios (ICERs, costs per unit of therapeutic gain) are required 
where one alternative is more expensive and better than the other.
Laparoscopic surgery 
(compared to open)
Costs higher Costs same Costs lower
Outcomes better ? V V
Outcomes the same X 0 V
Outcomes worse X X ?
Dominant solutions: V laparoscopic better, X open better, 0 neutral 
? value judgement required. Is the better outcome worth the extra cost?
Table 40: Cost effectiveness analysis: Decision rules for laparoscopic v open surgery (all 
patients).
Using the decision rules displayed in the grid above, the results of our study (whilst 
acknowledging the study limitations) suggest that laparoscopic surgery costs the same, but 
has a better outcome (improved HRQoL and faster return to normal activities), and is 
therefore cost effective. This picture is repeated with the subgroup of “no stoma” patients, as 
demonstrated in the balance sheet above. The story is different for patients with a stoma, 
where the costs are higher (although this is not a significant difference), but there is no 
improvement in HRQoL outcome. The results for patients with a stoma are therefore 
indifferent, although the open approach might prove to be the favoured option.
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Incremental cost effectiveness ratio
An incremental cost effectiveness ratio (ICER) for two treatment options can be
calculated by dividing the difference in costs with the difference in effectiveness. The 
measure of effectiveness that has been used for this analysis (given that the clinical and 
cancer outcomes, where applicable, are equivalent for the laparoscopic and open groups) is 
the number of days it takes to return to normal activities (Table 41). Later in the chapter, a 
similar analysis is performed using QALYs as the effectiveness measure.
Patient
group
Difference 
in cost
Measure of effectiveness (Time to 
return to normal activities in days)
ICER
All patients Lap Lap 32 Open 45 -£41 per day of
cheaper by 
£535
Difference 13 normal activity
No stoma Lap Lap 31 Open 44 -£54 per day of
cheaper by 
£696
Difference 13 normal activity
Stoma Lap more Lap 37 Open 45 +£78 per day of
expensive 
by £621
Difference 8 normal activity
Table 41: Cost effectiveness: Incremental cost effectiveness ratio. Laparoscopic v open 
patients, time to return to normal activities. Negative values represent a saving for 
laparoscopy.
This table demonstrates that for the whole study group, and the no stoma patients, 
there is a saving for the laparoscopic group, thus making laparoscopy the preferred option (it 
is cheaper, and has a better outcome).
With regards to the return to normal activities for the stoma subgroup, there is a 
difference of 8 days in favour of the laparoscopic group, which equates to an ICER of £78 for 
each day of normal activity. In other words, society needs to pay an extra £78 for each extra 
day of normal activity reached by the laparoscopic patients who have a stoma. This may make 
economic sense for patients who are in full employment. However, for those patients who are 
retired, this small benefit may not be clinically relevant.
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Cost utility analysis
A cost utility analysis measures the effect of different interventions (in this case
laparoscopic or open surgery) in terms of a single outcome measure, or utility. This utility 
assesses the impact of the surgical procedure from the patient’s perspective, and is a measure 
of how the operation affects HRQoL. The standard utility measure is a QALY (quality 
adjusted health year). QALYs are outcome measures which consider both quantity and quality 
of life, and are frequently used to compare different health interventions.
QALYs are derived from a single measure of HRQoL (as opposed to a profile 
measure, such as SF-36), which is provided by EQ-5D. Utility (or HRQoL) weighting has 
previously been derived for the 243 possible health states available with EQ-5D, by asking a 
population sample about their preferences for certain health states. Mathematical modelling 
enabled a single score to be assigned to each of these health states, which have been validated 
in a wide range of clinical and non-clinical situations.
EQ-5D scores translate directly into QALYs. This means that if, for example, 2 
patients recorded EQ-5D scores for a year, with one scoring 1 (maximum EQ-5D score) for 
the whole year and the other 0 (minimum score), the QALY gain would be 1 (one year of 
perfect health). For the current study, a six week period was assumed (and confirmed by the 
results) to be the maximum extent of any difference in HRQoL between the laparoscopic and 
open groups.
Therefore to calculate the QALY gain of one technique compared to the other, an 
area under the curve (AUC) analysis of the adjusted EQ-5D results was performed (the 
estimated difference between laparoscopic and open patients from the repeated measures 
model was used to calculate this, table 24, chapter 5). If the AUC scores of the open patients 
are subtracted from those of the laparoscopic patients, a QALY gain can be calculated. This 
QALY gain is for the 6-week study period, so to obtain an actual QALY, this should be 
converted into an annual figure.
The AUC for the laparoscopic group is 31.54, and that for the open group is 26.97, a 
difference of 4.57. Therefore, the EQ-5D gain for the laparoscopic group is 4.57 over the
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study period ie just over 4 and a half days of full health (compared to the open group). To 
calculate the actual QALY (a yearly figure), the EQ-5D gain is divided by 365, giving a result 
of 0.0125. The AUC results and QALY gain for the study group are presented in Table 42.
Area under the curve EQ- Mean difference in EQ-
5D scores (mean) 5D scores QALY
Laparoscopic Open (95% Cl, t test) gain*
All patients n=80 31.54 n=40 26.97 4.57 0.0125
No stoma n=69 32.24 n=26 27.88
(1.50-7.62, p=0.004) 
4.36 0.0119
Stoma n = ll 27.22 n=14 25.30
(0.89-7.82, p=0.014) 
1.92
(-5.53-9.37, p=0.597)
0.0052
Table 42: Area under the curve and QALY results. *for laparoscopic patients.
The cost utility analysis (cost per QALY gained) can then be calculated to identify 
how much it costs to achieve that QALY gain. For the study group as a whole costs are less 
for the laparoscopic patients, making the cost utility ratio nonsensical (cheaper cost and better 
outcome). However, by using NICE’S guidance that an intervention is worthwhile if the cost 
is less than £30,000 per QALY gained, it is possible to calculate what the cost would need to 
be in order for laparoscopic surgery to not be cost effective. The cost per QALY is £375 
(£30,000 x 0.0125 = £375); therefore the cost of laparoscopic surgery would need to be £375 
more than open surgery for the laparoscopic approach to not be cost effective. This would 
require a swing from the actual result of -£535 to +£375, or £910, which is highly unlikely, 
particularly given the consistency of our cost data.
For the stoma patients, where costs are greater by £621 (not significant, but limited 
by sample size), the laparoscopic approach is slightly more effective, and a cost utility 
analysis can be performed. For these patients the EQ-5D gain with the laparoscopic approach 
is 1.92 days, which equates to 0.0052 QALYs. The cost utility calculation therefore is £621 / 
0.0052 = £119423. In other words, the cost per QALY gain for patients requiring a stoma who 
have laparoscopic surgery is £119,423, significantly more than the threshold suggested by 
NICE.
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An incremental cost effectiveness ratio (ICER) can also be estimated for the QALY 
gain; again for the study population as a whole (and the no stoma group), this ratio is 
nonsensical, due to the cost saving and better outcome overall. However, for the stoma 
subgroup, where costs are higher in the laparoscopic patients, an ICER can be calculated. 
There is a small QALY gain (1.92 days of full health, a QALY gain of 0.005 years), which 
gives an ICER for each day of full health of £327 (Table 43).
Patient
group
Difference 
in cost
Measure of effectiveness 
(QALY gain in days)
ICER
All patients -£535 Lap 31.54 Open 26.97 
Difference 4.57
-£117 per day of 
full health
No stoma -£696 Lap 32.24 Open 27.88 
Difference 4.3
-£161 per day of 
full health
Stoma +£621 Lap 27.22 Open 25.30 
Difference 1.9
+£327 per day of 
full health
Table 43: Cost effectiveness: Incremental cost effectiveness ratio. Laparoscopic v open 
patients, QALY gain. QALYs are expressed in days. Negative values represent a saving for 
laparoscopy.
Discussion
This chapter has brought together the results of the quality of life part of the study 
together with the cost data in order to perform an economic evaluation. A number of different 
analyses have been performed, with consistent results for all of them, and these suggest that 
laparoscopic colorectal surgery is likely to be cost effective. However, it is difficult to make 
any confident conclusions due to some of the weaknesses in the methodology of the study. 
The results need to be tempered by the fact that this is not a randomised study, there are 
differences between the laparoscopic and open study groups, and these potential biases may 
have influenced the results. Interpretation of the economic analyses is therefore limited by 
these factors.
A cost-consequences analysis and cost effectiveness analysis using “decision rules” 
give simple but clear summaries of the clinical, HRQoL, and cost data. The results of our
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study would suggest that laparoscopic surgery is the dominant solution, with better 
effectiveness outcomes (HRQoL and return to normal activities), whilst being no more 
expensive.
The QALY gain with laparoscopic surgery is calculated by comparing the EQ-5D 
results of the laparoscopic and open group. This is performed by comparing the area under the 
curve of the EQ-5D results for the two groups. This has demonstrated a QALY difference of 
4.57 days (p=0.004), or an actual QALY gain of 0.0125. It should be noted that this figure is 
obtained using the adjusted EQ-5D scores from the repeated measures analysis, thereby 
adjusting for any potential confounding factors.
The Aberdeen Health Technology group estimated that for laparoscopic surgery to be 
cost effective, a QALY gain of 0.009 - 0.010 would be needed (Murray et al., 2006). It can be 
seen that our results have exceeded that figure, confirming that the laparoscopic approach is 
cost effective when compared to open surgery.
The cost utility analysis can be used to estimate a cost threshold at which point 
laparoscopic surgery would cease to be cost effective, which is £375 more than for the open 
patients. The results of the cost data for the whole study group demonstrated laparoscopic 
surgery to be less expensive by £535 with a 95 percent confidence interval of -£1526 to £454 
(p=0.286). Whilst the difference in total costs between the laparoscopic and open patient 
groups did not reach statistical significance, it can be seen that the £375 threshold lies very 
close to the 95 percent confidence interval, thus making it very likely that the laparoscopic 
approach is cost effective.
The subgroup of patients who required a stoma showed a non-significant increase in 
costs for the laparoscopic group, with minimal improvements in the outcome measures. The 
cost effectiveness analyses therefore suggest that it may not be cost effective performing 
laparoscopic resections in patients who require a stoma although analysis of this subgroup is 
limited by the small sample size.
The overall results suggest that laparoscopic surgery is cost effective when 
compared to the open technique with regards to colorectal surgery.
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Summary
• This study is the first to perform a cost effectiveness analysis comparing laparoscopic 
and open colorectal surgery
• It is not a randomised study, and methodological weaknesses limit the conclusions 
that can be made
• The cost effectiveness analyses takes the perspective of the healthcare provider
• A “balance sheet” is constructed in a cost consequences analysis; this summarises the 
study results and suggests that there are advantages for the laparoscopic group
• QALYs are an outcome measure assessing both quantity and quality of life, which 
can be used in an economic evaluation. QALYs are calculated from EQ-5D scores
• QALYS are calculated by comparing the EQ-5D scores of the laparoscopic and open 
groups using an AUC calculation
• NICE have estimated that a QALY gain of 0.010 is required for laparoscopic surgery 
to be cost effective
• This study has demonstrated that there is a QALY gain of 0.0125 with laparoscopy, 
and the various cost effectiveness analyses performed demonstrate that laparoscopic 
colorectal surgery is probably cost effective
• The cost effectiveness analyses suggest that it is not cost effective performing 
laparoscopic resections in patients who require a stoma
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Introduction
The results presented here have been published in the British Journal of Surgery3 
(Dowson et al., 2008b).
As discussed in Chapter 2, colorectal surgery accounts for a high proportion of the 
patients who subsequently develop adhesion-related problems (Parker et al., 2004, Parker et 
al., 2001), and it has been estimated that the prevalence of adhesion formation following 
major abdominal procedures is between 63% and 97% (Menzies and Ellis, 1990, Weibel and 
Majno, 1973, Parker et al., 2005). Adhesions have a significant economic impact, with the 
costs in the United Kingdom estimated to be £569 million over a 10-year period (Menzies et 
al., 2001, Wilson et al., 2002).
Adhesions may cause bowel obstruction, pelvic or abdominal pain, and infertility 
(Milingos et al., 2000, Vrijland et al., 2003, Swank et al., 2003), and prolong the time to gain 
access to the abdominal cavity at subsequent surgery, with inadvertent enterotomy more 
likely than at first procedure (Coleman et al., 2000).
This chapter presents the results of the study comparing the extent of adhesion 
formation following laparoscopic and open colorectal surgery. The first section describes the 
results of validating the adhesion scoring system; subsequently, the sample characteristics are 
described, and the study outcomes presented and discussed.
Validation of scoring system
Development of the adhesion scoring system, and the statistical method for validating 
this are described in Chapter 3. The weighted kappa2 was used to evaluate rater agreement as 
it penalises scores where there is a difference of more than one integer, but a high correlation 
is recorded when the scores are not more than one integer apart.
3 Dowson H, Bong J, Lovell D, Worthington T, Karanjia N, Rockall T. Adhesion Formation 
Following Laparoscopic and Open Colorectal Surgery. Brit J Surg 2008;95:909-14.
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The median kappa coefficient (weighted squared) for intra-observer reliability was 
0.82 (IQR 0.73-0.86), and for inter-observer reliability was 0.8 (0.74-0.86). Kappa 
coefficients of 0.8 or higher are classified as showing a very high agreement for both inter- 
and intra-observer reliability (Altman, 1991). This demonstrates that the scoring system was 
simple, accurate, and reproducible.
Sample characteristics
46 patients (18 female, 28 male) were recruited, all of whom had had an 
uncomplicated primary colorectal resection. 33 patients had had previous open colorectal 
surgery, and 13 laparoscopic surgery. 37 patients (80%) had had their original resection for 
cancer, 4 for ulcerative colitis, and 3 for diverticular disease. The reasons for the second 
procedure, at which time the laparoscopy was performed, are displayed in Table 44.
Original
diagnosis
Number
of
patients
Original operation
Indication for laparoscopy
Number o f 
patientsProcedure Open Laparoscopic
Colorectal 37 Anterior resection 13 6 Prior to liver resection 29
cancer Sigmoid colectomy 6 0 Staging laparoscopy 3
Right hemicolectomy 9 2 Closure of ileostomy 2
Hartmann’s procedure 1 0 Lap right hemicolectomy 1
Lap incisional hernia repair 2
Ulcerative 4 Subtotal colectomy 1 2 Completion proctectomy 3
colitis Proctectomy 0 1 Closure of ileostomy 1
Crohn’s 1 Ileocaecal resection 0 1 Laparoscopy for right iliac fossa 1
disease pain
Diverticular 3 Sigmoid colectomy 2 0 Lap reversal of Hartmann’s 2
disease Hartmann’s procedure 1 0 Lap incisional hernia repair 1
Rectal 1 Resectional rectopexy 0 1 Proctectomy 1
prolapse
Total 46 33 13 46
Table 44: Original diagnosis and indication for laparoscopy. Lap, laparoscopic.
The range of colorectal procedures that were performed at the original operation are 
displayed in Table 44. The commonest operation was anterior resection, performed in 46% of 
the laparoscopic and 30% of the open cases respectively, followed by right hemicolectomy 
(23% and 24%).
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Laparoscopic Open Significance
Number of patients 13 33
Age 62 (38-72) 70 (60-76) P=0.062
Interval between procedures 9 (6-17) 17 (7-38) P=0.078
Original diagnosis
Cancer 8 29
UC 3 1
Crohn’s 1 0
Diverticular disease 0 3
Prolapse 1 0
Previous surgery (total) 3 5
Appendicectomy 1 2
Sigmoid colectomy 0 1
Partial gastrectomy 0 1
Small bowel resection 1 1
Laparotomy for trauma 1 0
Table 45: Adhesions study: clinical details of patients.
Clinical details of patients recruited to the adhesions study are given in Table 45. The 
median age of the laparoscopic group was 62 (38-72), and the open group 70 (60-76) 
(p=0.062, Mann-Whitney U). This difference in age arises due to differences in diagnoses, 
with the laparoscopic group containing a greater proportion of patients with inflammatory 
bowel disease, whilst the majority of the open surgery group had had surgery for colorectal 
cancer. The sub-group analysis of cancer patients revealed a similar age between the 
laparoscopic and open groups (Table 46).
The median length of time between the original resection and subsequent procedure 
was 9 months (IQR 5.5-16.5) for the laparoscopic group and 17 months (6.5-37.5) for the 
open group. As there was a difference in this time, a subset analysis for patients having the 
second procedure within 2 years of the first was performed (median interval time 8 v 9 
months, Table 46).
Three patients in the laparoscopic group, and five in the open, had had previous 
abdominal surgery (Table 45). When assessing the adhesions in these patients, adhesions that 
were present in the areas of the abdomen relating to their first abdominal surgery (for 
example, in the patient who had had a gastrectomy, in the epigastric region), were discounted 
and not included in the adhesion score.
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Study outcomes
The main study results are presented in Table 45. The mean overall adhesion score 
(out of 10) in the open group was 6.5 (SD 2.0) and in the laparoscopic group 0.9 (SD 1.6) 
(Figure 16). This is a significant difference (p<0.001). There was a similar difference when 
assessing the main access wound (main site) for adhesions, 0.6 in the laparoscopic group v 
4.8 (p<0.001), figure 16.
Laparoscopy Open Significance*
All patients
Number of patients 13 33
Main site (0-6) 0(0-1) 6(4-6) P0.001
Overall score 0 (0-3) 7(5-8) P0.001
Subgroup analyses
Interval <2 years
Number of patients 11 20
Age 62 (38-75) 67 (58-76) P=0.355
Interval between procedures (months) 8(5-11) 9 (6-19) P=0.336
Main site (0-6) 0 (0-0) 6 (4-6) P0.001
Overall score 0 (0-3) 7(6-8) P0.001
Cancer patients
Number of patients 8 29
Age 67 (61-75) 71(61-76) P=0.758
Interval between procedures (months) 7(4-17) 17 (6-35) P=0.089
Main site (0-6) 0 (0-2) 6 (4-6) P0.001
Overall score 0 (0-2) 7(5-8) P0.001
Table 46: Study results: for all patients, and subgroup analyses. Results are given as median 
(IQR);* Mann-Whitney U.
Of the patients who had previously had a laparoscopic resection, 8 (67%) had no 
adhesions visible at all, with a further patient having no adhesions to the access wound or 
laparoscopic port-sites (9 out of 12, 75%). In the open group, 1 patient (3%) had no 
adhesions, and 2 patients (6%) had no adhesions to the main incision.
Multivariate analyses were not justified given the small number of patients in this 
study. Therefore, subgroup analyses were performed for patients with an interval between 
procedures of less than 2 years (so that the two groups had a similar interval time), and for 
patients whose original surgery was for colorectal cancer. These analyses showed similar 
significant differences between the laparoscopic and open groups for both the main incision
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adhesion score, and the overall score with the laparoscopic procedures resulting in 
significantly fewer adhesions (Table 46). A further subgroup analysis considering only those 
patients whose original diagnosis was cancer, had an anterior resection, and with an interval 
betw een procedures o f  less than two years, gave equally significant results, albeit with small 
num bers (6 laparoscopic, 11 open, data not shown). These subgroup analyses w ould suggest 
that the time interval, original diagnosis, and type o f  procedure, were not significant 
confounding variables when considering the overall results.
O  4 -
Figure 15: Overall adhesion score for all patients: Box and Whisker plot. Median, IQR, and range, 
outliers are indicated by a circle (1.5-3 times the IQR) or asterix (>3 times IQR).
Figure 16: Main site adhesion score for all patients: Box and Whisker plot. Median, IQR, and 
range, outliers are indicated by a circle (1.5-3 times the IQR) or asterix (>3 times IQR).
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Discussion
This exploratory study suggests that laparoscopic colorectal surgery results in the 
formation of significantly fewer adhesions than open colorectal surgery. Adhesion formation 
is almost inevitable following open resectional surgery, with only one patient in the open 
group in our study found to have no adhesions, whilst the majority of the laparoscopic group 
were adhesion free (9 out of 13 patients, 69%). This is consistent with findings from previous 
studies estimating the incidence of adhesion formation as over 90% following open surgery 
(Menzies and Ellis, 1990).
For this study, we have adapted an adhesion scoring system that is simple and reliable 
to use, with a very high degree of intra- and inter-observer agreement. This could be 
employed in other studies assessing adhesion formation following general surgical 
procedures.
It has been hypothesized that laparoscopic surgery, by minimising peritoneal trauma, 
may result in reduced adhesion formation following abdominal and pelvic operations. Recent 
experimental (Hanly et al., 2003) and clinical (Barry et al., 2002, Sietses et al., 1999) 
evidence has demonstrated that postoperative inflammation is less pronounced after 
laparoscopic procedures than open surgery. Manual manipulation of the small intestine is 
associated with increased adhesion formation in animal models (Hiki et al., 2006).
There have been no previous prospective studies evaluating the formation of 
adhesions following laparoscopic colorectal surgery. An abstract has been published 
describing a study which evaluated adhesion formation in patients with ulcerative colitis 
(Canete et al., 2007). Although this study had no open control group, it concluded that 
extensive adhesion formation following laparoscopic total colectomy or panproctocolectomy 
is rare. This is supported by the findings of the current study. Another paper compared 
patients after laparoscopic or open cholecystectomy (Polymeneas et al., 2001). This study was 
small, with only 26 patients in total, but it also demonstrated significantly fewer adhesions in 
the laparoscopic group (55% of patients having no adhesions).
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One study is attempting to evaluate the incidence of adhesion-related complications, 
particularly small bowel obstruction, following laparoscopic and open colorectal surgery 
(Taylor, 2007). This ongoing study has only reported preliminary results (in abstract form), 
but its aim is to investigate the rates of adhesive intestinal obstruction and incisional hernia in 
patients previously recruited to the CLASICC trial. The results published thus far demonstrate 
that the rates of small bowel obstruction are lower in the laparoscopic group, although with 
multivariate testing the operative technique (laparoscopic or open) did not significantly 
impact on rates of obstruction (Taylor, 2007). This study, based on the results published thus 
far, is inadequately powered to confirm whether there is a real difference or not between the 
two techniques (despite involving 468 patients).
A further study, from Oxford, has retrospectively reviewed the incidence of 
complications due to small bowel obstruction following open ileal pouch surgery, and 
compared these to (a relatively small) group of patients having had a laparoscopic pouch 
procedure. This study found that the laparoscopic patients required less adhesiolysis at 
second-stage surgery and had fewer episodes of SBO within 12 months of surgery when 
compared to the open patients (Sileri et al., 2008).
It should be emphasised that no association has been demonstrated in our study 
between adhesions and adhesion-related complications. The SCAR study group have 
demonstrated that very large numbers of patients (at least 5686) would be required to confirm 
this link in a prospective study (and also to demonstrate the efficacy of adhesion-reduction 
techniques), making such studies almost impossible to perform (Wilson et al., 2002).
Given the difficulties of performing a study using small bowel obstruction as an 
endpoint, many studies have therefore employed adhesion formation as the primary endpoint, 
with the implication that the severity and extent of adhesion formation is likely to be related 
to the incidence of adhesion-related complications. This technique of assessing adhesions has 
been particularly used in studies evaluating adhesion-reduction techniques (Kusunoki et al., 
2005).
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By its nature, the study presented here has to be an opportunistic study, as it is 
ethically unjustifiable to undertake a randomised trial performing re-laparoscopy in otherwise 
fit volunteers (Majewski, 2006). As a result of the opportunistic nature of this study, three 
potential biases arise.
Firstly, there are fewer patients in the laparoscopic group, and the results should be 
interpreted with some caution as it is possible there could have been a Type I error. Despite 
this, the difference in the adhesion scores between the laparoscopic and open groups are 
highly significant overall and for each of the subgroups (p<0.001), and these findings are 
supported by other studies in the literature (Polymeneas et al., 2001, Kavic and Kavic, 2002, 
Gutt et al., 2004).
Secondly, a smaller proportion of the laparoscopic group had colorectal cancer (66%) 
than in the open group (87%). For this reason, we performed a subset analysis of the cancer 
patients alone, and although there are only 8 subjects in the laparoscopic group (and 29 in the 
open group), the results are highly significant (p<0.001).
The third potential bias is the time interval between the resectional procedure and the 
subsequent “second-look” laparoscopy, with a median interval of 9 months in the 
laparoscopic group, and 17 months in the open patients. This interval between procedures is 
unlikely to be relevant, as it is thought that adhesion formation occurs predominantly within 
the first post-operative week (Burger et al., 2006). Further supporting evidence for this is that 
following an intestinal resection, 30% of the episodes of adhesive small-bowel obstruction 
occur within 30 days (Kariv et al., 2006). However, the subgroup analysis of patients with an 
interval between procedures of less than two years (similar median interval for the 2 groups), 
has still shown a highly significant difference between the groups.
A number of methods have been developed to attempt to reduce the incidence of 
adhesion formation following abdominal surgery, including bioabsorbable films such as 
Seprafilm®, gels (for example SprayGel™), and “hydroflotation” solutions such as Adept®. 
There is some evidence that Seprafilm may reduce the operative rate for adhesive small bowel 
obstruction (Kariv et al., 2006), and the results of large studies evaluating the efficacy of
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Adept are awaited (Parker, 2005). However, none of these methods have thus far been shown 
to have as significant a reduction in adhesion formation as has been demonstrated in the 
present study. The SCAR-2 study found that there had been no significant change in the 
incidence of adhesions between 1996 and 1999, despite advances in anti-adhesion prevention 
strategies (Parker et al., 2004). In addition, there is a disadvantage with these techniques as 
there is a significant cost associated with them.
Economic aspect of adhesions
The SCAR study group has investigated the financial implications of adhesions and
adhesion-reduction techniques, demonstrating that there is a significant financial burden 
resulting from adhesions, but that only inexpensive adhesion-reduction techniques are likely 
to be cost effective (Menzies et al., 2001, Wilson et al., 2002). Wilson et al based their cost 
effectiveness model on second-look surgery studies, which suggest an approximate 25-50% 
reduction in the number or density of adhesions after use of an adhesion reduction product 
(Becker et al., 1996, Brown et al., 2007). Using these efficacy values to analyse the SCAR 
data allowed the authors to calculate the percentage reduction in readmissions required of an 
adhesion reduction product to return the cost of investment.
Their cost effectiveness analysis demonstrates that routine use of adhesion reduction 
products costing £50 per patient will payback the cost of such investment if  they reduce 
adhesion-related readmissions by 16% after 3 years. A product costing £200 will need to offer 
a 64.1% reduction in readmissions after 3 years. Products costing £200 or more are unlikely 
to payback their direct costs (Wilson et al., 2002).
The largest study evaluating the efficacy of an adhesion reduction product (in this 
case Seprafilm®) used a mean of 4.5 sheets of Seprafilm per patient (Kariv et al., 2006). This 
resulted in a reduction of 47% in reoperations due to adhesions, although there was no 
reduction in actual episodes of bowel obstruction or re-admissions. In the United Kingdom in 
2002,4-5 sheets of Seprafilm would cost £350-£450 per patient.
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Our study has demonstrated a reduction in adhesions of over 80%, from a score of 6.5 
out of 10 in the open group to 1.0 in laparoscopic patients. Our study is similar in design to 
the second-look surgery studies used by Wilson et al for their cost effectiveness analysis, and 
it therefore seems reasonable to conclude (as the SCAR study group have done) that this 
reduction in adhesions would result in a reduction in readmissions, and a saving of at least 
£200 per patient.
Use of laparoscopic surgery would mean that an adhesion reduction product would 
not routinely be necessary, although there might still be a role in particularly complex or 
high-risk cases (such as rectal surgery, or panproctocolectomy). This would require further 
research.
Sileri et al have modelled the potential financial impact of a laparoscopic approach as 
an adhesion prevention strategy following ileal pouch surgery, having estimated the clinical 
and financial burden due to adhesive small bowel obstruction following open surgery. 
Laparoscopic patients required less adhesiolysis at the time of the second operative procedure 
(0% vs 36%, p < 0.0001) and had fewer obstructive episodes (0% vs 14%, p < 0.0001). They 
calculated that the laparoscopic approach cost $1,450 more due to the increased operative 
costs, but resulted in a saving of $3,282 (due to reduced readmission and reoperation costs 
due to adhesions), thus giving a saving of $1,832 per pouch constructed. Whilst these results 
should be interpreted with caution due to methodological issues relating to the design of the 
study, and the small number of patients in the laparoscopic arm, it is further evidence 
supporting the clinical and financial benefit of laparoscopic surgery with respect to adhesion 
formation.
Conclusion
The results of this study would suggest that there is a reduction in adhesion formation 
following laparoscopic as compared to open colorectal surgery. This suggests that in addition 
to the short-term benefits of laparoscopic colorectal surgery, there are also longer-term 
advantages with this approach. Further prospective studies are needed to confirm these
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findings, and to demonstrate whether there is an equivalent reduction in adhesion-related 
complications such as small bowel obstruction. A reduction in adhesions would also have a 
significant financial benefit.
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Summary
• The scoring system adapted for the assessment of adhesion formation was proven to 
be valid for both inter- and intra-observer reliability.
• Laparoscopic colorectal surgery is still performed in a minority of cases, resulting in 
a larger proportion of open patients within the study sample.
• Laparoscopic colorectal surgery results in the formation of fewer adhesions than open 
colorectal surgery.
• Only 3% of patients in the open group had no visible adhesions, whereas 67% of the 
laparoscopic group were free of adhesions.
• Subgroup analysis for patients with colorectal cancer and having the “second-look” 
laparoscopy within 2 years of primary colorectal surgery had no effect on the 
significance of the results.
• It is likely that formation of fewer adhesions would result in fewer episodes of 
adhesive small bowel obstruction, and a reduction in the other complications of 
adhesions.
• A reduction in admissions and operations due to adhesive small bowel obstruction 
would have a significant impact on the financial burden due to adhesions. This would 
increase the cost effectiveness of laparoscopic colorectal surgery when compared to 
open surgery.
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Introduction
This chapter briefly summarises the main findings of the thesis. It goes on to discuss 
some of the methodological issues with the work described, assessing the strengths and 
limitations of the studies performed. It concludes by describing some of the unanswered 
questions, and suggestions for future research.
Since the findings of the study have been discussed in relation to the current literature 
within each results chapter, the discussion in this chapter is limited to a selection of recent 
studies of particular relevance.
Summary of findings
The primary aim of this thesis was to investigate whether laparoscopic colorectal 
surgery is cost effective when compared to open colorectal surgery. Secondary aims were to 
evaluate the quality of life of patients following laparoscopic and open colorectal surgery, the 
direct costs of the two procedures, and the incidence of adhesion formation following these 
types of surgery.
The thesis describes two studies that were undertaken during the period o f research. 
A large prospective cohort study, comparing the quality of life and costs of laparoscopic and 
open colorectal surgery, and an observational study evaluating the extent of adhesion 
formation following the laparoscopic and open procedures.
Quality of life was evaluated using the SF-36 and EQ-5D validated HRQoL 
instruments, and these demonstrated a difference in favour of the laparoscopic approach. A 
comprehensive cost assessment was performed, recording all factors that contribute to the 
direct costs of a patient’s surgical episode. Operative costs are higher, and hospital costs 
lower, in laparoscopic surgery. Community costs were minimal in both groups.
EQ-5D scores were used to calculate QALYs by combining the cost and QoL data to 
perform a cost utility analysis. A number of other approaches were used for the economic 
analysis, with the results suggesting that laparoscopic surgery is cost effective.
180
For patients with a stoma, the hospital stay is longer (in both groups), and the costs 
are subsequently higher, but there is no improvement in QoL for the laparoscopic patients. It 
therefore may not be cost effective to perform laparoscopic surgery in patients who require a 
stoma. However, laparoscopic surgery does confer other advantages (less post-operative pain, 
faster return to normal activities, and fewer adhesions), and further research is warranted to 
investigate this group of patients further.
Adhesions following colorectal procedures are common, and result in a significant 
financial burden. Fewer adhesions are formed following laparoscopic surgery, and this may 
result in fewer episodes of small bowel obstruction. This would lead to a cost saving, and 
support further the suggestion that laparoscopic surgery is cost effective when compared to 
open surgery.
Interpretation of results in the context of recently published 
literature
Compared to previous studies, particularly considering those from the United 
Kingdom, the results of our study are consistent and report similar findings. The randomised 
trial from Yeovil reported by King and Kennedy (King et al., 2006), found that costs were 
similar between the laparoscopic and open patients, although they did not identify a 
difference in quality of life between the 2 groups (possibly due to the relatively small study 
size, and because assessments were only undertaken on 2 occasions post-operatively, as was 
discussed in Chapter 2). The case-matched study of Noblett and Horgan also found costs to be 
equivalent (Noblett and Horgan, 2007), as did the CLASICC trial (Franks et al., 2006).
This thesis has aimed to build on the results of these studies, by investigating HRQoL 
in more detail, and undertaking an economic analysis. The data demonstrate that the quality 
of life of patients is improved with laparoscopic as compared to open surgery, and this 
translates into a real benefit as measured by QALYs. Using the cost data, as described in this 
thesis, demonstrates that laparoscopic colorectal surgery is cost effective. This is further 
supported by comparison with the economic evaluation undertaken by NICE, which suggests
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that a QALY gain of 0.010, as has been demonstrated in our study, would make the 
laparoscopic approach cost effective.
Methodological issues
Throughout the thesis, I have attempted to highlight areas of methodological concern, 
which might give rise to potential biases with the results. The first issue to acknowledge is 
that this is not a randomised trial, and it would be beneficial if  the results, particularly with 
regards to HRQoL, could be further tested within an RCT. However, there are also 
advantages with so-called expertise-based studies, as I have described previously; for 
practical reasons, it allowed us to recruit more patients to the study, providing adequate power 
to make comparisons between the two groups.
By recruiting “all-comers” to the study, we are able to give a very real picture of the 
workload undertaken in a District General Hospital. This study was designed as a pragmatic 
study, and reflects current practice within the hospital. However, this has resulted in there 
being some potentially significant differences between the laparoscopic and open groups. 
Whilst adjustments for these differences have been made within the analysis, it is impossible 
to adjust for every covariate.
The multivariate analysis did identify the major factors that were expected to have a 
significant impact: the presence of a stoma (which also identifies patients having a low or 
complex rectal procedure), and laparoscopic or open surgery. As the presence of a stoma was 
the single most important factor impacting on quality of life and length of hospital stay, 
subgroup analyses were undertaken of the stoma and no stoma groups for the cost analysis.
A further point to make is that it is a single expert centre (with an established 
tradition in laparoscopic surgery), and the results may not therefore be generalisable.
Considering the adhesions study, for ethical reasons it is not possible to perform a 
randomised trial, and the study design is therefore “opportunistic” and observational in 
nature. A potential weakness of the study is the relatively small number of patients included 
who had previously had a laparoscopic resection. This was due to practical reasons, as there
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are fewer patients who have had a laparoscopic colorectal resection as compared to an open 
procedure, and consequently fewer numbers of these patients requiring a further operative 
procedure. The results of this study are significant, and support the findings of the limited 
number of studies previously published. These findings need to be further evaluated, 
preferably within a randomised trial.
Adhesion formation has been evaluated, not the clinical effects of adhesions such as 
small bowel obstruction. An assumption is therefore made with this study, as it has been in 
many other previous studies, that the extent of adhesion formation is related to the likelihood 
of adhesion-related complications. However, this assumption has not yet been proven in a 
clinical setting.
Unanswered questions and future research
This thesis has demonstrated: evidence of an improvement in HRQoL in patients 
undergoing laparoscopic colorectal surgery as opposed to an open procedure; confirmation 
that the laparoscopic approach is not associated with significantly increased costs; that 
laparoscopic colorectal surgery appears to be cost effective; and laparoscopic surgery results 
in the formation of significantly fewer adhesions than equivalent open colorectal surgery.
Key questions still to be answered include the management of patients requiring a 
low rectal procedure and formation of a stoma. Is there a benefit in performing laparoscopic 
resections for these patients, given that their length of hospital stay is more prolonged, there 
appears to be no benefit with respect to HRQoL, and the costs may be greater than equivalent 
procedures in open patients?
It is also important to understand whether the reduction in adhesion formation results 
in significant clinical benefit. Are there other long-term benefits with the laparoscopic 
approach, such as a reduction in the development of incisional hernias?
Randomised trials evaluating HRQoL in greater detail than have been performed 
previously would be valuable in confirming (or challenging) the results of our study. Using 
EQ-5D would facilitate a further economic analysis.
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The role of enhanced recovery programmes (ERP), following both open and 
laparoscopic surgery, needs further elucidation; this is already being investigated further with 
the UK based EnROL study, and the European LAFA (LAparoscopic and/or FAst track) trial 
(Wind et al., 2006). One disadvantage with the ERP is that it is labour intensive, which might 
adversely impact on cost. The perioperative care of these patients in general needs further 
research, for example are all aspects of the ERP protocol necessary, and is there a role for the 
oesophageal Doppler in laparoscopic surgery.
Surgical techniques are constantly being refined and improved. Laparoscopic 
colorectal surgery represents one small step in this development. Newer techniques are 
already being investigated, such as single incision laparoscopic surgery (SILS) and natural 
orifice transluminal endo-surgery (NOTES). These will require careful evaluation and 
comparison with laparoscopic surgery.
This study is one of the first to suggest that there are real benefits for our patients 
with laparoscopic surgery in terms of improving their quality of life as they recover from 
colorectal surgery. Based on the research carried out for this thesis, laparoscopic colorectal 
surgery is probably cost effective, a critical factor for the introduction of any new technique. 
These results build on the work of previous researchers, with the evidence suggesting that 
laparoscopic colorectal surgery should become the standard of care for our patients.
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Appendix 1
PATIENT INFORMATION SHEET Version 2 16/01/06
A COMPARISON OF THE COSTS AND OUTCOMES OF LAPAROSCOPIC AND OPEN 
COLORECTAL SURGERY
Thank you for reading this information sheet.
You are being invited to take part in a research study. Before you decide it is 
important for you to understand why the research is being done and what it will involve. 
Please take time to read the following information carefully, discuss it with others if you 
wish, and to decide whether or not you wish to take part. Ask us if  there is anything that is 
not clear or if you would like more information.
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If you decide 
to take part you are still free to withdraw at any time and without giving a reason. A decision 
to withdraw at any time, or a decision not to take part, will not affect the standard of care you 
receive.
What is the purpose of the study?
To evaluate:
1) Whether the costs of a new surgical technique are more or less than established 
techniques.
2) Whether there are benefits for patients with the new technique.
Background
Patients needing an operation for a bowel problem have traditionally had an open 
operation with an incision on the abdomen, and this is the type of operation that is currently 
performed in the majority of cases in the United Kingdom today (over 90%). Laparoscopic 
(or keyhole) surgery has been introduced into bowel surgery, but is currently not widely 
performed. This is because thus far there have been no clear-cut benefits demonstrated with 
this technique and the perceived costs are higher than an open operation. We aim to evaluate 
both of these issues.
Why have I been chosen?
All patients who have an operation for a colorectal (bowel) condition at The Royal 
Surrey County Hospital are being invited to participate. We aim to include 200 patients within 
the study.
What will happen to me if I take part?
This study is an Observational study. This means that we are only observing the 
outcomes and costs of the treatment which you will receive. Your consultant will have 
discussed your condition with you and together you will have come to a decision about the 
treatment you will receive. Entering into the study will not influence this decision.
We are looking at the costs of your treatment, both during your hospital stay, and 
after your discharge. We want to know how long you are off work, whether other friends or 
family have to take time off work to help care for you, and how often you need to see a health 
professional following your discharge from hospital.
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We are also keen to examine the effects of the treatment on you, by asking you to fill 
in a Quality of Life questionnaire. We will ask you to fill in a questionnaire whilst you are in 
hospital and every other day fo r  the first month following your surgery. This questionnaire 
will take less than 5 minutes to fill in. Following your discharge from hospital, we will ask 
you to complete a more detailed questionnaire four times (at 1, 2, 4, and 6 weeks after the 
operation). This will take less than 10 minutes to complete.
What do I have to do?
You need to be willing to answer questions about the treatment you have received, 
and how it has affected you during your hospital stay and after you have returned home. You 
need to be willing to allow a researcher to telephone you at home to discuss the same issues.
What is the procedure being tested?
We are comparing two methods of surgery for colorectal (bowel) conditions. These 
are open (traditional) surgery and laparoscopic (keyhole) surgery. Both of these procedures 
are safe and efficacious. There is currently no evidence that one of these methods is superior 
to the other.
What are the possible disadvantages and risks of taking part?
There are no risks or disadvantages.
What are the possible benefits of taking part?
There are no benefits to you as an individual. However your participation in the study 
will help to further our understanding of surgical outcomes.
Will my taking part in this study be kept confidential?
All information which is collected about you during the course of the research will be 
kept strictly confidential. Any information about you which leaves the hospital will have 
your name and address removed so that you cannot be recognised from it.
We plan to inform your General Practitioner of your involvement in the study, and if 
you have questions or concerns regarding the trial, you can discuss them with your doctor. 
However, we do require your permission to inform your GP. Please let us know if this is 
acceptable.
What will happen to the results of the research study?
The results will be presented and published in medical meetings and journals. You 
will not be identified in any report. If you are interested in knowing the results of the study, 
we will send you a summary of the main conclusions, once it is completed. Please let us know 
if you would like to receive this.
Who has reviewed the study?
The South West Surrey Research Ethics committee have reviewed the study, and 
given permission for it to take place.
Contact for Further Information
Henry Dowson BSc MBBS MRCS
Laparoscopic Fellow, Minimal Access Therapy Training Unit, Postgraduate Medical School, 
University of Surrey, Manor Park, Guildford, GU2 7WG
Telephone: 01483 688620 
Email: hdowson@doctors.org.uk
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Appendix 2: Theatre cost sheet
Theatre Data Collection
For: Colorectal cost study
To be completed for all Major Colorectal Procedures
HENRY DOWSON
MATTU
07974247540
Name:
(or sticker) 
Hosp No:
Date of op: 
Name of op:
Consultant:
Surgeon Grade:
Time Anaes start time: Anaes: Epidural/ Spinal Type Open
of op: Surgery start: (vol) Central line of Laparoscopic
Surgery end: Art line op: Converted
Drapes: High Fluid
Minor Lithotomy
Mayo
Touchscreen drape
Other
Swabs 4x4
6x4
18x18
Pledgets
Tonsils
Blades:
Dressings
Sutures/
Ties
Vicryl
Opsite
Other
Stoma
Small
Med
Large
Ties
Nylon
Prolene
Maxon
Others
2/0
2/0
3/0
Rapide
0___
Double
Instrument Trays Other equipment/ instruments Laparoscopic kit
General Yohannes Scope & cable
Upper GI Heavy grasper Harmonic hand piece
Laparotomy Purse-string applicator Harmonic ace
Bookwalter Diath
-ermy
Pencil Insufflation tubing
Extras Short blade OR-1 screen drape
Rockall colorectal Long Anti-fog
Lap Storz tray Eisenhammer Instrument pouch
Surgical drains?
Disposables Stapling devices etc
Ports Blunt CDH Gun
12mm Trocar & sleeve ATW 45
12mm sleeve ?refills (ATB)
5mm Trocar & sleeve TLC 75
5mm sleeve ?refills
Camera drape Contour stapler
Smoke evacuator ER420
Wound protector TX 30
TX 60
Suction Yanker + tubing Skin clips
Lap suction-irrigation device
Other instruments/ equipment used Length of incision (cm)
Drains (?type)
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Appendix 3: EQ-5D
By placing a tick in one box in each group below, please indicate which statements best 
describe your own health state today:
Mobility
I have no problems in walking about 
I have some problems in walking about 
I am confined to bed
Self-Care
I have no problems with self-care 
I have some problems washing or dressing myself 
I am unable to wash or dress myself
Usual Activities (e.g. work, study, housework, family or 
leisure activities)
I have no problems with performing my usual activities 
I have some problems with performing my usual activities 
I am unable to perform my usual activities
Pain/Discomfort
I have no pain or discomfort 
I have some pain or discomfort 
I have extreme pain or discomfort
Anxiety/Depression
I am not anxious or depressed 
I am moderately anxious or depressed 
I am extremely anxious or depressed
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To help people say how good or bad a health state is, we have
drawn a scale (rather like a thermometer) on which the best state
you can imagine is marked 100 and the worst state you can Best
imagine is marked 0. imaginable
health state
We would like you to indicate on this scale how good or bad your jqq
own health is today, in your opinion. Please do this by drawing a 
line from the box below to whichever point on the scale indicates 
how good or bad your health state is today.
Your own 
health state
S'S TO
6<‘0
3" TO
2~* »0
0
Worst 
imaginable 
health state
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Appendix 4: SF-36
Y o u r  H ea l t h  and  W e l l -B ein g
This survey asks for your views about your health. This information will help 
keep track of how you feel and how well you are able to do your usual 
activities.
1. In general, would you say your health is:
Excellent
L J V W
Very Good Good Fair Poor
2. Compared to one week ago, how would you rate your health in general now?
Much better now than one week ago
Somewhat better now than one week ago
About the same as one week ago
Somewhat worse now than one week ago
Much worse now than one week ago
3. The following items are about activities you might do during a typical day. 
Does your health now limit you in these activities? If  so, how much?
Yes, limited a 
lot
Yes limited a 
little
No, not limited at 
all
Vigorous activities, such as running, lifting heaw  
objects, participating in strenuous sports
Moderate activities, such as moving a table, pushing a 
vacuum cleaner, bowling or playing golf
Lifting or carrying groceries
Climbing several flights of stairs
Climbing one flight of stairs
Bending, kneeling or stooping
Walking more than a mile
Walking half a mile
Walking 100 vards
Bathing or dressing yourself
4. During the past week, have you had any of the following problems with your work or other 
regular daily activities as a result of your physical health? _________________ ________
Yes No
Cut down on the amount of time vou spent on work or other 
activities
Accomplished less than you would like
Were limited in the kind or work or other activities
Had difficultv performing the work or other activities (for 
example, it took extra effort)
5. During the past week, have you had any of the following problems with your work or other 
regular daily activities as a result of any emotional problems (such as feeling depressed or 
anxious)?___________________________________________________ _________________ ________
Yes No
Cut down on the amount of time vou spent on work or other 
activities
Accomnlished less than you would like
Did work or other activities less carefullv than usual
6. During the past week, to what extent has your physical health or emotional problems 
interfered
with your normal social activities with family, friends, neighbours, or groups?
Not at all Slightly Moderately Quite a bit Extremely
7. How much bodily pain have you had during the past week?
None Very Mild Mild Moderate Severe Very Severe
8. During the past week, how much did pain interfere with your normal work (including 
both work outside the home and housework)?_________________________________________
Not at all A little Bit Moderately Quite a bit Extremely
9. These questions are about how you feel and how things have been with you during the past 
week.
For each question, please give the one answer that comes closest to the way you have been 
feeling.
How much of the time during the past week.......
All of 
the 
time
Most o f 
the time
A good 
bit o f 
the time
Some of 
the time
A little 
of the 
time
None of 
the time
Did you feel full of life?
Have you been a very nervous person?
Have you felt so down in the dumps that nothing 
could cheer you up?
Have you felt calm and peaceful?
Did you have a lot of energy?
Have you felt downhearted and low?
Did you feel worn out?
Have you been a happy person?
Did you feel tired?
10. During the past week, how much of the time has your physical health or emotional
problemsjnterfered with your social activities (like visiting frienc s, re atives etc)?
All of the time Most of the 
time
Some of the 
time
A little of 
the time
None of the 
time
11. How TRUE or FALSE is each of the following statements for you?
Definitely true Mostly true Don’t
know
Mostly false Definitely false
I seem to get ill a little more easily 
than other people
I am as healthy as anybody I know
I expect my health to get worse
My health is excellent
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Appendix 5: Patient Diary
Consisted of:
1. Front sheet (printed on MATTU headed paper) (appendix 5i)
2. Patient information sheet (appendix 1)
3. Copy of consent form (appendix 5ii)
4. Notes on filling in the diary (appendix 5iii)
5. SF-36 (appendix 4) and EQ-5D (appendix 3) pre-op forms
6. Arranged chronologically
EQ-5D on days 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 35, 42 
SF-36 on days 6, 14, 28, 42
“After discharge” forms on days 8,16, 22,28,42 (appendix 5iv)
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Appendix 5i
Costs and Outcomes of Open and Laparoscopic 
Colorectal Surgery Study
PATIENT DIARY CONFIDENTIAL
Contact for further information:
Henry Dowson
Laparoscopic Fellow
Minimal Access Therapy Training Unit
Postgraduate Medical School
Manor Park
Guildford
Surrey
GU2 7WG
Tel: 01483 688620
Email: hdowson@doctors.org.uk
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Appendix 5ii
Centre: RSCH/ MATTU
CONSENT FORM
Title of Project: A Comparison of the Costs and Outcomes of Laparoscopic and 
Open Colorectal Surgery
Name of Researcher: Henry Dowson
Please initial each box
1. I confirm that I have read and understand the information sheet dated 
16/01/06 (version 2) for the above study and have had the opportunity to 
ask questions.
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical care 
or legal rights being affected.
3. I understand that sections of any of my medical notes may be looked at
by responsible individuals from the research team or from regulatory authorities 
where it is relevant to my taking part in research. I give permission for these 
individuals to have access to my records.
4. I agree to take part in the above study.
Name of Patient Date Signature
Name of Person taking consent Date Signature
(if different from researcher)
Researcher Date Signature
1 for patient; 1 for researcher; 1 to be kept with hospital notes
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Appendix 5iii
NOTES
• Please keep this diary safe -  it is the only copy.
• Please return to Henry Dowson, in the pre-paid envelope provided.
• Although it is quite a lot of paper, the questionnaire you need to fill in on alternate 
days should take less than 5 minutes.
• The day at the top of the page refers to the number of days after your operation: Day 
0 = day of the operation
Day 1 = first day after the operation 
Day 2 = the second day after the operation 
Day 14 = fourteenth day after the operation.
• When filling in the questionnaire, don’t look back to see what you wrote the previous 
time.
• Don’t worry if  you don’t understand a question -  leave it blank, or put a note in the 
diary. All comments and feedback would be greatly appreciated.
• Please try and fill in the questionnaires completely, if  at all possible.
• If you find it difficult to fill in or have any problems, please don’t hesitate to contact 
Henry Dowson, or discuss the issue with the specialist nurses if you are in contact 
with them.
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The following questions are about vou, your work, and social 
activities
Your Details: 
Name:
Date of Birth:
1. Are you a smoker? YES / NO
2. Which of the following best describes your usual activity:
In fulltime employment 
Part-time employment 
Self-employed 
Retired 
Housework 
Seeking work 
Other (please specify)
3. If you are in employment, what is your job?
4. Which of the following best describes your living arrangements?
Live alone
Live with spouse/ partner/ companion
5. Do you have dependents at home with you (children under 16 or dependent adults)?
Yes / No
6. Do you have any help at home with your household chores (such as shopping,
cooking, cleaning)?
Yes/No
7. Do you have any help at home with your personal care (such as washing or dressing)?
Yes/ No
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Appendix 5iv
Date: Day 8 post-op
Now that one week has passed since your operation, we would like vou to 
tell us about your recovery.
1) How m any days after your operation were you discharged from hospital?
Where did you go (please circle):
Own home / stay with friends or relatives /
To a convalescent or nursing home / other (please specify)
2) Please tell us o f  any medical problems or complications related to your surgery 
since you left hospital (for example problems with your wound, nausea and vomiting, 
etc).
3) Have you seen your GP since you left hospital? YES/ NO
If yes, how many times?
What was the reason?
Where did you see the GP? At the surgery / GP visited your home
4) Have you seen the District nurse or practice nurse since you left hospital?
If yes, how many times?
What was the reason?
5) Have you had contact w ith Angela Bates, the Colorectal Nurse Specialist? 
If so: Did she contact you, or did you phone her?
How many times did you talk to her?
6) Have you seen any other health professionals since you left hospital (eg stoma 
nurse)?
If so, whom, and how many times?
7) Since you were discharged from the hospital, have you received any more help at 
home than you normally received with personal care (such as washing) or household 
chores (such as shopping, cooking, or cleaning)?
YES /N O
If yes, who has helped you:
Friend/ relative, for how many hours?
Helper that you paid, for how many hours?
Helper provided by social services, for how many hours?
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8) Has a relative or friend taken time o ff their work to specifically look after you?
Y E S /N O
If yes, how much time (in days) have they taken off?
9) Have you returned to your normal activities or your work ( if  applicable)?
Not at all /  Partly / Fully
How m any days after your surgery did you fully resume your usual activities?
10) In your own words how  are you feeling as you recover from the operation?
(Please tell us about the impact your surgery has had on different aspects o f your life, 
for example your ability to do things around the house, work, and socialise. You m ay 
also wish to describe the different types o f support you have needed from friends and 
family)
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Appendix 5v -  Example of patient notes
8) Has a relativp-en friend taken time off their work to specifically look after you?
Y E S /( fe y
If yes, how much time (in days) have they taken off?
9) Have you returned to yopjsnormal activities or your work (if applicable)?
Not at all/ Partly/FuIM
How many days aner^our surgery did you fully resume your usual activities?
10) In your own words how are you feeling as you recover from the operation?
(Please tell us about the impact your surgery has had on different aspects of your life, for 
example your ability to do things around the house, work, and socialise. You may also 
wish to describe the differen t types of support you have needed from friends and 
family)
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Appendix 6: Adhesion Scoring Sheet
Assessment of Adhesions Study
A ll patients who have had a previous colorectal resection (either laparoscopic or open) are 
eligible.
Any  patient who has had a previous colorectal resection and is undergoing a second planned 
procedure is eligible (eg laparoscopy prior to liver resection, closure of ileostomy).
Please video the laparoscopy, and complete the adhesion score.
Patient Demographics
Patient name: (or patient label)
DOB:
Hospital number:
Current procedure
Date of laparoscopy:
Consultant:
Type of procedure:
Previous colorectal procedure
Open or Laparoscopic:
Date:
Diagnosis:
If cancer: What was Dukes stage:
Adjuvant treatment given, & if so, what was it:
Time (in months) between original procedure & laparoscopy: 
Has the patient had other previous abdominal surgery?
Either leave this sheet in theatre (in plastic folder) or return to:
Henry Dowson, MATTU, Postgraduate Medical School, Daphne Jackson Road, Manor Park, 
Guildford, GU2 7XX. (07974247540)
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SCORING SHEET
Has a video been performed? Yes / No 
5 aspects need to be assessed:
1. Sites o f  adhesions: Main incision; other incisions; anastanosis (eg RIF for Rt 
hemi); other (eg pelvis, liver).
2. The number o f  separate sites affected by adhesions
3. W hether there was small bowel involved within the adhesion
4. Severity of adhesions (score the worst area)
5. Extent of adhesions (score the worst area)
Please state the sites of adhesions & whether under a previous incision (eg 
midline, transverse, pfannensteil, stoma site, etc), area of previous surgery or other site.
Site 1: Site 4:
Site 2: Other:
Site 3:
Please grade the severity & extent o f  adhesions fo r  the main site/ area affected:
Site 1 (Site 2) (Other) Overall
Grade Severity of Adhesions
0 No adhesions
I Filmy, avascular adhesions, 
separate easily with blunt 
dissection
II Firm limited vascular adhesions, sep 
with aggressive blunt dissection
III Dense vascular adhesions, 
require sharp dissection
Grade Extent of Adhesions
0
I Mild: up to 25% of total area 
& length of incision
II Moderate: 26-50% of total area & le 
of incision
III Severe: >50% of total area 
& length of incision
Number of sites of separate adhesions
Small bowel involved (Y/N)
(Overall score = worst severity score (1-3) + overall (:'or peritoneal cavity) extent of
adhesions (1-3) + number of sites (1-3) +involvement of small bowel (0-1)
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Appendix 7
PATIENT INFORMATION SHEET Version 3 28/09/06
The Incidence of Adhesions Following Laparoscopic and Open Colorectal Surgery
Thank you for reading this information sheet.
You are being invited to take part in a research study. Before you decide it is 
important for you to understand why the research is being done and what it will involve. 
Please take time to read the following information carefully, discuss it with others if you 
wish, and to decide whether or not you wish to take part. Ask us if  there is anything that is 
not clear or if you would like more information.
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If you decide 
to take part you are still free to withdraw at any time and without giving a reason. A decision 
to withdraw at any time, or a decision not to take part, will not affect the standard of care you 
receive.
What is the purpose of the study?
To evaluate:
The incidence of adhesions (scarring) in the abdominal cavity following two different 
techniques of bowel surgery.
Background
Patients needing an operation for a bowel problem have traditionally had an open 
operation with an incision on the abdomen, and this is the type of operation that is currently 
performed in the majority of cases in the United Kingdom today (over 95%). Laparoscopic 
(or keyhole) surgery has been introduced into bowel surgery, but is currently not widely 
performed.
One of the effects of any surgery on the abdominal cavity is that it can cause scarring 
(or adhesions) within the abdomen. Adhesions can sometimes cause problems such as bowel 
obstruction, abdominal pain, infertility in women of child-bearing age, and can make further 
surgery much more difficult.
It appears that there are fewer adhesions formed following laparoscopic surgery 
compared to open surgery, but this hasn’t previously been investigated. We are performing a 
study comparing the extent and severity of adhesions in patients who have had previous open 
and laparoscopic bowel surgery.
Why have I been chosen?
All patients who have previously had an operation for a colorectal (bowel) condition, 
and are going to undergo a further abdominal operation, are being invited to participate. We 
aim to include 80 patients within the study.
What will happen to me if I take part?
This study is an Observational study. Entering into the study will not influence the 
type of treatment you receive.
If you have had previous bowel surgery, and are going to have another abdominal 
operation (such as a liver operation, closure of a stoma, or another operation on the bowel),
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we would like to assess the extent of the adhesions within your abdominal cavity from your 
previous surgery.
We would do this by introducing a small telescope (called a laparoscope) into the 
abdomen, and using this to examine the abdominal cavity. This additional part of the 
operation would take less than 5 minutes. The surgeon performing this operation would then 
grade the adhesions (if there are any), and would also video the laparoscopy so that the 
grading can be verified by another surgeon. You would not be identifiable from this video, as 
it is only show the inside of your abdominal cavity.
For many of the operations, you will already being having a laparoscopy as part of the 
procedure. Where this is not the case, we will perform the laparoscopy through the incision 
used for this second operation. You will therefore have no new scars on your tummy, and 
there are no risks to you having this small additional laparoscopy performed.
What do I have to do?
There is nothing that you will need to do. All we will ask you to do is sign a consent 
form for the study.
Do I have to take part?
It is up to you to decide whether or not to take part. If you do decide to take part you 
are still free to withdraw at any time and without giving a reason. A decision to withdraw at 
any time or a decison not to take part, will not affect the standard of care you receive.
What is the procedure being tested?
We are merely observing the incidence of scarring within your abdominal cavity following 
previous operations.
What are the possible disadvantages and risks of taking part?
There are no risks or disadvantages.
What are the possible benefits of taking part?
There are no benefits to you as an individual. However your participation in the study 
will help to further our understanding of surgical outcomes.
Will my taking part in this study be kept confidential?
All information which is collected about you during the course of the research will be 
kept strictly confidential. Any information about you which leaves the hospital will have 
your name and address removed so that you cannot be recognised from it.
We plan to inform your General Practitioner of your involvement in the study, and if 
you have questions or concerns regarding the trial, you can discuss them with your doctor. 
However, we do require your permission to inform your GP. Please let us know if this is 
acceptable.
Who has reviewed the study?
The study has been reviewed by Surrey Research Ethics committee which has raised 
no objection to it.
What if something goes wrong?
It is extremely unlikey that anything would go wrong. However, the study is 
sponsored by the University of Surrey, who provide indemnity insurance if there were any 
problems. This insurance provides two types of cover: liability and no-fault. The liability 
policies cover the University against liability claims. The no-fault cover is intended to provide 
compensation to subjects, in the event of their suffering an injury which is attributable to their 
involvement in the trial. The policies are with Zurich Municipal.
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Regardless of this, if you wish to complain or have any concerns about any aspect of 
the way you have been approached or treated during the course of this study the normal 
National Health Service complaints mechanisms will be available to you.
What will happen to the results of the research study?
The results will be presented and published in medical meetings and journals. You 
will not be identified in any report. If you are interested in knowing the results of the study, 
we will send you a summary of the main conclusions, once it is completed. Please let us know 
if you would like to receive this.
Contact for Further Information
Henry Dowson BSc MBBS MRCS
Laparoscopic Fellow, Minimal Access Therapy Training Unit, Postgraduate Medical School,
University of Surrey, Manor Park, Guildford, GU2 7WG
hdowson@doctors.org.uk
Telephone: 01483 688620 
Email: hdowson@doctors.org.uk
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Appendix 8: Operation equipment costs
Drapes: High Fluid 
Minor Lithotomy 
Mayo
Touchscreen
drape
Other
£12.67
£9.37
£4.21
£8.30
Swabs 4x4
6x4
18x18
Pledgets
Tonsils
£0.74
£1.77
£4.21
£1.30
£1.00
Blades: Any size £0.57 Sutures/ Vicryl J £2.57 3/0 £2.16
Ties
Ties
2/0
2/0
£1.94
£0.48
Rapide
0
£2.84
£2.24
Dressings Opsite Small £0.15 Nylon 1 £2.03 0 £2.51
Med £0.67 Prolene 0 £2.12 Double £3.01
Large £1.80 Maxon 3/0 £1.93 1PDS £4.31
Other Others
Stoma £1.94
Time 
of op:
Anaes start time:
Surgery start:
Surgery end:
Anaes:
(vol)
Epidural/ Spinal £8.81 
Central line 
Art line
Type 
of op:
Open
Laparoscopic
Converted
Instrument Trays Other equipment/ instruments Laparoscopic kit
General 
Upper GI 
Laparotomy
£16.3
£18.9
£11.3
Bookwalter £14.7
Extras £11.5
Rockall colorectal £19.6 
Lap Storz tray £8.31
Yohannes £1.98
Heavy grasper £2.74
Purse-string £2.21
applicator
Diath Pencil £4.85
-ermy Short blade £2.14 
Long £3.26
Eisenhammer £2.74
Surgical drains? below
Scope & cable 
Harmonic hand piece 
Harmonic ace
Insufflation tubing 
OR-1 screen drape 
Anti-fog
Instrument pouch
Table
29
£3.44
£15.04
£4.45
£3.00
Disposables Stapling devices etc
Ports Blunt
12mm Trocar & sleeve 
12mm sleeve
5mm Trocar & sleeve 
5mm sleeve
Table
29
CDH Gun 
ATW 45 
?refills (ATB)
TLC 75 
?refills 
Contour stapler 
ER420 
TX 30 
TX 60
See Table 29
Camera drape 
Smoke evacuator 
Wound protector
£4.92
£8.49
£40.00
Suction Yanker + tubing
Lap suction-irrigation
£1.30
£33.0
Skin clips £4.28
Other instruments/ equipment used Length of incision (cm)
Drains Redivac £5.35
Robinson’s £6.46-£6.82
Operation cost proforma, and cost of relevant items. Costs given are the costs incurred for 
each procedure ie the cost of a disposable instrument, or the cost of sterilisation of re-usable 
equipment.
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